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Abstract 
 
The present thesis is concerned with the development and characterization of new diferric 
purple acid phosphatase (PAP) model systems, which include functional groups that are 
meant to act as a second coordination sphere in phosphoester hydrolysis. A short review on 
purple acid phosphatases, including the postulated reaction mechanisms in phosphoester 
hydrolysis, and published PAP model complexes is given in Chapter 2. Furthermore, 
important data regarding published bridged diferric complexes are presented, in order to have 
a basis for interpretation of the analytical data in the results part. 
In Chapter 3, the results on the new model complexes are presented and discussed. At 
first, the cyclam-based ligand L1 and its coordination chemistry are described (Chapter 3.1). 
The most important findings are the following: Ligand L1 predominantly forms a µ-oxo 
bridged diferric complex when reacted with [FeCl4]- in situ. This complex, called K1, can 
readily coordinate phosphate and inactive phosphoesters, also in partly aqueous solution. 
Interestingly, the inactive phosphodiester diphenylphosphate (DPP) coordinates in a 
monodentate mode to one FeIII, whereas the monoesters para-nitrophenylphosphate (pNPP) 
and 1-naphthylphosphate (1-NP) bind in a bridging mode to both FeIII centers. The 
monodentate coordination of DPP is encouraging in terms of the intended reactivity in 
phosphoester hydrolysis, as this coordination mode is believed to be the active one, leading to 
a terminal hydroxide as a possible nucleophile. 
Chapter 3.2 deals with the phenolate-based ligands HL2 and H3L3 and their coordination 
chemistry. These ligands are derivatives of the published HBPMP ligand and incorporate 
amino and amido functional groups as second coordination sphere mimics. Diferric 
complexes, called K2 and K3, are obtained by in situ reaction of the ligands with a ferric salt. 
A spectrophotometric pH titration was performed and revealed the pH dependent species 
distribution and the corresponding pKa values of the complex solutions. K2 has three 
equilibria between pH 4.6 and 11, where the second equilibrium is the deprotonation of the 
second coordination sphere amines. In contrast, K3 has only two equilibria due to the low pKa 
of the amido protons. Regarding the coordination of phosphoesters, K2 shows a similar 
behavior to K1. DPP is coordinated monodentately to one FeIII, whereas pNPP and 1-NP form 
bridging complexes. This is not observed with K3, which shows bridging coordination with 
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both, mono- and diesters, possibly due to the lack of hydrogen bond donors in the second 
coordination sphere.  
The complexes K1, K2 and K3 were tested for hydrolytic activity towards the activated 
phosphoester substrates bis-(2,4-dinitrophenyl)phosphate (BDNPP) and 2,4-dinitrophenyl-
phosphate (DNPP). The results of these experiments are presented in Chapter 3.3. K1 and K2 
are the first examples of PAP model complexes that catalyze the hydrolysis of the 
phophomonoester DNPP. So far, only diester hydrolysis with PAP model complexes has been 
reported in literature, while the inactive bridging coordination mode is observed for 
phosphomonoesters. We draw the fact, that K1 and K2 can hydrolyze monoesters, back to the 
hydrogen bonding interaction of the coordinated substrates to the remote ligand parts. A 
closer analysis of the reactivity of K1 towards DNPP and BDNPP, based on DFT calculations, 
shows that 1) BDNPP is stabilized by the interaction with the protonated cyclam in the 
monodentate coordination mode, 2) the hydrolysis of DNPP has a significantly lower  
activation barrier with the hydrogen bonding interactions than without and 3) this barrier is 
lower than the energy barrier to a bridging coordination mode. As a conclusion, a mechanism 
is proposed, where the substrate binds in a monodentate coordination mode and is 
subsequently attacked by a terminal hydroxide. This active species is in equilibrium with the 
inactive bridging complex. In the case of the diester BDNPP, the equilibrium is shifted to the 
active species, while the monoester DNPP is more stable in the bridging coordination mode. 
The hydrolysis product remains bound to K1 and inhibits catalysis. 
  
  V
Kurzfassung 
 
Die vorliegende Arbeit beschäftigt sich mit der Entwicklung und Charakterisierung neuer 
zweikerniger FeIII Komplexe als Modelle für das Enzym Purple Acid Phosphatase (PAP), die 
zusätzliche funktionelle Gruppen tragen, welche als zweite Koordinatiossphäre die Hydrolyse 
von Phosphatestern beschleunigen sollen. Eine kurze Übersicht über PAPs und die 
postulierten Reaktionsmechanismen in der Phosphatesterhydrolyse sowie über 
literaturbekannte PAP Modellsysteme wird in Kapitel 2 gegeben. Zusätzlich werden die 
Eckdaten von verbrückten zweikernigen FeIII Komplexen im Hinblick auf die Interpretation 
der analytischen Daten im Ergebnisteil beschrieben. 
In Kapitel 3 werden die Ergebnisse der Arbeit präsentiert und diskutiert. Zu Anfang wird 
der Cyclam-basierte Ligand L1 und seine Koordinationchemie behandelt (Kapitel 3.1). Die 
wichtigsten Erkenntnisse sind: Der Ligand L1 bildet bevorzugt einen µ-oxo-verbrückten 
zweikernigen FeIII Komplex, genannt K1, wenn er mit [FeCl4]- in situ umgesetzt wird. 
Phosphat und inaktive Phosphatester koordinieren bereitwillig an diesen Komplex. 
Interessanterweise werde unterschiedliche Koordinationsmodi des inaktiven Phosphatdiesters 
Diphenylphosphat (DPP) und der Monoester para-Nitrophenylphosphat (pNPP) und 1-
Naphthylphosphat (1-NP) beobachtet: DPP koordiniert als monodentater Ligand an nur ein 
FeIII, während die Monoester als verbrückende Liganden an beide FeIII Zentren binden. Dieses 
Ergebnis ist ermutigend im Hinblick auf die beabsichtigte Aktivität in der 
Phosphatesterhydrolyse, da der monodentate Koordinationsmodus als die aktive Form 
angesehen wird und von einem terminalen Hydroxid als mögliches Nukleophil angegriffen 
wird. 
Kpitel 3.2 beschäftigt sich mit den Phenolat-basierten Liganden HL2 und H3L3 und deren 
Koordinationschemie. Diese Liganden sind Derivate des literaturbekannten HBPMP Liganden 
und tragen zusätzliche Amino- und Amidogruppen als zweite Koordinationssphäre. Die K2 
und K3 genannten zweikernigen FeIII Komplexe werden durch in situ Reaktion der Liganden 
mit einem FeIII Salz erhalten. Spektrophotometrische pH Titrationen der beiden Komplexe 
liefern die pH-abhängige Verteilung der verschiedenen Spezies und die dazugehörigen pKs 
Werte. K2 liegt zwischen pH 4.6 und 11 in drei Gleichgewichten vor, wobei das mittlere 
Gleichgewicht der Deprotonierung der zusätzlichen Aminogruppen entspricht. Im Gegensatz 
dazu findet man bei K3 nur zwei Gleichgewichte, da die zusätzlichen Amide bereits bei 
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niedrigen pH Werten deprotoniert werden. In Bezug auf die Koordination von Phosphatestern 
verhält sich K2 ähnlich wie K1: DPP bindet monodentat an ein FeIII, wohingegen pNPP und 1-
NP als verbrückende Liganden an beide FeIII Zentren koordinieren. Dieses Verhalten wird bei 
K3 nicht beobachtet; stattdessen binden sowohl Mono- als auch Diester als verbrückende 
Liganden. Dies ist vermutlich auf die fehlenden Wasserstoffbrücken-Donoren in der zweiten 
Koordinatiossphäre zurückzuführen. 
Die Komplexe K1, K2 und K3 wurden in der Hydrolyse der aktivierten Phosphatester Bis-
(2,4-dinitrophenyl)phosphat (BDNPP) und 2,4-Dinitrophenylphsophat (DNPP) untersucht. 
Die Resultate dieser Experimente werden in Kapitel 3.3 dargestellt. K1 und K2 sind die ersten 
PAP Modellkomplexe, die die Hydrolyse des Monoesters DNPP katalysieren. Bisher wurde 
in publizierten Arbeiten mit Modellkomplexen nur Diesterhydrolyse gefunden. Bei 
Phosphatmonoestern wurde nur die inaktive verbrückende Koordinationsform beobachtet. 
Wir führen die Fähigkeit von K1 und K2, Phosphomonoester zu hydrolysieren, auf den 
Einfluss der zweiten Koordinationssphäre durch Wasserstoffbrückenbindungen zu den 
koordinierten Substraten zurück. Eine nähere Betrachtung der Reaktivität von K1 mit DNPP 
und BDNPP mit Hilfe von DFT Methoden führte zu folgenden Ergebnissen: 1) BDNPP wird 
durch die Wasserstoffbrückenbindungen zum protonierten Cyclam in der monodentaten 
Koordinationsgeometrie stabilisiert, 2) die Hydrolyse von DNPP hat mit den 
Wechselwirkungen zwischen Substrat und zweiter Koordinatiossphäre eine deutlich 
niedrigere Aktivierungsbarriere als ohne und 3) diese Barriere ist kleiner als die der Reaktion 
zum verbrückenden Substrat. Zusammenfassend wird ein Mechanismus postuliert, bei dem 
das Substrat monodentat an ein FeIII gebunden ist und von einem terminalen Hydroxid 
nukleophil angegriffen wird. In Konkurrenz dazu steht das Gleichgewicht zum inaktiven 
verbrückenden Koordinationsmodus. Für den Diester BDNPP liegt dieses Gleichgewicht auf 
der Seite der aktiven, monodentat gebundenen Spezies, während der Monoester DNPP in der 
verbrückenden Koordination stabiler ist. Nach der Hydrolyse verbleibt das Produkt 
koordiniert am Komplex und verhindert eine katalytische Reaktion. 
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  Chapter 1: Introduction and Objective 3
 
“As I look at a living organism, I see reminders of many questions that need to be answered. 
[…] How do I feel things? How are nerves build and how do they function? […] How do the 
enzymes in my body break up the food that I eat, burn it to keep me warm and permit me to do 
work, and build new tissues for me from the food fragments?” 
(Prof. Linus Pauling, Nature 1948, 161, 707-709.) 
 
A huge diversity of living organisms and, therein, even more complex metabolic processes 
confront mankind with a multitude of problems. Malfunctions of these processes are very 
likely and numerous and usually lead to diseases, which are, of course, not desirable. Whereas 
in past times and also nowadays, treatment of many diseases was based on mere trial and error 
approaches, a deep understanding of enzymatic and metabolic processes can lead to a well-
directed development of therapeutic agents. One example is osteoporosis, a bone-degenerative 
disease that is associated with elevated levels of a certain enzyme, purple acid phosphatase. In 
the present thesis, this enzyme is the main research target. A detailed knowledge, of how the 
enzyme catalyzes the hydrolysis of phosphoesters and which factors influence its activity, 
would help to find new approaches for drug design. On the other hand, the question about 
modes of action itself is highly interesting. Identifying the methods for high turnover rates is a 
very attractive target for chemical synthesis and industrial applications.  
Different approaches are used to gain insight into enzymatic reactions. Whereas 
crystallization of enzymes in their resting state or with additional substrate mimics, i.e. 
inhibitors, gives rather static information about general structures and geometric features, 
spectroscopy and kinetic analysis of reactions are more useful in terms of reactivity and 
mechanisms. Another interesting tool is site-directed mutagenesis, where individual amino 
acid residues are selectively replaced. By this, the influence of certain positions in the active 
site can be studied in detail. A more chemical approach is the design and investigation of 
small molecules mimicking enzymes. These simplified systems can fulfill different roles. 
Structural models aim at reproducing the geometric features of the enzyme´s active site, 
usually as a first step to identify crucial aspects. The spectroscopic data of an enzyme provide 
more information about reactivity and structures in solution. Therefore, spectroscopic models 
target on reflecting these data as accurately as possible. The final goal is the development of 
functional models, showing the same reactivity as the natural prototype. It is not necessary 
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that the mimetic has the same structural setup as the enzyme to perform well. A nice example 
is the superoxide dismutase mimetic M40403, a mononuclear seven-coordinated MnII 
complex (different structure than enzyme) that has equivalent or superior catalytic activity to 
that of the native enzyme. Nevertheless, the direct copy of a feature found in enzymes can 
lead to the desired result of high activity and selectivity.  
 
The present thesis is concerned with the development and investigation of a new type of 
diferric complexes mimicking purple acid phosphatases, which are designed to enable 
hydrogen bonding interactions between bound substrates and the surrounding second 
coordination sphere. A main purpose is to build functional PAP mimics, i.e. catalysts that 
have the ability of hydrolyzing phosphomonoesters. So far, only diesters could be hydrolyzed 
by PAP mimetics, whereas the actual function of PAP is the hydrolysis of monoesters.  
Based on recent results, it is proposed that a monodentate coordination of phosphoester 
substrates is highly desirable in terms of activity and efficiency of the catalyst. In the natural 
PAP systems, an extended hydrogen bonding network holds the substrates in place and 
optimizes the geometric arrangement of reactants. The aim of the present work was therefore, 
to mimic this kind of interaction in small diferric complexes, which shall result in an active 
coordination mode for both, phosphomono- and diesters. The synthesized complexes are 
characterized spectroscopically, and their reactivity towards hydrolysis of the activated 
phosphoesters (2,4-dinitrophenyl)phosphate (DNPP) and bis-(2,4-dinitrophenyl)phosphate 
(BDNPP) are investigated. DFT calculations on structures, properties and reaction pathways 
help to understand the observations. 
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Chapter 2: 
State of Knowledge 
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2.1.   Enzymatic Modes of Action 
 
Since many years, enzymes are known to catalyze biological reactions, but the mechanistic 
principles behind the observed high activity are still up to debate. First attempts to explain this 
observation were made by Emil Fischer in 1894. He found that yeast reacts with 
stereoisomeric hexoses in different ways and concluded that the enzymes present in yeast and 
their substrates, the different sugars, must fit perfectly to each other to result in high reactivity 
(lock and key principle, see Figure 2.1).[1] Similar observations were summarized by Pauling 
in 1948, concerning the interactions in serological reactions and crystallization processes.[2] 
 
Figure 2.1: Schematic representation of the lock and key principle in an enzymatic activity. 
 
This principle was adapted to the knowledge on chemical reactions in the following 
years, leading to the hypothesis that enzymes are not complementary to the reactants but to 
the activated complex (i.e. the transition state) that is formed during reaction (Figure 2.2).[2, 3] 
Stabilization of these transition states results in lowering of the activation energy of a reaction 
and therefore in a faster conversion of the substrate to products. 
 
Figure 2.2: Schematic energy profiles of catalyzed (dashed line) vs. uncatalyzed reactions (solid line). 
enzyme
S 1
S2
enzyme
S 1 S 2
product
enzyme
product
enzyme
EA, cat
EA, uncat
substrate products
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The reverse phenomenon, i.e. lowering the activation energy by destabilizing the 
substrates, is called “entatic state”[4] (from entasis, greek = tension) which means “a state of 
an atom or group which, due to its binding in a protein, has its geometric or electronic 
condition adapted for function”.[5] By this, the substrates are forced into a structure that is 
already close to the structure of the transition state. Nice examples are redox reactions 
catalyzed by heme iron proteins, where the bonds between FeIII and the ligand are longer than 
expected. This makes it easier for the enzyme to change the redox state of the metal and 
therefore catalyze redox processes.[6, 7] Hydrolytic reactions, where zinc or cobalt in the 
enzyme´s active site facilitate ligand substitution by accepting distorted geometries, are 
another example.[8, 9]  
These suggestions are the usually accepted modes of action for enzymes nowadays. They 
culminated in the recently reported design of artificial enzymes, so called “theozymes”, where 
functional groups have been arranged in a way that gives optimum interactions with predicted 
transition states to yield the best stabilization, i.e. the largest lowering in energy.[10, 11] 
Nevertheless, one has to pay attention to the fact that optimum transition state stabilization 
may lead to stabilization of the reactant structure as well. This would not necessarily result in 
lowering of activation barriers, but the opposite effect might be observed. And indeed, a 
recently published comparison of oxo-anion hole structures in enzymes and small molecules 
arrives at the following conclusion: The hydrogen bonding interactions between the enzyme´s 
H-bond donors and carbonyl groups observed in there are not optimized for the expected 
transition states. Evolution rather caused an arrangement, which results in lower activation 
energies.[12] 
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2.2.   Purple Acid Phosphatases 
 
Purple Acid Phosphatases (PAPs) belong to the enzyme family of binuclear 
metallohydrolases, which catalyze the hydrolysis of amides and esters of carboxylic and 
phosphoric acids. They contain dinuclear metal ion centers in their active sites, which can be 
homo- or heterovalent. Some examples, together with their metal composition and, if known, 
their metabolic roles are summarized in Table 2.1.[13] 
 
Table 2.1: Examples of binuclear metallohydrolases.[13] 
enzyme metal center metabolic roles 
purple acid phosphatases Fe(III)-Fe(II) 
Fe(III)-Zn(II) 
Fe(III)-Mn(II) 
bone resorption, iron transport, ROS generation; 
mobilization of inorganic phosphate 
ser/thr phosphatases[a] Fe(II)-Fe(II) 
Fe(II)-Zn(II) 
Mn(II)-Mn(II) 
glycogen metabolism, muscle contraction,  
signal transduction, neuronal activities, cell  
cycle progression, RNA splicing 
ureases Ni(II)-Ni(II) hydrolysis of urea 
leucine aminopeptidases Zn(II)-Zn(II) protein degradation, amino acid biosynthesis 
3´-5´exonucleases Mn(II)-Mn(II) correction of errors during DNA replication 
phosphotriesterase[a] Zn(II)-Zn(II) 
Cd(II)-Cd(II) 
Zn(II)-Cd(II) 
Co(II)-Co(II) 
removal of organophosphates as response to 
toxic stress 
[a] in vivo metal composition not established 
 
As indicated in Table 2.1, PAPs exhibit diverse metabolic roles that also depend on the 
organism. An important finding was that osteoporosis patients or people with bone metastases 
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have elevated PAP concentrations.[14] Transgenic mice, in which the enzymes are over-
expressed, develop a mild form of osteoporosis with increased bone resorption.[15] Knock-out 
mice, which completely lack the enzyme, exhibit the opposite phenotype (osteopetrosis).[16] 
Nowadays, PAP has become the most commonly used histochemical marker for 
osteoporosis.[17] Its obvious involvement in this disease makes it a very attractive target for 
the development of therapeutics.[18] Other functions of mammalian PAP include iron transport 
during pregnancy[19] and the generation of reactive oxygen species through Fenton-type 
chemistry.[20-22]  
Plant PAP is presumably responsible for mobilizing organic phosphate esters.[23] In 
tomatoes, high PAP expression has been observed when phosphate starvation occurs.[24] A 
second role is an alkaline peroxidase type function of some forms of plant PAP. Reactive 
oxygen species (ROS) are produced by PAPs with peroxidase activity as a response to 
pathogen attack or biotic and abiotic stress.[24] The main problem of studying plant PAP 
activity is that a multitude of genes encode different isoforms of this enzyme.[25]  
Purple acid phosphatases are the only enzymes among the group of hydrolases, where a 
heterovalent metal composition is crucial for activity. They always contain FeIII and a second, 
divalent metal ion, depending on the source.[13, 26] Mammalian PAP, for example, uses FeII,[27-
29] whereas plant PAP contains ZnII or MnII.[30-33] This is not the only difference: Mammalian 
PAP is a rather small monomeric enzyme with ≈ 38 kDa,[27-29] while most plant PAPs are 
homodimeric proteins with two subunits of ≈ 55 kDa each, connected via disulfide bridges.[30-
32] Also, heterodimeric forms of plant PAP have been reported.[24] Fungal PAP is supposed to 
exist in a monomeric form with a molecular weight of ≈ 85 kDa and its metal ion composition 
is not yet known.[34, 35] No bacterial PAP has been characterized so far, but there is evidence 
that PAPs only occur in a limited number of microorganisms.[36] Nevertheless, independent of 
the type, the active site amino acids in all PAPs are conserved, as shown in Figure 2.3.[37] The 
two metal ions are bridged by an aspartate and surrounded by six more amino acids that form 
two sites of different hardness. As one would expect, FeIII is bound to the hard site, the 
divalent metal ion M to the soft one. Typical metal-metal distances observed in crystal 
structures are in the range of 3.1 to 3.3 Å for FeIII-ZnII in red kidney bean PAP,[13] 3.3 Å for 
FeIII-MnII in sweet potato PAP[13] and 3.1 to 3.5 Å for mammalian PAP.[13] These are in good 
agreement with the values obtained from EXAFS studies.[38, 39] The proposed bridging and 
terminal aqua, hydroxo and oxo ligands, which indicate how the resting state of the enzyme 
might look like, are supported by various spectroscopic studies (CD/MCD, CW and pulsed 
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EPR, Mössbauer, UV/vis)[40-43] as well as X-ray crystallography.[44, 45] Depending on the 
metal ion composition and pH value, different bridging units are observed: The FeIIIFeII core 
in mammalian PAP is only weakly coupled at pH 4.9, according to EPR and magnetization 
measurements. Most probably, a µ-hydroxo bridge is present in this case. The EPR spectrum 
shows a broad anisotropic signal with effective g values < 2.0, which has been assigned to the 
S = ½ state of the antiferromagnetically coupled FeIIIFeII pair.[40] In contrast, FeIIIMnII centers 
from sweet potato PAP are strongly coupled at this pH. This is consistent with a µ-oxo 
bridge.[33] 
 
Figure 2.3: Schematic representation of the active site of PAPs at physiological pH; MII = FeII, ZnII, MnII.[44, 45] 
 
Acid dissociation constants determined by spectrophotometric titrations have been 
assigned to aqua ligands coordinated to the metal ions. Water coordinated to the FeIII site has 
pKa values between 3.8 and 4.8,[41, 43] whereas ZnII-bound aqua ligands give rise to pKas 
around 9.5.[45] The additional protonated histidine residues shown in Figure 2.3 represent the 
second coordination sphere of the enzyme and together with the asparagine amido group are 
able to build up an extensive hydrogen bonding network.[46, 47]  
The term “purple acid phosphatase” originates from the acidic to neutral pH optimum for 
PAP catalyzed reactions[17, 48, 49] and a tyrosine-to-FeIII CT, which is responsible for the purple 
colour (λmax = 510 – 560 nm; ε = 3000 – 4000 M-1cm-1) of the enzyme.[50-52] In the case of 
mammalian PAP, the ferrous ion can be reversibly oxidized to a ferric ion, resulting in an 
inactive enzyme.[53, 54] This process is accompanied by a change in colour from pink (λmax ≈ 
515 nm) to purple (λmax ≈ 560 nm).[50, 52] It is proposed that redox switching from active to 
inactive states is an in vivo regulation of PAP activity,[53] facilitated by low redox potentials 
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for the FeIIIFeII / FeIIIFeIII couple (E1/2 = 306 mV vs. NHE, i.e 92 mV vs. SCE).[53, 54] The plant 
PAP´s FeIIIZnII center is missing any redox activity.[13]  
PAPs catalyze, among others, the hydrolysis of phosphomonoesters.[13, 26] 
Phosphodiesters were generally found to be unaffected. Only small diester substrates, like the 
methyl derivative of pNPP, which are biologically irrelevant, are hydrolyzed by PAPs.[55] 
Different reaction mechanisms have been proposed so far and there is an ongoing debate 
about the various suggestions.[13, 37, 55-57] The most important questions to solve concern the 
mode of substrate coordination (monodentate vs. bridging), the nature of the attacking 
nucleophile (µ-hydroxide vs. terminal hydroxide or water/hydroxide bound in the second 
coordination sphere) and the reaction type (concerted vs. stepwise). The possible pathways 
are summarized in Scheme 2.1.[56] 
 
Scheme 2.1: Possible pathways for PAP catalyzed phosphoester hydrolysis; MII = FeII, ZnII, MnII. 
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Early publications about red kidney bean PAP and uteroferrin (pig uterus PAP) propose a 
monodentate binding mode of the substrate at the divalent metal and subsequent attack of an 
FeIII-bound terminal hydroxide via pentacoordinate, associative-type phosphorous 
intermediates or transition states, which is consistent with pathway a in Scheme 2.1.[41, 45] 
Later on,[56] spectroscopic studies on bovine spleen PAP showed that the CT bands observed 
in UV/vis spectra and EPR signals associated with FeIII are only slowly affected during 
reaction of the enzyme with phosphate. Based on these findings, mechanistic suggestions 
were made that support the monodentate binding mode of substrate, but argue against an FeIII-
bound terminal hydroxide as nucleophile. A reasonable explanation is that this hydroxide acts 
only as a base, which deprotonates a water molecule bound in the second coordination sphere 
of the enzyme. The resulting “free” hydroxide can then attack the substrate (pathway b), 
giving rise to a monodentate phosphate as product.[56] Different inhibition processes are 
discussed; they all include formation of bridging substrate or product coordination modes 
(equilibria c and e in Scheme 2.1).[41, 45] Pathway d was therefore excluded, which is further 
justified by the low nucleophilicity of µ-hydroxides. Labeling studies with [18O]-phosphate 
demonstrated successive oxygen exchange between enzyme-bound phosphate and water.[58] 
This result supports the existence of equilibrium e with nucleophilic substitution at the bound 
phosphate, as indicated by the reaction arrow, instead of simple replacement of the FeIII-
bound terminal hydroxide. The latter process is discussed to be less plausible due to slow 
ligand exchange at trivalent metal ion sites, which would also favor path b over path a.  
A few years ago, an eight step mechanism was published, which is based on X-ray 
structures in conjunction with spectroscopic studies of different enzyme-inhibitor complexes 
as well as kinetic data for phosphoester hydrolysis.[37] Schenk and co-workers suggest a pre-
coordination of the substrate in the second coordination sphere, followed by monodentate and, 
subsequently, bridging coordination. The attacking nucleophile would then be a µ-hydroxide, 
which is rather asymmetrically bound (“quasi-terminal”) and therefore believed to be more 
active. This proposal was originally made by Wang et. al.[38] and resembles the previously 
excluded pathway d in Scheme 2.1. The product of such a reaction would be a phosphate 
bound in a tripodal way. Although this coordination mode was only observed in sweet potato 
PAP, which has an FeIIIMnII active site, the mechanistic proposal was attributed to red kidney 
bean PAP, which has ZnII as divalent metal ion in its native form.  
Stopped-flow experiments on phenyl phosphate hydrolysis by the native FeIIIFeII form 
and the artificial FeIIIMnII derivative of uteroferrin were reported recently.[59] In the native 
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form, they show that hydrolysis of the substrate occurs definitely faster than perturbation of 
the CT bands of FeIII, which again supports monodentate substrate binding and non-FeIII-
bound hydroxide as nucleophile (pathway b). With the MnII derivative, the ratio of hydrolysis 
vs. FeIII involvement rate is smaller by one to two orders of magnitude, but still catalysis is 
faster than formation of bridging substrate. 
It is likely that, depending on the metal composition in the PAP active site and the 
substrate used, different mechanisms operate.[60] Nevertheless, a non-bridging coordination 
mode of the substrate and a hydroxide bound in the second coordination sphere as nucleophile 
seems to be more plausible, especially when the recently reported stopped-flow experiments 
are considered.[59] 
In PAPs[37, 45, 59] as well as in many other enzymes,[61-63] the second coordination sphere is 
believed to play a crucial role for catalytic efficiency. Possible functions include 
preorganisation, orientation and activation of substrates, stabilization of transition states as 
well as acceleration of product release by hydrogen bonding and its role as a proton source. 
Krebs et al. already suggested in 1996 that the substrate is bound by the divalent metal and 
two protonated histidine residues (His216 and His113 in Figure 2.4a; the numbering Scheme 
corresponds to rat bone PAP) and is by that optimally aligned for an in-line attack of the FeIII-
bound hydroxide.[45] During reaction, the negative charges of the pentacoordinate 
intermediate or transition state are likely to be balanced by the protons, resulting in over-all 
stabilization. In 2010, Schenk et al. also included hydrogen bonding interactions into their 
considerations: A water molecule positioned in the second coordination sphere (which is 
deprotonated by FeIII-bound hydroxide) is believed to act as nucleophile (see Figure 2.4a).[59] 
More interactions were found in X-ray structures of PAPs with inhibitors, like sulfate, which 
are also bound by an extensive hydrogen bonding network.[37]  
Site-directed mutagenesis studies, where the mentioned histidines were replaced by other 
amino acids, gave more insight into the function of the second coordination sphere. Rat bone 
PAP and its mutants were examined in acid phosphatase activity (AcP) as well as in activity 
towards generation of reactive oxygen species (ROS).[21] The relative activities are presented 
in Figure 2.4b. All mutations reported in this paper lead to significantly lower AcP activity, 
while ROS activity remained nearly unaffected. 
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Figure 2.4: Numbering (a) and effects of replacement (b) of second coordination sphere amino acids in PAPs. 
 
No definite mechanistic conclusions can be drawn from these results, but it becomes clear 
that the two metabolic roles of mammalian PAP involve different reaction mechanisms. Also, 
hydrogen bonding seems to be crucial for AcP activity, although the glutamines in the 
HisxGln mutants are technically capable of hydrogen bonding interactions but still lead to 
lower activity. This is clarified by experiments with another mutant, where His113 is replaced 
by an asparagine, which is the shorter analogue of glutamine.[64] This mutant shows a three-
time larger activity than the wild-type enzyme. Probably, in this case an optimum geometry 
for hydrogen bonding is achieved. 
 
  
a)  b) 
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2.3.   PAP Model Systems 
 
Small molecules mimicking enzymatic reactions have been widely used to gain a better 
understanding of possible pathways and mechanisms in enzymes. They do not only serve as a 
means to an end, but are themselves meant to act as therapeutics or catalysts. In fact, the field 
of “biomimetic chemistry” was mainly established in order to use obvious natural principles 
in chemical laboratories, especially for selectivity in chemical reactions (bioinspired 
catalysis), and not for a deeper understanding of natural processes.[65] This latter ambition was 
rather developed over time, when one realized that this deep understanding is often required 
to identify which motifs lead to high reactivity and selectivity. 
When thinking about hydrolase mimetics, the need for accelerating this type of reactions 
is not obvious at first. Hydrolysis is in general not a difficult problem under laboratory 
conditions. Things become more complicated when physiological conditions are required. Of 
course, enzymes are perfectly developed for high performance at nearly neutral pH and 
ambient temperature, but their use has some limitations. Expression and purification of 
enzymes is time consuming and economically disadvantageous. Storage problems are another 
factor. The most problematic fact is that very complex analytical work has to be done on 
enzymatic systems. So it is desirable to have small, stable molecules that can catalyze 
hydrolysis under mild conditions. A major application target is the degradation of nerve 
agents and organophosphate pesticides, which are mainly phosphotriesters.[66, 67] This highly 
toxic class of compounds is generally quite stable and may accumulate over time. 
In contrast, the scope of PAP mimetics is not the acceleration of hydrolysis, but the 
elucidation of the enzymatic mechanism. Osteoporosis, as well as some other diseases, have 
been proposed to be greatly affected by PAPs,[14] therefore a profound understanding of the 
mode of action will lead to new approaches in the for development of therapeutics.  
Up to date, a variety of model systems for PAPs has been published.[13, 68-70] First 
structural models were built from relatively simple mononucleating ligands (see Figure 2.5 for 
structures and Table 2.2 for data and references) and resulted in symmetric diferric 
complexes, which imitate the inactive, diferric form of mammalian PAP. Good agreement 
was achieved regarding magnetic properties and geometric features (see Chapter 2.4 for more 
details on diferric systems). 
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Figure 2.5: Mononucleating ligands for simple PAP model systems. 
 
Table 2.2: Magnetic and geometric parameters of oxidized mammalian PAP and diferric model complexes.  
parameter ox. PAP[51] a b c d 
-J [cm-1]* ≥ 150 119 119 121 117 
d(Fe-Fe) [Å] 3.50 3.24 3.12 3.15 3.08 
Fe-O-Fe [°] 122.1 127.9 119.7 123.5 118.7 
d(Fe-O) [Å] 2.00 1.80 1.80 1.78 1.80 
*  H = -2JSASB; a = [Fe2(TPA)2O(OBz)]3+;[71] b = [Fe2(Me3tacn)2O(OAc)2]2+;[72] c = [Fe2(HB(pz)3)2O(OAc)2];[73] 
d = [Fe2(BBA)2O(OBz)2]3+.[74] 
 
In 1988, Que et al. reported a nice example of a spectroscopic model, where the 
tyrosinate-FeIII feature of the natural enzymes was mimicked.[75] Using the tripodal ligand N-
(o-hydroxybenzyl)-N,N-bis-(2-pyridylmethyl)amine (HDP) and benzoic acid as co-ligand, a 
µ-oxo-µ-benzoato bridged diferric complex was obtained (Figure 2.6). 
 
 
Figure 2.6: Spectroscopic PAP model complex based on ligand HDP.[75] 
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For the first time, the high molar extinction coefficient for the phenolate-to-iron CT 
transition observed in the enzyme was nearly reproduced by a model complex (λ = 552 nm; ε 
= 3300 M-1cm-1/Fe vs. λ = 550 nm; ε = 4000 M-1cm-1 in the oxidized enzyme).  
A major challenge towards functional PAP model complexes is the introduction of 
heterodimetallic sites. With mononucleating ligands this task could not be performed. A big 
success was then the development of dinucleating ligands, where a bridging donor atom is 
included in the ligand backbone. The main motifs used thereby are shown in Figure 2.7 (upper 
part).[69] Many different ligands were synthesized based on these linkers, at first with four 
equal residues Rx leading to symmetric systems. Examples included ligands based on linker A 
with residues 2 (HBIMP),[76] 3 (HL-Bzim)[77] or 5 (HXTA).[78] Starting from ferrous salts, all 
reactions under anaerobic conditions resulted in heterovalent di-iron complexes with weak 
exchange coupling (-J ≈ 2-7 cm-1), which is in good agreement with the reduced form of 
mammalian PAP (-J = 7-10 cm-1).[51] Also, the reduction potentials for the FeIII2/FeIIIFeII 
couples have been reported for the complexes with Hbimp and HXTA ligands: They are 
435 mV and -286 mV vs. SCE, respectively. In contrast, the redox potential of mammalian 
PAP is 92 mV vs. SCE.[53, 54] These model complexes obviously do not reproduce the 
electrochemical properties of the enzyme. The symmetric ligand HBPMP (linker A with four 
picolyl residues 1) was used for the synthesis of heterodimetallic complexes, e.g. FeIIIZnII,[79, 
80] FeIIICuII,[81, 82] FeIIICoII [83] and FeIIINiII,[83] resulting in very similar asymmetric structures. 
 
Figure 2.7: Variety of dinucleating ligands used for PAP model complexes.[69] 
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The next big achievement was the development of synthetic protocols giving rise to non-
symmetric ligands with two or more different coordinating residues. Based on the HSAB 
principle, sites of non-equivalent hardness (different number of N- and O-donors, see Figure 
2.7, bottom) resulted in selective coordination of di- and trivalent metals, respectively. The 
first complex of this type was presented by Bernhard et al. in 1994.[84] The ligand was based 
on linker A in combination with three picolyl (1) and one methylphenolate (4) residues 
(Figure 2.8; H2BPBPMP = 2-bis[{(2-pyridylmethyl)-aminomethyl}-6-{(2-hydroxybenzyl)-(2-
pyridylmethyl)}-aminomethyl]-4-methylphenol). The phenolate containing site is the hard 
one and therefore FeIII preferably binds there. The softer bis-pyridyl site is coordinated to the 
divalent metal ion. In the reported case, FeII is used as divalent metal ion. The geometric 
features of this complex determined by X-ray crystallography and some spectroscopic and 
magnetic properties are very close to the ones of the enzyme´s active site: the metal-metal 
distance is 3.42 Å vs. 3.52 Å in the reduced form of the enzyme.[51] In the UV/vis spectrum, 
the phenolate-to-FeIII CT transition is found at λ = 535 nm (ε = 1700 M-1cm-1). Also, the 
oxidation potential of 220 mV vs. SCE fits better to the enzyme´s redox potential than those 
for the symmetric complexes mentioned above. Asymmetry is also nicely visible in the bond 
lengths from the two iron centers to the bridging phenolate, where a significant difference of 
0.124 Å is observed. This leads to the conclusion that both iron ions are in localized valence 
states. Later on, the heterovalent di-iron complex of H2BPBPMP was used to elucidate the 
redox regulation of enzymatic activity in mammalian PAP. It was shown that the product of 
hydrolysis (i.e. phosphate) is able to promote the oxidation of the complex.[85] 
 
 
Figure 2.8: Asymmetric dinucleating ligand H2BPBPMP. 
 
H2BPBPMP was also used to synthesize a variety of heterodinuclear complexes. Their 
catalytic properties in the hydrolysis of the activated diester substrate bis-(2,4-dinitrophenyl)-
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phosphate (BDNPP) are summarized in Table 2.3.[69] Looking at the effects of different metal 
compositions on catalysis can give important hints about the reaction mechanism. For 
example, the Michaelis-Menten constant KM, which can be interpreted as a measure of 
substrate affinity, strongly depends on the divalent ion: whereas MnII results in the lowest KM 
(2.1 mM, i.e. best affinity), complexes with CoII have an almost 50-fold higher KM (50-fold 
lower affinity). In contrast, substitution of the trivalent metal (FeIII  GaIII) has almost no 
effect on KM, but leads to slightly increased turnover rates. These findings suggest that a) the 
substrate is only bound to the divalent metal ion during catalysis and b) the nucleophile is 
likely bound to the trivalent metal ion. The pH dependencies of all catalysts were measured 
and all resulted in bell-shaped profiles. The observed pKas and the pH at which maximum 
activity occurs are all quite similar to each other. Interestingly, both pKas are affected by a 
change of the divalent and the trivalent metal ion. This indicates a significant interaction 
between the metal ions. However, when changing the divalent metal ion, the effect is larger 
for the second pKa. 
 
Table 2.3: Catalytic properties of different complexes with the asymmetric, dinucleating ligand H2BPBPMP.[69] 
catalyst pHmax pKa(I)[a] pKa(II)[a] 
kcat 
[s-1]*10-3 
KM  
[mM] 
kcat/KM 
[s-1M-1 ] 
[FeIIIFeIIBPBPMP(µ-OAc)2]+[86] 6.0 4.74 7.54 3.00 13.0 0.23 
[FeIIIZnIIBPBPMP(µ-OAc)2]+[87] 6.1 4.80 7.50 0.73 8.1 0.09 
[FeIIIMnIIBPBPMP(µ-OAc)2]+[88] 6.7 5.80 7.76 0.45 2.1 0.21 
[FeIIICuIIBPBPMP(µ-OAc)2]+[89] 7.0 5.20 8.50 1.77 11 0.16 
[FeIIINiIIBPBPMP(µ-OAc)2]+[90] 6.0 4.91 8.34 0.45 3.85 0.12 
[FeIIICoIIBPBPMP(µ-OAc)2]+[91] 7.0 5.20 8.80 1.42 93 0.02 
[GaIIIZnIIBPBPMP(µ-OAc)2]+[60] 6.8 5.35 8.55 1.41 7.15 0.20 
[GaIIICoIIBPBPMP(µ-OAc)2]+[91] 7.5 5.70 8.90 1.87 88 0.02 
[a] The assignment of the dissociation constants is depicted in Scheme 2.2. 
 
Based on known pKa values for metal ion bound water molecules and supported by 
spectrophotometric titrations of the complexes, the following mechanistic proposal was made 
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(Scheme 2.2): The first pKa value belongs to water that is bound to the trivalent metal ion. Its 
deprotonation leads to formation of a suitable nucleophile for substrate hydrolysis. At a pH 
lower than the second pKa value, at first, a water molecule is bound to the divalent metal 
which can easily be substituted by the substrate. Deprotonation of the water at higher pH 
leads to formation of a hydroxo ligand, which is more difficult to substitute. This diprotic 
model is a good explanation for the observed pH profiles, with an aqua-hydroxo complex of 
the following constitution being the active species: [LMIII(OH)(µ-OH)MII(OH2)] (middle 
structure in Scheme 2.2). The bridging hydroxide was included in this model as it was found 
in several X-ray structures of these complexes.[92] It is most probably inert, because bridging 
hydroxides are known to be poor nucleophiles. 
 
 
Scheme 2.2: Kinetically relevant protonation equilibria in H2BPBPMP-based model complexes. 
 
Some mechanistic investigations regarding the hydrolysis of activated phosphoesters 
were conducted with the FeIIIZnII derivative of H2BPBPMP.[92] UV/vis spectra of the complex 
with an excess of the diester BDNPP showed almost no change in the phenolate-to-FeIII CT 
band, suggesting that no interaction between the substrate and FeIII occured. When DNPP, the 
monoester analogue of BDNPP (and therefore the reaction product of the first hydrolysis step) 
is used as substrate, a hypsochromic shift of the mentioned band is observed but, apart from 
the background activity, no hydrolysis can be seen. This is interpreted as a bridging 
coordination of the monoester, which represents an inhibitory state. The coordination of 
DNPP is rather weak and it can be easily replaced by BDNPP, showing perfectly recovered 
hydrolytic activity. Based on these results, the following catalytic cycle was proposed 
(Scheme 2.3):[92] 
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Scheme 2.3: Proposed catalytic cycle for PAP model complexes.[92] 
 
This pathway has also been investigated by DFT calculations,[93] using a simplified 
system, where the phenolate ring had been cut resulting in a 3-pentanol bridged ligand. 
Dimethyl phosphate (DMP) was used as simple phosphodiester substrate. Starting from 
monodentately coordinated DMP on ZnII and a hydroxo ligand on FeIII, the reaction proceeds 
to a pentacoordinated phosphorane structure via a transition state which is close to the 
intermediate. The activation barrier for this process is 12.3 kcal/mol, which is a rather small 
value. From this intermediate, two other structures are found before reaching the product 
state. The energy values for these do not indicate a second transition state, but this can be 
explained with a very flat energy surface in combination with the inaccuracy of DFT methods. 
In comparison to the previously calculated uncatalyzed DMP hydrolysis (32 kcal/mol), the 
barrier for the catalytic reaction is 2.6 times lower, which would mean an unrealistic 
acceleration rate of ca. 1014. Unfortunately, no calculations were performed on substrate 
coordination or product release, which might be involved in the rate determining step. Also, 
the energy barrier for the attack of the bridging hydroxide at the bridging monoester would be 
interesting in terms of explaining the lack of reactivity. 
So far, no PAP type model complexes were reported to catalyze phosphomonoester 
hydrolysis, which is the actual function of the enzymes.[87, 88, 90] The main problem could be 
the inhibitor-like bridging coordination mode together with a µ-hydroxide as nucleophile that 
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is too weak to perform the reaction. In the enzymes, the substrate is most probably bound 
monodentately to the divalent metal ion, with subsequent attack of either an FeIII bound 
hydroxide or a hydroxide located in the second coordination sphere.[41, 45, 56, 59] The goal of 
functional PAP mimetics should therefore be to preorganize the monoester substrate in a 
monodentate coordination mode. A possible way to achieve this could be the incorporation of 
a second coordination sphere mimic into the model systems. Only few publications are 
available, where this principle has been examined (see Figure 2.9 for the structures): Masuda 
et al. reported the stabilization of a terminal CuII bound hydroxide through interaction with 
hydrogen bond donors and shielding by bulky neopentyl groups (structure 1 in Figure 2.9).[94] 
Marque-Rivas and Williams et al. clearly showed a rate enhancement of phosphodiester 
hydrolysis by cooperation of double Lewis activation (2 x ZnII) and the hydrogen-bonding 
environment provided by the used ligand (structure 2 in Figure 2.9).[95] These results 
encourage the development of PAP mimetics containing a second coordination sphere but no 
iron complexes or PAP mimetics have so far been reported, where these types of interactions 
were present. 
 
 
Figure 2.9: Examples of model complexes with a second coordination sphere. 
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2.4.   Chemistry of Bridged Diferric Complexes 
 
In order to simplify the envisioned study of second coordination sphere effects, we have 
chosen to work on diferric model complexes only. Although mammalian PAPs are reported to 
be exclusively active in their heterovalent state,[96] some diferric model complexes are known 
to catalyze phosphoester hydrolysis.[97-101] The results of these studies suggest that in the 
model systems the slow exchange of product is not a significant barrier to the hydrolysis 
reaction, whereas in the PAP enzyme systems a diferric active site would be. 
Bridged diferric complexes can be formed with relatively simple, mononucleating ligands, 
including EDTA4-, TPA, BBA, HDP, HB(pz)3- and Me3tacn (see Chapter 2.3 for ligand 
structures). Extensive structural and spectroscopic studies have been performed on this kind 
of complexes with different types of bridging groups (Figure 2.10). The complex synthesis is, 
generally, rather simple: Ligand solutions in MeOH or MeCN, sometimes in other solvents or 
with additional base, are reacted with solutions of ferric salts, like ferric perchlorate or nitrate, 
and subsequently co-ligands are added.[102, 103] With Me3tacn[104] and HB(pz)3,[105] an already 
formed diferric complex with an easily replaceable acetate bridge was used as starting 
material and reacted with the respective co-ligand under ligand exchange. Almost in every 
case, X-ray quality crystals were obtained with established crystallization methods. 
 
 
Figure 2.10: Structural variations of bridged diferric complexes relevant for this work. 
 
Table 2.4 summarizes the obtained structural and magnetic parameters for selected 
complexes of the type shown above. Generally, µ-oxo bridged complexes give rise to strong 
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antiferromagnetic coupling with –J > 80 cm-1. No correlation is observable between the actual 
J-value and structural factors like number of bridging/non-bridging co-ligands or Fe-O-Fe 
angles, which span a range between 123 and 175°. Different metal-metal distances result from 
these varying angles, lying between 3.15 and 3.57 Å. 
 
Table 2.4: Structural and magnetic data of selected diferric complexes. 
entry complex d(Fe-Fe) 
[Å] 
d(Fe-O) 
[Å] 
< Fe-O-Fe 
[°] 
-J[a] 
[cm-1] 
ref. 
1 [Fe2(A)2O(O2P(OPh)2)2] 3.34 1.81 134.7 98 [105]
2 [Fe2(A)2OH(O2P(OPh)2)2]+ 3.59 1.96/1.98 131.1 15 [106]
3 [Fe2(A)2(O2P(OPh)2)3]+ 4.68 - - 0.8 [106]
4 [Fe2(A)2O(OAc)2] 3.15 1.78 123.6 121 [73] 
5 [Fe2(A)2OH(OAc)2]+ 3.44 1.96/1.95 123.0 17 [106]
6 [Fe2(B)2O(O3POPh)2] 3.20 1.82 123.2 98 [104]
7 [Fe2(B)2(O3POPh)3] n.a n.a n.a 3.5 [104]
8 [Fe2(B)2O(HPO4)2] n.a n.a n.a 80 [104]
9 [Fe2(B)2(HPO4)3] n.a n.a n.a 2.9 [104]
10 [Fe2(C)2O(O2P(OPh)2)]+ n.a n.a n.a 96 [107]
11 [Fe2(C)2(O2P(OPh)2)2]2+ 4.82 - - 0 [107]
12 [Fe2(C)2O(OBz)]+ 3.22 1.78/1.80 128.3 111 [75] 
13 [Fe2(D)2O(O2P(OPh)2)]3+ 3.36 1.82/1.78 138.1 101 [71] 
14 [Fe2(D)2O(OBz)]3+ 3.24 1.80/1.78 129.7 119 [71] 
15 [Fe2(D)2O(Cl)2]3+ 3.58 1.79 174.7 116 [108]
16 [Fe2(E)2O]2- 3.57 1.80/1.79 165.0 95 [109]
 
A = HB(pz3); B = Me3tacn; C = DPA; D = TPA; E = H2EDTA; n.a = data not available; [a] H = -2JSASB. 
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In contrast, µ-hydroxo bridged structures show significantly longer distances, e.g. 3.44 
vs. 3.15 Å with acetate (entries 4 and 5) and 3.59 vs. 3.34 Å with diphenyl phosphate (entries 
1 and 2). This is a result of longer Fe-OH bonds in comparison to Fe-O bonds. Also, the µ-
hydroxo bridge is a less effective mediator of exchange coupling interactions, resulting in 
relatively small –J values of 15 to 17 cm-1. When no µ-oxo or µ-hydroxo bridge is present in 
addition to the bridging co-ligands, even weaker coupling is observed with –J between 0 and 
3.5 cm-1. This is not only a consequence of the strongly reduced magnetic exchange, but also 
of long metal-metal distances (> 4.5 Å, entries 3 and 11). In summary, the three types of 
bridged diferric complexes (µ-oxo, µ-hydroxo and no additional bridge) have well separated 
ranges of values for structural and magnetic properties. Especially, the J values can give 
essential structural information. 
Electronic and vibrational spectroscopy is also an important tool for the characterization 
of diferric compounds (see Table 2.5). Asymmetric and symmetric stretching frequencies 
from IR and raman spectra, respectively, can give information about the strength of the Fe-
oxo bonds and, regarding the intensities, about the extent of symmetry in the complexes. 
Labeling studies support the assignment of bands. Yet, no correlation between spectroscopic 
and structural features is found in the examples shown. Also the definitive interpretation of 
UV/vis spectra is not easy in this case. In the visible region, almost no bands are present; this 
is due to Laporte forbidden dd transitions in high spin ferric ions. In contrast, very intense 
bands (ε > 1000 M-1cm-1) can be seen in the near-UV or UV region, arising from a 
combination of ligand-to-metal and oxo-to-metal CT transitions. Although the number and 
position of these bands strongly differs from complex to complex, their presence is a good 
general indication for µ-oxo bridged structures.  
 
Figure 2.11: Typical UV/vis spectra of different µ-oxo bridged diferric complexes based on TPA.[110] 
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Table 2.5: Spectroscopic data of diferric complexes.[a] 
entry complex LMCT λ [nm] νas 
[cm-1] 
νs 
[cm-1] 
1 [Fe2(A)2O(O2P(OPh)2)2] 321; 366; 500 767 478 
2 [Fe2(A)2OH(O2P(OPh)2)2]+ n.a. n.a. n.a. 
3 [Fe2(A)2(O2P(OPh)2)3]+ n.a. - - 
4 [Fe2(A)2O(OAc)2] 339; 358; 400; 528 751 528 
5 [Fe2(A)2OH(OAc)2]+ n.a. n.a. n.a. 
6 [Fe2(B)2O(O3POPh)2] 6 bands at 300 - 520 694 n.a. 
7 [Fe2(B)2(O3POPh)3] ca. 330 (sh) - - 
8 [Fe2(B)2O(HPO4)2] 6 bands at 300 - 520 706 n.a. 
9 [Fe2(B)2(HPO4)3] ca. 325 (sh) - - 
10 [Fe2(C)2O(O2P(OPh)2)]+ 350; 516[b] n.a. 461 
11 [Fe2(C)2(O2P(OPh)2)2]2+ 380; 605[b] - - 
12 [Fe2(C)2O(OBz)]+ 350; 522[b] 763 494 
13 [Fe2(D)2O(O2P(OPh)2)]3+ 322; 360; 446; 480;496; 518 778 454 
14 [Fe2(D)2O(OBz)]3+ 328; 368; 460; 492; 504; 534 772 497 
15 [Fe2(D)2O(Cl)2]3+ 320; 380; 490; 573 816 363 
16 [Fe2(E)2O]2- 307; 343; 403; 455; 477; 544 838 409 
[a] see Table 2.4 for references and ligand abbreviations; [b] phenolate-to-Fe CT transitions from HDP ligand; 
n.a. = data not available. 
 
Electrochemical studies were performed on a series of diferric µ-oxo bridged TPA 
complexes with a multitude of bridging oxo-anions, like acetate, phosphates, vanadate, 
molybdate, as well as with chloride as non-bridging terminal co-ligand.[111] Their redox 
potentials for the FeIII2/FeIIIFeII couples cover a range of almost 600 mV. With diphenyl 
phosphate, the highest redox potential was obtained (-64 mV vs. SCE), whereas the carbonate 
bridged complex had the lowest (-624 mV vs. SCE). Almost all complexes showed a 
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reversible redox behavior, apart from the phosphate and carbonate bridged species. In the case 
of phthalate bridging, a quasi-reversible reduction was observed. By choosing the right type 
of co-ligand, it is therefore possible to stabilize the heterovalent state in µ-oxo bridged di-iron 
complexes. Nevertheless, the question remains if stability is retained under aerobic conditions  
Reduced Uf (uteroferrin, a form of mammalian PAP) is reported to slowly undergo 
autoxidation, having a redox potential of 92 mV vs. SCE,[53, 54] and Uf-phosphato complexes 
(-130 mV vs. SCE)[53] are oxidized even faster, whereas with molybdate as co-ligand, an air-
stable form of reduced Uf is obtained (254 mV vs. SCE).[53] Regarding the redox potentials, a 
substantial aerobic stability of the heterovalent states in the cited complexes is not expected. 
 
Figure 2.12: Dinucleating ligands used for diferric complexes.[69] 
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When dinucleating ligands of the type presented in Figure 2.12 are used, usually triply 
bridged structures are obtained. One bridge arises from the ligand itself; mainly, phenolate or 
alcoholate type ligand backbones are used. The other bridges are built up by additional co-
ligands of the same kind as presented in Figure 2.10. As the core structures in these kinds of 
complexes do not vary much, the magnetic properties are very similar. The coupling constants 
for antiferromagnetic coupling –J lie in the range of 5 to 15 cm-1, which is typical for 
phenoxo/alkoxo/hydroxo bridges.[112, 113] The number of coordinated phenolates is reflected in 
the actual value, as the trans effect of phenolate ligands elongates the Fe-O-Fe bonds and 
therefore weakens the interaction, resulting in rather small –J values in the mentioned 
range.[112] UV/vis spectra of diferric complexes with phenolate-based ligands are dominated 
by the relatively broad phenolate-to-iron CT transitions, which are in the range between λ = 
500 - 700 nm with extinction coefficients of ε = 1000 – 2000 M-1cm-1. Additional pπ – dσ* 
type transitions are present in the range between λ = 300 – 400 nm (ε = 2500 – 
5000 M-1cm-1).[112-115] Mixed-valent FeIIIFeII complexes usually have bands in the same 
regions, but with significantly smaller extinction coefficients (ε ≈ 500 M-1cm-1) due to the 
presence of only one ferric ion per complex.[115] The reported redox potentials span a wider 
range, depending on which dinuclating ligand is used and the nature of the co-ligands. Several 
examples are given in Table 2.6, (see Figure 2.12 for ligand structures). 
 
Table 2.6: Redox potentials of diferric complexes with dinucleating ligands (in mV vs. SCE; n.a = data not 
available). 
co-ligand // ligand BPMP BBPMP BIMP BIOMP BBPPNOL 
OAc- 690[116] -190[115] 435[76] 155[113] -230[114] 
O2P(OPh)2- n.a -200[112] n.a n.a 60[112] 
 
When ferrous salts are used as precursors under anaerobic conditions, all presented 
ligands can form heterovalent complexes.[115, 116] As solids, these complexes are quite stable 
against oxidation. Their solution behavior is well reflected by their redox potentials. Some 
trends can be seen regarding the type of ligand and co-ligands. The complexes with BPMP 
and BIMP have very positive redox potentials, and in fact, only the heterovalent states are 
stabilized and obtained, even when ferric salts are used as precursors.[76, 115] The di-phenol 
derivatives, BBPMP and BIOMP result in complexes with redox potentials that are 880 and 
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280 mV lower, respectively, and therefore the homovalent, diferric states are obtained in 
solution under aerobic conditions.[112, 113, 115] The co-ligands only show marginal effects in the 
BBPMP case, whereas with BBPPNOL as ligand, a change from acetate to diphenyl 
phosphate results in a positive shift of the redox potential of almost 300 mV. Still, this value 
is not high enough to yield air-stable heterovalent complexes. In summary, the integration of 
more than one phenolate into the coordination sphere results in complexes with low redox 
potentials and rather stabilizes their diferric state than the heterovalent one. 
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3.1.   Preliminary Considerations 
 
The aim of this work is to explore the effects of a second coordination sphere on the activity 
towards hydrolysis of phosphoesters, especially monoesters. Suitable ligand systems must be 
found that have the following prerequisites: A coordination sphere is required that can bind 
two metal centers in an appropriate distance, which is between approximately 3.2 and 4 Å.[13] 
At least one free coordination site per metal is needed in order to provide the possibility of 
substrate and nucleophile coordination. As the used substrates, BDNPP and DNPP, are 
relatively bulky due to their 2,4-dinitrophenol groups, enough space must be provided around 
the metals to prevent a large steric strain.  
There are some difficulties associated with the incorporation of a second coordination 
sphere into the ligand system. Important considerations include which kind of atoms to use 
and at what distance to the metal center to place them. In natural systems, mainly histidine 
residues with their protonated imidazoles fulfill this role. Enzyme X-ray structures of red 
kidney bean PAP[37, 45] and mammalian PAP[46, 117, 118] reveal metal – second coordination 
sphere distances between 4.9 and 6.3 Å, depending on which co-ligand is used and how this is 
bound to the active site. Usually, the ligand backbone with its amino acid residues is relatively 
flexible, so these deviations are not unexpected. 
 
Figure 3.1: Distances between metal and second coordination sphere in rat PAP with sulfate.[117] 
 
Only one X-ray structure of a purple acid phosphatase with a monodentately bound 
substrate mimic exists, which is proposed to be an artifact of the crystallization method as 
Fe
Fe
Zn
S
His
His
6.2 Å
5.4 Å
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additional zinc is present in the second coordination sphere.[117] In this case, the distances 
from the coordinated metal to the closest protonated histidine residues are 5.40 and 6.20 Å, 
respectively (Figure 3.1). To further explore an appropriate distance between the metal ions 
and a second coordinaton sphere, the following model was established (see Figure 3.2): Two 
metal ions were connected via a µ-oxo bridge in a distance of 3.4 Å. A phosphate anion was 
coordinated to one of these metals forming an angle of 150° between metal, oxygen and 
phosphorous atoms. Hydrogen atoms were added to the oxygen atoms at a distance of 1.1 Å 
and additional nitrogen atoms, representing the second coordination sphere, were attached to 
them. Finally, the distance between the metals and the second coordination sphere nitrogen 
atoms was measured and resulted in values between 6 and 6.5 Å. Of course, this procedure is 
not very accurate but at least gives an idea about the geometric features that are needed to 
ensure interactions between a bound substrate and the remote ligand parts. 
 
Figure 3.2: Modeling the appropriate distances between metal and second coordination sphere. 
 
Regarding the choice of metal, we focused on diferric systems as a first approach. Some 
FeIIIFeII complexes are known with redox potentials that are high enough to stabilize the 
heterovalent state under anaerobic conditions,[76, 115] but most of them are only air-stable in 
their homovalent, diferric form.[112, 113, 115] Although it is known that no activity is observed 
for mammalian PAP´s in their diferric state,[53, 54] this is not necessarily the case for model 
complexes. Certainly, no direct comparison of reactivities and kinetic data can be expected 
due to this difference, but this is not the aim of our work. 
Based on these ideas, the development of new ligand systems for PAP model complexes 
was performed and will be described in the following chapters. 
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3.2.   The Cyclam-based Ligand L1  
 
3.2.1. Synthesis and Properties of Ligand L1 
 
The retrosynthetic approach for ligand L1 is depicted in Scheme 3.1. Based on 1,4,8,11-
tetraazacyclotetradecane (cyclam), the desired molecule is synthesized in six steps. An 
important step is the selective alkylation of two cyclam nitrogen atoms that are situated trans 
to each other. The resulting key intermediate 1,8-dimethylcyclam[119] is shown in the scheme. 
 
 
Scheme 3.1: Retrosynthesis of ligand L1. 
 
Different considerations gave rise to the development of ligand L1. Cyclam was chosen 
as a linker between the two coordination sites due to its high basicity (pKa=11),[120] that favors 
protonation of the nitrogen atoms over coordination of a metal ion. The protonated cyclam is 
designed as a second coordination sphere mimic. Another important feature is the 
conformational flexibility, which should allow varying metal-metal distances in the desired 
dinuclear complex. In a postulated mechanism by Schenk et. al.,[37] the catalytic cycle shows 
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different binding modes of substrate and product. A flexible model system should be able to 
reproduce this behavior more accurately than a rigid one. The two coordinating units are 
connected to the cyclam platform via two trans-disposed nitrogen atoms. On one hand, this is 
crucial to ensure an appropriate distance. On the other, this cyclam substitution pattern is well 
known in the literature and therefore easy to adopt.[119] The use of ethylene bridges between 
cyclam and the coordination sites derives from N-tosylaziridine as a building block. This 
reacts selectively with the secondary amines in 1,8-dimethylcyclam via nucleophilic ring 
opening. The coordination site of the ligand resembles the known ligand di-
(2pyridyl)methylamine (abbr. as dipa or dpma).[121, 122] Almost all well-established PAP 
model systems have chosen bis-(2-pyridylmethyl)amine (also known as bis-(picolyl)amine) as 
a coordinating unit.[69] In our case, the introduction of such a group was not feasible (see 
Scheme 3.2). Usually, bis-(2-picolyl)amine is reacted with a primary chloro- or bromoalkane 
in a nucleophilic substitution reaction. The latter are not directly accessible from cyclam. 
Another possible route would involve a fourfold alkylation reaction of two primary amines. 
Such a reaction is not favored from an entropic point of view. Therefore, this type of 
coordination site was not further considered. 
 
 
Scheme 3.2: Failed routes to a bis-(picolyl)amine substituted ligand. 
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A successful approach is the reaction of two equivalents di-(2-pyridyl)methylchloride 
with the primary amines in structure 6 (Scheme 3.3). The resulting donor set is also superior 
regarding the coordination chemistry with FeIII. The coordination of two dipa-type units to 
one ferric ion in ligand L1 is unlikely, as FeIII(dipa)2 complexes were shown to be 
unstable.[121] They are reduced to FeII(dipa)2. In contrast, FeIII complexes with only one dipa 
ligand and additional co-ligands (like chloride) are easily accessible and stable.[122] Therefore, 
the desired uptake of two FeIII per ligand should be favored. Scheme 3.3 shows the complete 
synthetic route to L1: 
 
Scheme 3.3: Synthesis of ligand L1. 
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The first step is the reaction of cyclam with formaldehyde in aqueous solution. The 
resulting product is the doubly methylene-bridged cyclam 2, which is obtained as a white 
powder in 89% yield (lit. 96%). Nucleophilic substitution with methyliodide in acetonitrile 
gives the bis-methylated salt 3 in 96% yield (lit. 90%). Hydrolytic cleavage in 3M aqueous 
NaOH removes the methylene bridges to yield 98% 1,8-dimethylcyclam 4 (lit. 100%).[119] 
The next step involves the reaction of N-tosylaziridine 9 with the secondary amines of 
1,8-dimethylcyclam 4. N-Tosylaziridine is synthesized from 2-aminoethanol in two steps in 
61% yield (lit. 49%, see Scheme 3.4).[123, 124] The selective nucleophilic ring-opening of 
aziridine by secondary amines is the key step of the presented synthetic route.[125] After 
recrystallization of the crude reaction mixture, the product 1,8-dimethyl-4,11-bis-(2-
tosylaminoethyl)cyclam 5 is obtained in 66% yield. The protecting groups are cleaved off 
subsequently by refluxing in conc. H2SO4 for 48h to give 1,8-dimethyl-4,11-bis-(2-
aminoethyl)cyclam 6 (quantitative yield). At last, 6 is reacted with di-(2-
pyridyl)methylchloride 12 and potassium carbonate as base in dry acetonitrile. 12 is 
synthesized from di-(2-pyridyl)ketone in two steps in 75% yield (lit. 52%, see Scheme 
3.5).[126] The crude reaction mixture is purified by column chromatography and subsequent 
recrystallisation in hot hexane. L1 is obtained as a pale yellowish powder in 26% yield. The 
overall yield over six steps is 14%. 
 
 
Scheme 3.4: Synthesis of N-tosylaziridine.[123, 124] 
 
 
Scheme 3.5: Synthesis of di-(2-pyridyl)methylchloride.[126] 
 
  Chapter 3.2: The Cyclam-based Ligand L
1 39
As already mentioned, the cyclam moiety of L1 is likely to induce a high flexibility to the 
ligand. In order to investigate this assumption, a conformational search is performed using 
MacroModel[127] (see Chapter 4.5 for details). Two starting points were chosen, a transoid 
ligand structure and a cisoid one. The resulting lowest-energy conformers are shown in Figure 
3.3 (with 685.03 kJ/mol for the cisoid and 687.26 kJ/mol for the transoid structure): 
 
                     
Figure 3.3: Lowest-energy conformers from a conformational search on L1. 
 
All other conformers have a maximum deviation in energy of ca. 8 kJ/mol. Most of them 
adopt very diverse geometries. Interestingly, starting from the cisoid structure, also transoid 
conformers are found and vice versa. These findings strongly support the anticipated high 
flexibility of L1. 
The crystal structures of L1 and [H2L1]2+ are shown in Figure 3.4. A transoid structure is 
favored in a crystal lattice, yielding Ci symmetry (triclinic space group) in the non-protonated 
and C2h symmetry (monoclinic space group) in the protonated ligand. A cisoid structure 
would lead to lower symmetry and less favorable crystal packing. The protonated ligand 
(Figure 3.4 b) shows small deviations from the free ligand structure: the dipa-units are rotated 
such that the two pyridines face the doubly-protonated cyclam ring. The cyclam part is in an 
all-chair conformation in both structures. 
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Figure 3.4: Ortep plots of the X-ray structures of a) L1 and b) [H2L1]2+ (hydrogen atoms are omitted for clarity, 
except for the two cyclam-nitrogen protons in b); ellipsoids are drawn at 50% probability level). 
 
 
3.2.2. FeIII Coordination Chemistry of L1 
 
3.2.2.1. Coordination Chemistry of L1 in MeCN 
 
The coordination chemistry of ligand L1 with FeIII in MeCN solution was investigated 
thoroughly using various techniques, i.e. UV/vis, NMR and EPR spectroscopy, high 
resolution mass spectrometry and cyclic voltammetry. In addition, density functional theory 
calculations gave insight into structures and properties of the complexes.  
All complexation reactions and experiments were carried out under aerobic conditions, 
unless otherwise stated, and no absolutely water-free MeCN is required. Tetraethylammonium 
tetrachloroferrate [FeCl4](NEt4) 13 is used as the FeIII source in all reactions with L1 because 
of its good solubility in organic solvents and the non-lewis-acidity of the tetrachloroferrate 
anion. ESI-MS predominantly showed peaks of the protonated ligand and only small peaks of 
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complexes when a lewis-acidic iron salt, like ferric nitrate, was used. The tetrachloroferrate 
salt was synthesized by mixing anhydrous FeCl3 and tetraethylammonium chloride in ethanol 
(see Scheme 3.6). The product was obtained as a yellow powder in 76% yield.[128] 
 
Scheme 3.6: Synthesis of the non-lewis-acidic iron salt tetraethylammonium tetrachloroferrate. 
 
UV/vis and 1H-NMR titrations of the ligand with [FeCl4](NEt4) were performed to gain 
insight into the in situ formation of complexes. Samples with 0 to 2 eq FeIII vs. L1 were 
prepared and 1H-NMR spectra were measured (see Figure 3.5). Upon addition of FeIII, the 
signals between 7 and 8.5 ppm (pyridine protons), as well as the signal at 5 ppm (CH between 
the pyridines and the secondary amine) broaden and eventually start to disappear, but the 
chemical shifts remain the same. With 1 eq of FeIII, the intensity of these signals is 
approximately halved, compared to the metal-free ligand spectrum. As reference for 
integration, the tetraethylammonium signals at 1.22 and 3.20 ppm are used. When adding 2 eq 
of FeIII, the mentioned signals completely disappear. In the aliphatic region, it is clearly 
visible that the cyclam signals between 2 and 2.5 ppm are broadened and also slightly shifted, 
but they are still present even with 2 eq of FeIII. The conclusions from this experiment are the 
following: one ligand L1 takes up two ferric ions; they are coordinated via the pyridines and 
secondary amines, as anticipated. The cyclam moiety is not involved in metal coordination, 
otherwise the corresponding NMR signals would also disappear. 
 
Figure 3.5: 1H-NMR titration of L1 (5 mM) with [FeCl4](NEt4) in MeCN-d3. 
L1
0.1 eq Fe(III)
0.5 eq Fe(III)
1 eq Fe(III)
1.5 eq Fe(III)
2 eq Fe(III)
L1
0.1 eq Fe(III)
0.5 eq Fe(III)
1 eq Fe(III)
1.5 eq Fe(III)
2 eq Fe(III)
0.05.010.0ppm (t1)
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The UV/vis titration of L1 with FeIII (Figure 3.6 a) reveals more important details. The 
two bands at λ = 330 nm (shoulder; ε = 21120 M-1cm-1) and λ = 378 nm (ε = 16450 M-1cm-1) 
increase linearly. They are assigned to oxo-to-iron CT transitions.[102, 103] Interestingly, the 
spectra with 1 and 2 eq of FeIII (bold lines) look almost alike, with only small differences due 
to negligible amounts of uncoordinated FeIII in the upper bold spectrum (evolving band at λ = 
310 nm; visible in the uppermost spectrum with 2.4 eq of FeIII, i.e. FeIII in excess). This 
suggests that only one species is formed, independent of the amount of FeIII added. 
 
 
Figure 3.6: a) UV/vis titration of L1 (0.05 mM) with [FeCl4](NEt4) (in steps of 0.2 eq; bold lines represent 1 and 
2 eq, respectively) and b) detailed UV/vis spectrum of L1 with two equivalents of [FeCl4](NEt4) in MeCN. 
 
The UV/vis spectrum of L1 with two eq of FeIII is shown in Figure 3.6 b. In addition to 
the two intense bands in the UV region, a third band in the visible area at λ = 600 nm 
(shoulder, ε = 120 M-1cm-1) can be observed. It corresponds to a dd transition of a high-spin 
ferric ion (6A1 → 4T2), which is spin- and Laporte forbidden and therefore should have a low 
extinction coefficient.[129] In this case, the CT bands at lower wavelengths lead to an increased 
intensity of this transition due to the overlap of these bands. 
The intense bands in the UV region are very similar to oxo-to-iron charge transfer bands 
reported in the literature.[102, 103] Therefore, it can be concluded, that a µ-oxo bridged di-FeIII 
complex is formed predominantly, independent of how many equivalents of FeIII are present 
in solution. High resolution ESI mass spectra in MeCN confirm the presence of an oxo-unit in 
the complex molecule: All peaks with two FeIII also contain exactly one oxygen, most 
probably as O2-. Figure 3.7 shows the experimental and calculated isotope pattern of the main 
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peak at m/z = 921.19821 (calc. m/z = 921.19838 for [HL1FeIII2Cl4O]+) and the next intense 
signal at m/z = 883.22483 (calc. m/z = 883.22465 for [L1FeIII2Cl3O]+). The two peaks at [M-2] 
and [M-1] represent a typical isotope pattern of species with two iron.  
 
Figure 3.7: Isotope patterns of experimental (top) and calculated mass spectra (bottom) of [L1FeIII2Cl3O]+ (left) 
and [HL1FeIII2Cl4O]+ (right). 
 
In mass spectra of solutions with L1 and only one eq of FeIII, the main peak is the 
protonated ligand [HL1]+ at m/z = 651.46085 (calc. m/z = 651.46057). Other species present 
are, surprisingly, a mononuclear FeII complex at m/z = 741.35714 (calc. m/z = 741.35709 for 
[L1FeIICl]+) as well as different dinuclear species also appearing in spectra with two eq of 
FeIII. It is likely that the mononuclear FeII complex is a minor impurity, but well ionized 
during measurement. Mononuclear FeIII species are not observed at all.  
It is not fully understood why L1 only forms dinuclear complexes with FeIII, or more 
exactly, with [FeCl4]-. The best explanation so far is based on the observation that ferric 
chloride forms µ-oxo bridged dimers when reacted with additional chloride in wet basic 
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solutions (see Scheme 3.7 a).[130] Due to its cyclam part L1 is a strong bas and a basic 
environment is present during the addition of tetrachloroferrate to pre-dissolved L1. It can be 
assumed that tetrachloroferrate reacts in a similar way with base as ferric chloride does in 
Scheme 3.7 a, namely tetrachloroferrate should be an intermediate in this reaction. The 
resulting diferric species can then react with L1 under partial ligand exchange (chloride vs. 
pyridine/amine) to form a µ-oxo bridged diferric complex (K1 in Scheme 3.7 b). Monomeric 
FeIII should not be present under these conditions and therefore, no mononuclear FeIII 
complex of L1 is observed. 
 
 
Scheme 3.7: Reactions of ferric ions in basic solution. 
 
Based on these observations and for simplicity, a solution containing L1 and two eq of 
FeIII is called “K1” from now on. Scheme 3.8 shows the postulated structure of this complex. 
The ferric ions are coordinated by two pyridines and one secondary amine of L1, each. Two 
chloro ligands and a µ-oxo bridge complete the octahedral coordination of the metal ions. The 
cyclam is likely to be protonated (see Scheme 3.7 b). The result is a twofold positively 
charged complex. 
 
Scheme 3.8: Postulated structure of K1. 
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In order to explore the magnetic properties of K1, molar susceptibilities were measured 
using 1H-NMR as described by Evans.[131] The theory behind these experiments is, that the 
frequency shift Δf of a signal from a diamagnetic substance (e.g. the solvent), caused by a 
paramagnetic compound dissolved in it, is proportional to the paramagnetic susceptibility 
Xpara,subst of the compound (see eq. 3.1).  
 
   ܺ௣௔௥௔,௦௨௕௦௧ ൌ   ଷ∆௙ସ గ∗௙∗௖ ൅ ܺௗ௜௔,௦௢௟௩ ൅ ܺௗ௜௔,௦௨௕௦௧   (eq. 3.1) 
 
The effective magnetic moment µeff is then calculated as  
 
 ߤ௘௙௙ ൌ 2.828 ∗ ඥܺ௣௔௥௔,௦௨௕௦௧ ∗ ܶ (eq. 3.2) 
 
The results of these experiments are summarized in Table 3.1. In the two last columns, 
the expected spin state and the theoretical spin-only value for µeff are shown. 
 
Table 3.1: Results of Evans-NMR experiments with K1 in MeCN-d3. 
sample 
exp. µeff [B.M.] 
per complex unit
expected        
spin state S 
calc. µeff [B.M.] for 
expected spin state 
K1 (ceff = 2 mM) 4.97 2 4.90 
L1 + 1 eq of FeIII assuming only 
dinuclear complexes (ceff = 1 mM) 
3.69 2 4.90 
L1 + 1 eq of FeIII assuming only 
mononuclear complexes (ceff = 2 mM) 
2.49 5/2 5.92 
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The observed spin state of K1 at room temperature is S = 2. A fully uncoupled system 
with two high spin ferric ions would result in µeff = 11.83 B.M. per complex and can therefore 
be excluded. On the other hand, the proposed µ-oxo bridged dinuclear FeIII complex would be 
strongly antiferromagnetically coupled (J ≈ -100 to -150 cm-1), and therefore have an S = 0 
ground state. At room temperature, higher spin states may be populated. Which spin states 
contribute to µeff in this case cannot be analyzed on the basis of the available experimental 
data. Therefore, it cannot be excluded that a small fraction of non-coupled FeIII is present. The 
Evans experiment with L1 and only one eq of FeIII reveals some interesting facts: assuming 
the formation of only mononuclear complexes, a µeff value of 5.92 would be expected 
(S = 5/2, high spin ferric ion). The observed lower value of µeff = 2.49 at the resulting 
effective complex concentration ceff suggests that this interpretation is wrong. If only 
dinuclear complexes were present (i.e. the effective complex concentration ceff is halved), the 
same spin state as for K1 would be expected (S = 2). The experimental value is even smaller 
than that. Therefore, the ferric ions in this sample are proposed to be coupled. The deviation 
between the effective magnetic moments can be explained by a small excess of “free” FeIII in 
K1 due to small errors during the sample preparation, leading to a larger than expected value 
of µeff. These observations strongly support the idea, that L1 forms predominantly one species, 
which is the dinuclear complex K1, independent of the amount of FeIII, as already concluded 
from the UV/vis titration. 
EPR spectra of K1 in MeCN at 1.7 K show a moderately intense signal at geff = 4.3 (see 
Appendix 2 for spectra), which is typical for octahedral high-spin FeIII. It is clearly different 
to the signal of [FeCl4](Net4) in MeCN. Usually, this kind of signal is very strong, leading to 
the interpretation that there is only a relatively small amount of uncoupled FeIII present. This 
is consistent with the Evans-NMR data. 
 
 
3.2.2.2. Redox Properties of K1 
 
Although we focus our experiments on the homovalent redox state of K1, a reduction to the 
heterovalent FeIIIFeII complex of L1 would be desirable. Cyclic voltammetry (CV) 
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experiments were conducted in order to explore the redox behavior of K1 and find a suitable 
method for the reduction. Figure 3.8 presents the results.  
 
    
    
    
Figure 3.8: CVs of K1 and L1Fe: a) K1 full sweep and b) K1 at different chart speed; c) L1Fe full sweep and d) 
L1Fe at different chart speed; overlay of K1 and L1 Fe at e) 200 mV/s and f) 400 mV/s; all recorded in MeCN 
with 0.1M NBu4ClO4 vs. Ag/Ag+, with E1/2 (FeCp2) = 0.08 V. 
b) a) 
c)  d) 
e)  f) 
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The observed reversible redox potential of K1 (Figure 3.8 a) at E1/2 = -0.39 V (-0.09 V vs. 
SCE, ΔE = 217 mV) can be attributed to an FeIII2/FeIIIFeII couple. The oxidation branch shows 
an additional, irreversible peak around 0.45 V (0.75 V vs. SCE) which might be due to an 
oxidation to FeIV. The scans at different speed do not show special features. As expected, the 
peak height rises at higher scanning speed. We also recorded CVs of L1 with only one eq of 
FeIII (L1Fe) and compared them to the results of K1 (Figure 3.8 c-f). The oxidation and 
reduction peaks are less intense but in comparison to the CVs of K1 (see Figure 3.8 e and f) 
clearly appear at the same potential. No additional peaks are observable so that it can be 
concluded that one species is formed, which is the dinuclear complex. 
The reversible redox behavior of K1 indicates that a one-electron reduction to the 
heterovalent complex should be possible. At the time scale of the CV experiments, the 
reduced, i.e. heterovalent FeIIIFeII species is stable. Cobaltocene was chosen as the reducing 
agent (E1/2 = -0.95 V vs. SCE; 10 fold excess) under anaerobic conditions, as it is a powerful 
one-electron reductant. In the EPR spectra (4.8 – 50 K) no changes could be observed after 
reaction of K1 with cobaltocene. The only signal in both, K1 and the reduction product, was 
that at geff = 4.3, assigned to high spin FeIII. The UV/vis spectra differ only in the relative 
intensities of the the absorption bands, their position remains the same (Figure 3.9). HR-ESI 
MS showed no mass peaks belonging to a heterovalent species, but the known peaks of K1. 
We assume that the reaction was not successful. A possible explanation is that both 
complexes are too bulky (pyridine groups are shielding the ferric ions in K1 and the 
cyclopentadienyl ligands in cobaltocene) and, therefore, the metal centers cannot directly 
interact in an outer-sphere electron transfer reaction. As a consequence, bulk electrolysis was 
applied in order to reduce K1 to the heterovalent complex. Solutions of K1 in MeCN or 
MeCN/DMF mixtures were held at a constant potential of -0.3 V (vs. SCE) for one hour 
under argon. EPR spectra at liquid nitrogen temperature (140 K) show striking changes (see 
Appendix 3 for spectra): Whereas the spectrum of K1 consists of the usual geff = 4.3 signal for 
high spin FeIII and an additional small peak at geff = 2.1, a freshly reduced solution spectrum is 
dominated by the previously small signal at geff = 2.1, which might be due to an S = ½ 
species. An antiferromagnetically coupled FeIIIFeII complex would result in exactly this spin 
state. Moreover, the charge Q that was transferred during electrolysis corresponds to one 
equivalent of electrons. However, when the solution is left standing for a while, the EPR 
signal at geff = 2.1 disappears. Also, no adequate mass peaks could be identified in the HR-
ESI-MS. UV/vis spectra of the electrolyzed solution have the same appearance as reported for 
the cobaltocene reaction mixture. Our interpretation of these results is that the desired 
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heterovalent complex is formed, but cannot be stabilized even though anaerobic conditions 
were used. A disproportionation reaction of the reduced, heterovalent species into diferric and 
diferrous complexes is likely, with subsequent decomposition of the diferrous complex. 
 
Figure 3.9: UV/vis spectrum of K1 (dashed line) and K1 with cobaltocene (solid line) in DMF (0.33 mM). 
 
 
3.2.2.3. Coordination Chemistry of L1 in Aqueous Media 
 
In order to explore the behavior of K1 at different pH values, experiments were extended to 
MeCN/aqueous buffer mixtures (1:1). K1 was prepared in MeCN and subsequently, a 
multicomponent buffer, containing MES, HEPES and CHES, was added, the pH of which had 
been adjusted by aqueous NaOH. At first, UV/vis spectra at pH 5 were measured and 
compared to the spectrum of K1 in MeCN (see Figure 3.10 a). The two oxo-to-iron CT bands 
at 330 and 378 nm disappear and new bands at 360 and 466 nm arise. There are different 
possibilities to interpret these changes: As the band at 466 nm may also be assigned to a 
LMCT (ε ≈ 4000 M-1cm-1), the two new bands can be regarded as shifted due to ligand 
exchange at the coupled dinuclear FeIII complex. In MeCN, chloride is the most likely co-
ligand, which is exchanged by water and/or hydroxide upon addition of aqueous buffer. 
Another possibility is that a completely new species is formed, e.g. uncoupled dinuclear or 
mononuclear FeIII complexes. Comparison of our spectra to literature-known species supports 
the first suggestion, as the band at 466 nm is typical for µ-oxo bridged diferric systems with 
water or hydroxide as co-ligands.[132] 
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Figure 3.10: a) UV/vis spectra of K1 (0.05 mM) in MeCN (dashed line) and MeCN/buffer pH 5 (solid line) and 
b) time-resolved UV/vis spectra (1/30 sec) of K1 (0.025 mM) in MeCN/buffer pH 5 at 0 to 30 min after mixing. 
 
Time-resolved UV/vis spectra, which were recorded in the first 30 min after addition of 
the buffer solution, show an isosbestic point around 350 nm (see Figure 3.10 b). Only small 
changes can be observed in the region between 300 and 380 nm, whereas the formation of the 
LMCT band at 466 nm is the predominant feature in the spectrum. Interestingly, the oxo-to-
iron CT transition at 378 nm is not visible, although the measurement was already started 
approximately 10 sec after mixing. There is a very fast process leading to the loss of this 
band. This behavior is in contrast to the slow spectral changes observed over 30 min. A 
combination of the assumptions described above might help to interpret these results: when 
reacting with water, the µ-oxo bridged diferric complex is hydrolyzed to a non-bridged di-
hydroxo species, which explains the disappearance of the band at 378 nm. Subsequently, the 
assumed exchange of co-ligands (chloride to aqua/hydroxo) takes place. In the meantime, the 
µ-oxo bridge is slowly re-established and the new oxo-to-iron CT bands rise. 
This proposal is supported by EPR spectroscopy: the high spin FeIII signal at geff = 4.3 
observed in MeCN solutions of K1 at first gains intensity and then completely disappears over 
time when buffer is added, and no other signal is observed at 1.7 K. Obviously, an EPR-silent 
species is formed, which very likely is the anticipated µ-oxo bridged diferric complex with an 
S = 0 ground state. In addition, the effective magnetic moment µeff of K1 in MeCN/buffer is 
significantly smaller than in pure MeCN (3.77 vs. 4.97 B.M.). This suggests either a more 
strongly coupled dimer or, more likely, smaller fractions of non-coupled species. 
a)  b) 
  Chapter 3.2: The Cyclam-based Ligand L
1 51
 
 
Scheme 3.9: Proposed reactions after addition of buffer to K1 solution in MeCN. 
 
In summary, the species most likely existing, when K1 is prepared in MeCN/buffer 
mixtures, is a µ-oxo bridged diferric complex. Dependent on the pH of the buffer, aqua and/or 
hydroxo co-ligands should present. The exact distribution of species remains unclear, as 
spectrophotometric titrations did not give suitable results. The UV/vis spectra were not 
changed significantly upon variation of the pH value. Unfortunately, the CT absorptions of K1 
are not very sensitive to pH changes. Other techniques must be used to explore the pH 
dependent properties of K1 (see Chapter 3.4.1 for more information). 
An interesting question that arises, when considering that K1 is dissolved in a 
MeCN/buffer mixture, is whether MeCN hydrolysis is possible. Usually, nitriles are quite 
resistant against hydrolysis.[133] Only when coordinated to metal ions, a nucleophilic attack of 
a metal bound hydroxide leads to a fast conversion of MeCN to acetamide.[132, 134] In our case, 
the use of a 1:1 mixture of buffer and MeCN should prevent the coordination of MeCN and 
favor binding of aqua/hydroxo co-ligands, as FeIII is known to be rather oxophilic. 
Nevertheless, the observed CT band at 466 nm might be arising from coordinated acetamide, 
which is the product of MeCN hydrolysis. We recorded a time-resolved UV/vis spectrum of 
K1 with acetamide in excess in MeCN/buffer pH 5 (see Appendix 4 for spectrum and details). 
The resulting spectrum is similar to that in Figure 3.10 b, showing the characteristic CT band 
at 466 nm. However, this band is growing slower in the experiment with acetamide, 
suggesting that it does not belong to a K1acetamide complex. A weak shoulder at 488 nm can 
be observed in both cases, with and without additional acetamide, which is in a typical range 
for diferric complexes with a bridging acetamide.[132] From these results, we conclude that 
MeCN hydrolysis is probably occurring with K1 in MeCN/buffer mixtures, although very 
slow.  
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3.2.2.4. Coordination of Phosphate and Phosphoesters to K1 
 
As the purpose of K1 is to act as a PAP mimic, it is crucial to know how substrates and 
products interact with the complex. Important information includes the number of coordinated 
molecules, their coordination mode (monodentate vs. bridging) and possible interactions with 
the protonated cyclam moiety, as well as the number and nature of additional co-ligands (µ-
oxo vs. µ-hydroxo vs. terminal hydroxo). These data should contribute to the understanding of 
the mechanism of phosphoester hydrolysis. The products of phosphoester hydrolysis are the 
corresponding alcohol and inorganic phosphate or a phosphomonoester. As substrate mimics, 
the inactive phosphoesters pNPP (para-nitrophenylphosphate), 1-NP (1-naphthylphosphate) 
and DPP (diphenylphosphate) were chosen (see Scheme 3.10). pNPP is used as a substrate in 
enzymatic reactions, because enzymes are usually more active than model compounds. This is 
also the case with K1, which showed no detectable catalytic activity with pNPP. 
 
 
Scheme 3.10: Substrate mimics p-nitrophenylphosphate pNPP (left), 1-naphthylphosphate 1-NP (middle) and 
diphenylphosphate DPP (right). 
 
A good tool for the investigation of phosphorous containing compounds is 31P-NMR. 
Inorganic phosphate as well as mono- and diesters can easily be distinguished due to their 
typical chemical shifts. Quantitative information can be obtained by using an internal 
standard, which delivers data about species distribution. In order to gain insight into the 
number of coordinated substrate molecules per K1 unit, 31P-NMR spectra were recorded with 
different equivalents of K1 vs. phosphorous compound. Due to the paramagnetic character of 
K1, the 31P signals of coordinated compounds are massively broadened and therefore not 
visible. Therefore, the loss of intensity of the uncoordinated substrate is proportional to the 
magnitude of coordination and consequently, the number of coordinated molecules per 
complex. The results for phosphate, pNPP and DPP at pH 5 (in MeCN/buffer) as well as 
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pNPP at pH 10 are summarized in Table 3.2. Interestingly, two molecules of pNPP are bound 
to K1 at pH 5, whereas in the other cases only one substrate molecule is coordinated. This 
finding suggests different coordination modes, dependent on the substrate and the pH used. 
Further spectroscopic studies are needed for a reasonable interpretation of the stoichometries 
found. 
 
Table 3.2: Results from 31P-NMR titrations of substrate mimics (5 mM in MeCN-d3/buffer D2O 1:1) with K1. 
substrate mimic pH chemical shift [ppm] no. of coord. molecules 
phosphate 5 -0.17 1 
pNPP 5 -4.50 2 
pNPP 10 -0.66 1 
DPP 5 -10.59 1 
 
 
In contrast to these results, species found in HR-ESI mass spectra of K1 with phosphate 
or pNPP (in large excess) always contain two substrate molecules. One should not over-
interpret this, as weak adducts can form during ionization. Moreover, K1 itself in 
MeCN/buffer is not easy to detect due to protonation of the cyclam ring. The resulting high 
positive charge requires an appropriate number of counter-ions to generate only singly or 
doubly positively charged species. Therefore, two phosphate or pNPP molecules are 
necessary. The observed ESI-MS species are summarized in Table 3.3. Again, no 
mononuclear species or free ligand peaks are observed. A remarkable fact is that each peak 
also contains exactly one “free” oxygen. In Table 3.3, it is written as hydroxide, but this 
assignment is not sure. No conclusions can be drawn yet regarding the number and 
coordination mode of possible oxo, hydroxo or aqua co-ligands. 
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Table 3.3: Species observed in HR-ESI-MS of K1 with phosphate or pNPP in MeCN/buffer (pH 5). 
species calc. m/z exp. m/z peak height [%] 
[HL1FeIII2(HPO4)2(OH)]2+ 486.12812 486.12784 100 
[H2L1FeIII2(HPO4)2(OH)(ClO4)]2+ 536.10629 536.10619 5 
[HL1FeIII2(HPO4)2(OH)Cl]+ 1007.22508 1007.22480 11 
[HL1FeIII2(HPO4)2(OH)(ClO4)]+ 1071.20474 1071.20482 15 
[HL1FeIII2(pNPP)2(OH)]2+ 607.14450 607.14412 100 
[LiL1FeIII2(pNPP)2(OH)]2+ 610.14859 610.14830 47 
[L1FeIII2(pNPP)2(OH)]+ 1213.28166 1213.28025 31 
[HL1FeIII2(pNPP)2(OH)Cl]+ 1249.25784 1249.25757 45 
 
 
EPR spectra were recorded at low temperatures (1.6 to 16 K) in MeCN/buffer mixtures in 
order to elucidate the spin state of K1/phosphate, pNPP or DPP complexes. As already 
mentioned, without any additional substrate mimic, an EPR-silent species is formed, most 
probably a µ-oxo bridged complex. Mixtures of K1 and the inactive diester DPP in excess 
(c(K1) = 0.5 mM; c(DPP) = 10 mM) show only a moderately intense signal at geff = 4.3, 
which belongs to high spin ferric ions. This signal is constant over time and decreases with 
increasing temperature. It seems that also in this case, mainly an EPR-silent species is present. 
Upon addition of pNPP or phosphate (same concentrations as in the DPP experiment), a 
complex signal develops over time at pH = 5. Coupled diferric systems have various possible 
spin states between S = 0 and 5, which are populated depending on the type and strength of 
exchange coupling as well as the temperature (see Appendix 5 a for schematic energy 
diagram). Measurements at variable temperatures (VT) revealed a dependence of signal 
intensity, which at first grew with increasing temperature and then slowly decreased again 
(Figure 3.11). This behavior is typical for antiferromagnetically coupled systems with S = 0 as 
the ground state.[135] Maximum intensity was obtained at 2.4 ± 0.2 and 3.5 ± 1.0 K for K1 with 
pNPP and phosphate, respectively. This results in exchange coupling constants of J = -1.67 ± 
0.14 and -2.43 ± 0.69 cm-1 (1 K = 0.694 cm-1). 
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Figure 3.11: VT X-band EPR spectra of a) K1pNPP (9.376664 GHz) and b) K1phosphate (9.37824 GHz). 
 
A first attempt to simulate the spectra with XSophe,[136] neglecting the FeIII-FeIII 
interactions and treating the system as one FeIII with S = 3, lead to a reasonable match. 
However, several features, including the relative intensities of the smaller signals between 
2000 and 3000 as well as around 3800 Gauss, were not correctly reproduced. Therefore, we 
decided to adopt a full description of the system, using Molecular Sophe (MoSophe)[137] for 
the simulation. The total spin Hamiltonian Htotal is composed of the sum of individual spin 
Hamiltonians for an isolated paramagnetic center HAi and the interaction Hamiltonian HAij 
a) 
b) 
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(eq. 3.3).[135, 138-140] Although the interaction Hamiltonian used in the simulation defines 
positive J* values for antiferromagnetic coupling, all reported J values in this work are based 
on the Hamiltonian ܪ஺௜௝ ൌ  െ2ܬ஺௜௝ ∗ ஺ܵ௜ ∗ ஺ܵ௝ with ܬ ൌ െ2ܬ∗ and, therefore, negative J values 
indicate antiferromagnetically coupled systems. For a first guess, the same zero-field splitting 
value D was used as in the XSophe simulation. Based thereon, the FeIII-FeIII distance was 
approximated to be around 4.7 Å for K1pNPP and 4.5 Å for K1phosphate, using the relation 
between the dipole-dipole zero-field splitting Ddd and the dipole-dipole coupling constant 
Jdd.[137] The J value was taken from the VT experiments. These parameters were refined, 
together with the isotropic g-factor, the rhombicity parameter E and orthorhombic line widths. 
Euler angles, relating the relative orientation of the fine structure parameters D and E on the 
two metal centers, were included and further improved the simulation. The recorded and 
simulated spectra of K1 with pNPP and phosphate, respectively, are shown in Figure 3.12. 
Parameters obtained from the simulations are presented in Table 3.4. 
   ܪ௧௢௧௔௟ ൌ ∑ ܪ஺௜ே௜ୀଵ ൅ ∑ ܪ஺௜௝ே௜,௝ୀଵ;௜ஷ௝ .. (eq. 3.3) 
with ܪ஺௜ ൌ Ԧܵܦ Ԧܵ ൅ ߚܤሬԦ݃ Ԧܵ (eq. 3.4) 
and ܪ஺௜௝ ൌ ஺ܵపሬሬሬሬሬԦܬ஺௜௝∗ ஺ܵఫሬሬሬሬሬԦ (eq. 3.5) 
 
Table 3.4: Simulated parameters for K1 with pNPP and phosphate (MoSophe). 
parameter K1 + pNPP K1 + phosphate 
giso[a] 1.99 2.01 
D [cm-1][a] 185 * 10-4 [b] 217 * 10-4 [c] 
E/D[a] 0.33 0.33 
d (Fe-Fe) [Å] 4.60[d] 4.57[e] 
Jiso [cm-1] -2.40 -3.80 
[a] equal for both FeIII centers; [b],[c] The D tensors are rotated by β = ± 35 and ± 40°; [d] The positions of Fe(1) 
and Fe(2) are 0/0/0 and 4.60/0/0; [e] The positions of Fe(1) and Fe(2) are 0/0/0 and 4.57/0/0. 
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Figure 3.12: Experimental (black) and simulated (blue) X-band EPR spectra of K1 (0.5 mM in MeCN/buffer 
pH 5) with a) pNPP and b) phosphate (10 mM each); spectra were recorded at 9.376664 and 9.37824 GHz at 2.4 
and 1.7 K, respectively. 
 
The combination of EPR simulations and DFT calculations is a powerful method to gain 
structural information about molecules in solution. In our case, additional information is given 
by the magnetic interaction between the two FeIII centers, leading to well-determined values 
for the coupling constant J and metal-metal distance d (simulated parameters, see Table 3.4). 
DFT calculations can provide calculated values for both. The latter can be estimated from 
geometry optimized structures, whereas J values are determined using the broken symmetry 
formalism.[141]  
Three different structures are plausible for complexes of K1 with pNPP at pH 5: when 
two pNPP molecules are coordinated to each complex, as known from the 31P-NMR titrations 
described above, one free coordination site at each FeIII remains, which can be occupied by a 
bridging oxo-group (µ-O), a bridging hydroxide (µ-OH) or two terminal hydroxides. The 
geometry-optimized structures (for computational details see Chapter 4.5) are shown in 
Figure 3.13 and the corresponding parameters are listed in Table 3.5 and compared to 
experimentally obtained values of similar complexes (see Chapter 2.4 for details and 
references). It appears that the observed EPR signal for the K1pNPP complex belongs to a 
species, where no other bridge than the two pNPP molecules is present, mainly due to the 
obtained coupling constant J. The estimated FeIII-FeIII distance of 4.68 Å fits to the value used 
in the simulation of the EPR spectrum (4.60 Å). Moreover, the simulated Euler angle of β = ± 
35° almost resembles the rotation of the N-FeIII-OH axes relative to the z-axis (perpendicular 
to the FeIII-FeIII axis) in the calculated structure (Figure 3.14). 
a)  b) 
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Figure 3.13: Geometry-optimized structures of K1 with two pNPP and a) µ-oxo, b) µ-hydroxo and c) two 
terminal hydroxo ligands; non-polar hydrogen atoms are omitted for clarity; light grey = carbon, white = 
hydrogen, blue = nitrogen, red = oxygen, yellow = phosphorous, dark grey = iron. 
 
 
Figure 3.14: Rotation of the N-Fe-OH axes with respect to the cartesian axes. 
 
Table 3.5: Calculated parameters for µ-oxo, µ-hydroxo and non-bridged K1 with pNPP in comparison with 
literature-known parameters[a] of diferric complexes 
parameter µ-oxo µ-hydroxo non-bridged 
Jcalc [cm-1] -67.35 -10.24 -3.11 
Jlit [cm-1] -70 to -125 -10 to -20 0 to -3.5 
d (Fe-Fe)calc [Å] 3.20 3.65 4.68 
d (Fe-Fe)lit [Å] 3.15 to 3.60 3.45 to 3.60 4.60 to 4.85 
[a] see Table 2.4 in Chapter 2.4 for details and references. 
33.8°- 31.6°
z1 z2
x
a)  b)  c) 
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In order to further probe the magnetic properties of K1pNPP, Evans-NMR measurements 
were performed. The magnetic moment significantly rises to µeff = 4.71 B.M. (vs. 3.77 B.M 
for K1 in MeCN/buffer without pNPP). This indicates a less strongly coupled species, which 
is consistent with the parameters obtained by EPR. Nevertheless, the low J-value of 
-1.67 cm-1 for the bis-hydroxo species (value from the VT EPR experiments) should result in 
a much higher magnetic moment, as the S=5 state should be populated at temperatures higher 
than 74 K and the Evans-NMR measurements were done at ambient temperature. This leads 
to the conclusion that a significant amount of K1 is still present in the strongly coupled, µ-oxo 
bridged form (see Scheme 3.11). As such a species occupies an S=0 spin state at very low 
temperatures, no additional EPR signals are expected. The postulated formal hydrolysis of the 
µ-oxo bridge includes a deprotonation step of a µ-hydroxo intermediate. Therefore, the shown 
equilibrium should be driven towards the µ-oxo side at high pH values. This can indeed be 
observed by EPR spectroscopy: with rising pH the signal intensity decreases and no signal is 
observed at pH 10. The relatively long time needed to fully develop the signal (around 4 h) 
suggests that the equilibrium is slow. 
 
 
Scheme 3.11: Postulated equilibrium between µ-oxo bridged and open species of K1 with pNPP. 
 
In the case of K1phosphate complexes, slightly different structures can be expected. On 
one hand, it is known from the 31P-NMR titrations that only one phosphate binds to K1 at pH 
5. On the other hand, the simulated parameters from EPR measurements differ a bit from 
those of the K1pNPP complex. Therefore, four different structures (Figure 3.15) were 
calculated with one coordinated phosphate, each. In analogy to the K1pNPP species, µ-oxo 
and µ-hydroxo bridged phosphate complexes (Figure 3.15 a and b) were postulated and 
geometry-optimized. The calculated J-values of these species are too large compared to the 
experimental value of -2.43 cm-1 (Table 3.6). Figures 3.15 c and d show two possibilities for 
structures without additional bridges, where the phosphate is either used as a tridentate or as a 
bidentate ligand. This small geometric variation leads to major differences in the calculated J-
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values with a change from weak antiferromagnetic coupling in the tridentate coordination 
case to weak ferromagnetic coupling when phosphate coordinates bidentately.  
 
                   
 
                 
Figure 3.15: Geometry-optimized structures of K1 with phosphate and a) µ-oxo, b) µ-hydroxo, c) three terminal 
hydroxo ligands and tridentate phosphate (non-bridged 1) and d) four terminal hydroxo ligands and bidentate 
phosphate (non-bridged 2); non-polar hydrogen atoms are omitted for clarity; light grey = carbon, white = 
hydrogen, blue = nitrogen, red = oxygen, yellow = phosphorous, dark grey = iron. 
 
Table 3.6: Calculated parameters for µ-oxo, µ-hydroxo and non-bridged K1 with phosphate in comparison with 
literature-known parameters of diferric complexes. 
parameter µ-oxo µ-hydroxo non-bridged 1 non-bridged 2 
Jcalc [cm-1] -68.31 -13.63 -2.61 +0.57 
Jlit [cm-1] -70 to -125 -10 to -20 0 to -3.5 0 to -3.5 
d (Fe-Fe)calc [Å] 3.32 3.66 4.54 4.23 
d (Fe-Fe)lit [Å] 3.15 to 3.60 3.45 to 3.60 4.60 to 4.85 4.60 to 4.85 
 
a)  b) 
c)  d) 
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Again, the observed EPR signal seems to belong to a species with no additional bridge 
apart from phosphate. Most probably, this phosphate coordinates in a tridentate way, as 
shown in Figure 3.15 c. As in the case with K1pNPP, it cannot be excluded that only a 
fraction of the molecules are present in this form and the other species is EPR-silent due to a 
µ-oxo bridged structure, as shown in Figure 3.15 a.  
UV/vis spectra of K1 with the different substrate mimics (pNPP, 1-NP and DPP) as well 
as with phosphate as product of hydrolysis were recorded at different concentrations. The 
iron-oxo bands were investigated at 0.05mM K1 (Figure 3.16 a) and the less intense dd bands 
at a tenfold higher concentration (Figure 3.16 b). 
 
 
Figure 3.16: Comparison of UV/vis spectra of K1 with coligands in MeCN; spectra were recorded at a) 0.05 mM 
K1 and b) 0.5 mM K1 with one equivalent coligand each. 
 
Whereas the spectrum of K1 with pNPP (dark blue) very much resembles the original 
spectrum of K1 (black), only with less intensity in the UV region, addition of 1-NP (dashed 
dark blue) or DPP (light blue) leads to large differences. The K1DPP spectrum shows a very 
interesting feature in its dd region: the band is split into two peaks. This is an indication for 
the presence of two ferric ions with a different environment. As one equivalent of substrate 
was added in each experiment, the conclusion is that DPP coordinates in a monodentate way 
to K1, leaving the other ferric ion unaffected. In all other cases only one dd band is observed. 
This means that these substrate mimics are bridging the two ferric ions. In constrast, the dd 
band of the 1-NP mixture is hardly visible. No definite conclusion can be drawn from the UV 
a)  b) 
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region. It seems that the two monoesters pNPP and 1-NP have a different coordination mode, 
as the wavelengths of the iron-oxo bands differ significantly. The iron-oxo bands of the DPP 
sample are very similar to the 1-NP one, only with some additional shoulders in the 1-NP 
spectrum, arising from the naphthyl residue. Probably, these features come from the 
differences in steric demand of the substrate mimics. pNPP is smaller than 1-NP, which has a 
similar size to DPP. It is known that the angle of the Fe-oxo-Fe unit strongly influences the 
spectra in the UV region.[103] This might also be the case here, as different sizes of the 
substrate will change the complex structure and enforce different angles. Addition of 
phosphate leads to a complete loss of the iron-oxo transitions. This means that the oxo bridge 
is lost, probably by hydrolysis into two terminal hydroxides. 
As the UV/vis spectrum of K1 changes slowly upon the addition of buffer, time 
dependent UV/vis spectra were measured to investigate the behavior of K1/substrate mimic 
mixtures in partly aqueous media. pNPP was not used this time, because the hydrolysis 
product, para-nitrophenolate, has very intense absorptions that conceal all other bands even at 
small concentration. The spectra of K1 with phosphate, 1-NP and DPP are shown in Figure 
3.17. Different concentrations were utilized for the different wavelength regions, as described 
in the figure caption. Only relatively small changes in the UV region are observed in all three 
cases. With phosphate, the previously present iron-oxo bands between 300 and 400 nm are 
hardly visible, indicating a fast hydrolysis of the µ-oxo bridge (Figure 3.17 a). In contrast, the 
spectra with 1-NP and DPP exhibit clearly visible shoulders in this region. With the 
monoester 1-NP (Figure 3.17 c), the overall intensity rises, whereas with DPP (Figure 3.17 e), 
an isosbestic point is formed at around 350 nm, leading to an iron-oxo band that is shifted by 
around 20 nm to higher wavelengths compared to 1-NP. In the visible region, the predominant 
feature is the already observed CT band at 470 nm in each case (see Figure 3.10 b). More 
interesting are the relatively weak dd bands around 600 nm. In the phosphate spectrum 
(Figure 3.17 b), the intensity of this band decreases over time (i.e. the shoulder becomes 
flatter), which can be explained by the loss of asymmetry due to the hydrolysis of the oxo 
bridge. The more asymmetric the environment of the ferric ions, the more intense the formally 
forbidden dd will bands be. The increase of the absorption band at 470 nm is due to the 
overall increase of intensity, visible in Figure 3.17 a. With 1-NP (Figure 3.17 d), the dd band 
retains its shape and is only shifted up as whole due to the shift of the whole spectrum. In the 
case with DPP (Figure 3.17 f), very small changes are visible regarding the dd band. In line 
with the spectra in pure MeCN, a split band can also be observed, although one could argue 
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that this is due to the bad resolution of the spectrum and too low concentrations. 
Unfortunately, no higher concentrations can be obtained for solubility reasons. 
 
       
      
      
Figure 3.17: Time dependent UV/vis spectra of K1 in MeCN/buffer pH 6 with a), b) phosphate; c), d) 1-NP and 
e), f) DPP; left spectra (i.e. a, c and e) were recorded with 0.05 mM K1 and 1 mM coligand for 20 min, right 
spectra (i.e. b, d and f) with 0.25 mM K1 and 5 mM coligand for 10 min with one scan per minute each. 
a)  b) 
c)  d) 
e)  f) 
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Nevertheless, it becomes clear that 1-NP and DPP exhibit a very different behavior, and 
we conclude that the monoester 1-NP is preferentially bound in a bridging coordination mode 
whereas the diester DPP binds monodentately. 
The combination of the EPR and UV/vis results allows for a more detailed interpretation 
of the stoichometries observed by 31P-NMR titrations at the beginning of this chapter. The 
proposed monodentate coordination of the relatively bulky diester DPP is in agreement with a 
1:1 coordination to K1. In the case of pNPP, the postulated hydrolysis equilibrium at low pH 
between the structures with a µ-oxo bridge and terminal hydroxides, respectively, leads to the 
possibility of ligand exchange (aqua/hydroxo vs. pNPP) and due to the smaller size of this 
substrate, the coordination of a second pNPP molecule is possible. However, at high pH the 
µ-oxo bridge is conserved and no further ligand exchange occurs. With phosphate, the 
sterically demanding tridentate coordination mode of this relatively small molecule prevents 
the coordination of a second substrate. Therefore, only 1:1 complexes are observed with K1 
and phosphate.  
 
 
3.2.2.5. Solid State Coordination Chemistry of L1 
 
When preparing solutions of K1 in MeCN at high concentrations (> 5 mM), an ochre 
precipitate is obtained. Elemental analysis (C, H, N, Cl and Fe) yields the following 
composition: [L1FeIII2Cl4O] * 2 HCl * 5 H2O. The precipitate is in soluble in organic solvents, 
except for methanol, but soluble in water. In order to dissolve it, MeCN with 1 % water was 
used. This behavior can be explained by formation of polymeric structures. A reasonable 
possibility is a chain-type polymer 14, intermolecularly connected via Fe-oxo-Fe units 
(Scheme 3.12). The pre-formed dinuclear ferric complex [Cl3Fe-O-FeCl3]2- described in 
Chapter 3.2.2.1 (Scheme 3.7) reacts with two ligand molecules instead of one due to the high 
concentration of L1. When water is added, the µ-oxo bridges can be hydrolyzed, giving rise to 
monomeric K1 type complexes. HR-ESI-MS supported this proposal by showing different 
peaks, which were already observed for K1 solutions in MeCN. The predominant peak is m/z 
= 847.24790, which is calculated to 847.24797 for [L1FeIII2Cl2O]+. When MeCN is used as 
solvent without water, no complex peaks can be identified.  
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Scheme 3.12: Synthesis and possible structure of the precipitate of K1.  
 
UV/vis spectra were recorded in solid state, as well as in MeCN with 1 % water and are 
compared to solution K1 spectra in Figure 3.18. The solution spectra (dotted and solid line) 
are very similar with only small deviations in intensities being observed. Interestingly, the 
additional band at 466 nm has been previously observed, namely in the MeCN/buffer spectra 
(see Chapter 3.2.2.3). This is a hint for partial co-ligand exchange (chloro to aqua). The solid 
state spectrum (dashed line) shows bands at nearly the same wavelengths as in solution, only 
with completely different intensities. The most intense absorption is the oxo to iron CT 
transition at 400 nm and other bands appear as shoulders on this absorption. Also the FeIII dd 
transition around 600 nm is clearly visible as a shoulder. 
 
 
Figure 3.18: UV/vis spectra of K1 in MeCN (0.05 mM; dotted line), 14 in MeCN with 1% H2O (0.05 mM; solid 
line) and in solid state in Al2O3 (dashed line). 
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EPR measurements of 14 in the solid state show only one not very intense signal at geff = 
4.3, corresponding to high spin ferric ions. No other signal can be observed, which leads to 
the conclusion that the main species must be strongly coupled and therefore EPR-silent. This 
is in agreement with the postulated µ-oxo bridges between the complex units. Complex 14 
was further examined by cyclic voltammetry (Figure 3.19). Again, 1% water had to be added 
to MeCN to make the solid dissolve. The obtained E1/2 of 0.01 V vs. SCE is consistent with 
the value of -0.09 V measured with the in situ prepared complex solutions within 
experimental errors and due to the addition of water. This provides further support for the 
assumption that the precipitate forms the same species as the in situ prepared complexes when 
dissolved. 
 
 
Figure 3.19: CV of 14; recorded in MeCN with 1%H2O and 0.1 M NBu4ClO4 vs. SCE. 
 
Figure 3.20 shows a comparison of the ligand IR spectrum with that of 14. The 
predominant ligand peak at 2787 cm-1 is a Bohlmann band arising from a C-H starching 
frequency where the C-H bond is in trans position to a nitrogen atom lone pair.[142] In our 
case, this type of bond is found in the cyclam part of the ligand. It vanishes when the complex 
forms, which can be explained by a loss of the nitrogen lone pair. This comes either from 
coordination of metals in the cyclam moiety or from protonation of the nitrogen atoms. The 
latter is more plausible in this case, as coordination to the cyclam part of L1 was excluded by 
various spectroscopic techniques. Another interesting band is the one at 1667 cm-1 in the 
ligand spectrum, which belongs to a C=N stretch vibration of the pyridines. Upon reaction 
with FeIII, this band is shifted to 1627 cm-1, which indicates coordination of the pyridines to 
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the iron that causes weaker bonds and therefore vibrations at lower wave numbers. The band 
at 826 cm-1 in the K1 spectrum is assigned to the asymmetric Fe-O-Fe stretch vibration. It has 
a slightly higher frequency than other µ-oxo bridged diferric complexes (for comparison see 
Table 2.5 in Chapter 2.4). Only the last two entries in that table have similar values: These 
complexes have no additional bridge, like phosphate or similar co-ligands, and therefore the 
Fe-O-Fe angle is relatively large (between 160 and 180°).[108, 109] This is important structural 
information regarding K1. 
 
 
Figure 3.20: IR spectra of L1 (top) and 14 (bottom) in KBr. 
 
 
3.2.3. Coordination Chemistry of L1 with ZnII and CuII 
 
So far, only little work was done on L1 complexes with metals other than FeIII. The main 
focus was on ZnII and CuII. The idea was to block the cyclam moiety of L1 with a metal ion 
and leave the pyridine and amine functions free for FeIII to build up “blocked” K1. This 
should mimic the absence of the hydrogen bridge forming abilities of the cyclam part. 
Unfortunately, neither ZnII nor CuII tend to go into the macrocycle, but rather are coordinated 
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by the pyridine and amine site. This can be seen in the X-ray structures of the respective 
complexes 15 and 16 (Figure 3.21). The CuII complex 16 was further examined in solution by 
spectroscopic methods (UV/vis and EPR). The data resemble those for CuII(dipa)22+ (dipa = 
di-2-pyridylmethylamine; see Table 3.7 for comparison).[121] Therefore, it can be concluded, 
that the coordination mode observed in the solid state is retained in solution. 
 
           
Figure 3.21: Ortep plots of the X-ray structures of a) [L1Zn]2+ (15) and b) [L1Cu]2+ (16) (hydrogen atoms are 
omitted for clarity; ellipsoids are drawn at 50% probability level). 
 
Table 3.7: Comparison of spectroscopic parameters of [L1Cu]2+ 16 and [Cu(dipa)2]2+. 
 λmax (dd) [nm] g║ g┴ A║ [*10-4 cm-1] A┴ [*10-4 cm-1]
[L1Cu]2+ 639 2.23 2.05 180 n.a. 
[Cu(dipa)2]2+[121] 616 2.23 2.08 188 23 
 
As the approach, to first block the cyclam site and subsequently form K1, did not lead to 
the desired results, another route was taken by first mixing L1 and the iron salt to prepare K1 
in situ, and afterwards adding ZnCl2 or CuCl2. ZnII with its d10 configuration is not useful in 
terms of spectroscopic experiments, therefore only the K1Cu mixture was used for UV/vis and 
EPR measurements, to determine whether the mixed metal complex was formed. The UV/vis 
spectrum of K1Cu in MeCN (Figure 3.22 a) shows a band in the CuII dd region (dashed line), 
that is clearly different to that of L1Cu (dotted line). The typical iron-oxo bands in the UV 
a)  b) 
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region are still present, but slightly shifted, which indicates a slightly different Fe-oxo-Fe 
structure. This might be interpreted as the presence of a mixed metal complex, where K1 has 
an additional CuII ion coordinated in the cyclam moiety. It cannot be excluded, that the CuII 
center is only weakly attached to K1. In contrast, the spectra in MeCN/buffer show some 
alterations (Figure 3.22 b): In the UV region, the iron-oxo bands become significantly more 
flat when going from K1 to K1Cu. Also, the dd band is dramatically changed so that it is 
hardly visible as a shoulder around 610 nm. A comparison with the dd band of L1Cu shows 
some similarity. Therefore, it can be concluded that the previously formed mixed complex 
K1Cu is destroyed when buffer is added. Most probably, the CuII displaces the ferric ions and 
is finally coordinated as shown in the X-ray structures above (Figure 3.21 b). 
 
    
Figure 3.22: UV/vis spectra of K1 (solid line), K1Cu (dashed line) and L1Cu (dotted line) in a) MeCN (0.05 mM 
for left and 0.5 mM for right axis) and b) MeCN/buffer pH 6 (0.025 mM for left and 0.25 mM for right axis).  
 
Further comparison of K1Cu and L1Cu was made by EPR measurements. The spectra of 
K1Cu (solid line) and L1Cu (dashed line) are shown in Figure 3.23. Although the overall 
shape of the signals differs significantly, the g values are similar. The different form can be 
explained by the additional paramagnetic influence of the ferric ions present in the K1Cu 
sample. This is in agreement with the interpretation that K1 is slowly destroyed by addition of 
CuII in MeCN/buffer solution and replaced by L1Cu. 
 
a)  b) 
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Figure 3.23: Comparison of X-band EPR spectra (in g space) of K1Cu (0.625 mM; solid line) and L1Cu 
(0.625 mM; dashed line); spectra were recorded at 9.457661 or 9.435719 GHz and 120 K in MeCN/buffer pH 6. 
 
Our attempt, to eliminate the influence of a second coordination sphere of the cyclam 
moiety by adding another metal to K1, failed. In MeCN solution, the desired complex is most 
probably formed, but under the conditions for the kinetic measurements (i.e. in MeCN/buffer 
1:1), it is destroyed. 
 
 
3.2.4. Summary L1 
 
Ligand L1 with its flexible cyclam spacer has unique properties in the coordination chemistry 
especially with ferric ions. An important observation for its intended function as mimic for 
PAPs is that it predominantly forms in situ µ-oxo bridged diferric complexes, even with less 
than two eq of FeIII. A thorough characterization based on 1H-NMR and UV/vis titrations, HR 
ESI mass spectrometry, Evans-NMR measurements and EPR spectroscopy, supports the 
assumed nature of the complex. The observed behavior is mainly due to the use of an 
appropriate precursor, tetrachloroferrate, in combination with the high basicity of the cyclam 
moiety, that results in the formation of a µ-oxo bridged diferric precursor with subsequent 
coordination of the pyridine and secondary amine parts of L1 to produce K1. Cyclic 
voltammetry revealed the redox potential of K1 to be E1/2 = -0.09 V vs. SCE. Experiments 
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with a one-electron reduction of K1 were only partly successful, as the resulting heterovalent 
FeIIIFeII complex is unstable over time, even under anaerobic conditions. 
A further requirement for a suitable PAP mimic is the preservation of the observed 
structure in aqueous conditions, which are applied during kinetic measurements, and at 
different pH. This was also shown to be the case by EPR, Evans-NMR measurements and, to 
some extent, time-resolved UV/vis spectroscopy. The latter revealed that ligand exchange 
reactions after the addition of buffer to a solution K1 are relatively slow.  
Importantly, phosphate and substrate mimics, like the phosphomonoesters pNPP and 1-
NP, or the diester DPP, readily coordinate to K1, as shown by HR ESI mass spectrometry, 
UV/vis and 31P-NMR. The stoichometry differs from monoester to phosphate and the diester 
substrate mimic, being 1:2 for K1 with pNPP and 1:1 for K1 with phosphate and DPP at low 
pH. This is explained by the different coordination modes suggested by spectroscopic 
measurements. In combination with EPR measurements, spectra simulation and DFT 
calculations, structures for K1pNPP2 and K1phosphate complexes were proposed. The weak 
antiferromagnetic coupling between the two metal ions (low J values) leads to the conclusion 
that the µ-oxo bridge is slowly hydrolyzed upon reaction of K1 with pNPP or phosphate, 
leading to a complex where the metal ions are bridged by the substrates alone. However, 
Evans NMR suggests that this applies only for a small fraction of the complex molecules, i.e. 
an equilibrium between an EPR-silent µ-oxo bridged species and a species with a hydrolyzed 
µ-oxo bridge is to be expected. This multitude of different structures with varying metal-metal 
distances reflects the high flexibility of the system. 
Highly interesting with respect to the expected PAP mimicking abilities is the presence of 
two dd bands in the UV/vis spectrum of K1 with the diester DPP. In conjunction with the 
result from EPR experiments, where no signal is observed, this indicates a monodentate 
coordination mode, which is necessary for an efficient attack by a terminally bound hydroxide 
in a PAP like hydrolysis reaction. Unfortunately, no observation of this kind is made with 
monoester substrate mimics. 
Another outstanding observation is the coordination of CuII and ZnII in the pyridine and 
secondary amine part of L1. Cyclam is a ligand which usually results in highly stable 
complexes, especially with CuII. Therefore, the preference for the dipa type coordination site 
and not for the cyclam moiety is rather surprising and should be studied in more detail. 
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3.3.   The Phenolate-based Ligands HL2 and H3L3 
 
3.3.1.  Synthesis and Structures of the Ligands HL2 and H3L3 
 
In analogy to the known literature model systems presented in Chapter 2.3, HL2 and H3L3 
were designed. The aim is to derivatize the ligand HBPMP[143] (see Chapter 2.3) in a way that 
coordinated substrates can interact with a second coordination sphere. The use of HBPMP as 
a basis for attaching a second coordination sphere has several advantages, namely that the 
synthetic pathways towards these type of ligands are well established.[79, 116, 143] On the other 
hand, extensive experimental and mechanistic studies have been performed with these 
systems, providing a basis for comparison.[55, 69, 92] 
The retrosynthetic approach is shown in Scheme 3.13. The key step is the depicted 
twofold nucleophilic substitution of the primary chlorides in the p-cresol derivative by 
secondary amines. 
 
Scheme 3.13: Retrosynthetic approach to ligands HL2 and H3L3. 
 
We chose the position ortho to the pyridine nitrogens for functionalization. Again, 
synthetic considerations were one reason for this decision, but also the obvious proximity to 
the first coordination sphere seemed promising. Preliminary modeling studies encouraged this 
idea, as well. The nature of the functional group was also important. In contrast to the cyclam 
part in L1, which has a very high proton affinity, a less basic group should be used in this case 
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to mimic the histidine residues in PAP enzymes more closely. The pKa of imidazole is around 
6, which means that at a physiological pH (7.4), 10 % of the histidines exist in a protonated 
form. The primary amine in 2-aminopyridine, which already has been used in similar ligands, 
has a pKa of 6.8.[144] This is in sufficient agreement with the natural system. In order to keep 
the resulting positive charge small, only two of the available four pyridines are functionalized. 
 
 
Scheme 3.14: Synthesis of ligands HL2 and H3L3. 
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Scheme 3.14 describes the full synthesis of both ligands. Starting from commercially 
available 2-amino-6-methylpyridine 17, pivaloyl chloride is used to introduce a protecting 
group on the primary amine to give 2-pivaloylamino-6-methylpyridine 18 as white crystals in 
83 % yield (lit. 84 %).[145] In the next step, the methyl group is doubly brominated with NBS 
in CCl4 under reflux conditions. To achieve relatively high yields of dibromo- vs. monobromo 
product, NBS and benzoyl peroxide are added in small portions over 8h. Although small 
monobromide impurities are present at the end, 19 is used in the next step without further 
purification (60 % yield, lit. 55 %).[145] It is hydrolyzed by AgNO3 in aqueous acetone under 
light shielding conditions to the corresponding aldehyde 20 in 51 % yield (lit. 89 %).[145] 
Subsequently, 20 is reacted with 2-picolylamine, forming the imine formation which is then 
reduced in situ with NaBH4 to give the secondary amine 21 in quantitative yield. Ligand H3L3 
is directly accessible in quantitative yield from 21 and 2,6-bis(chloromethyl)-p-cresol 24. The 
latter is synthesized in one step by stirring 2,6-bis(hydroxomethyl)-p-cresol 23 in conc. HCl in 
97 %yield (lit. 94 %, see Scheme 3.15).[146, 147] Attempts to obtain HL2 from H3L3 by cleaving 
off the protecting groups under reflux in 2M HCl failed. It seems that these conditions are too 
harsh for the ligand backbone, as only decomposition peaks were observed in ESI-MS of the 
raw reaction mixture. Therefore, an alternative approach was necessary: Amine 21 was 
refluxed in 2M HCl to deprotect the primary amine in quantitative yield. Subsequent reaction 
of the free amine 22 with 2,6-bis(chloromethyl)-p-cresol 24 resulted in exclusive formation of 
HL2 in 96 % yield. As expected, the secondary amine functionality turned out to be the more 
active nucleophile and the primary amine protecting group was not necessary in this reaction. 
The overall yields for HL2 and H3L3 are 24 % (six steps) and 25 % (five steps), respectively. 
 
 
Scheme 3.15: Synthesis of 2,6-bis(chloromethyl)-p-cresol.[146, 147] 
 
No crystals of HL2 and H3L3 could be obtained that were suitable for X-ray analysis. To 
get insight into the structural properties of the ligands, a conformational search was performed 
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in the same manner as for L1. The lowest energy conformations of HL2 and H3L3, 
respectively, are shown in Figure 3.24. Various conformations were found within 10 kJ/mol 
for HL2 with the amine bearing pyridines either on one side (cisoid) or on different sides 
(transoid) of the central phenol group. This accounts for a high degree of flexibility, regarding 
the relative position of the coordinating groups. In the case of H3L3, up to 25 kJ/mol 
difference lies between the lowest energy cisoid structure and its transoid counterpart. Due to 
the more bulky amido groups, rotations around the C-C and C-N bonds of the methylene 
bridges become less favourable. Yet, this process is feasible. An additional effect can be 
observed in the lowest energy conformation shown in Figure 3.24 (right): The amido groups 
can form intramolecular hydrogen bonds and, by this, stabilize the molecule. This interaction 
is only observed in the shown conformation, not in any other obtained structure.  
 
         
Figure 3.24: Lowest-energy conformers from a conformational search on HL2 (left) and H3L3 (right). 
 
 
3.3.2. FeIII Coordination Chemistry of HL2 and H3L3 
 
3.3.2.1. Solution Chemistry of In Situ Prepared K2 and K3 Complexes 
 
Due to the similarity of HL2 and H3L3 to the well known PAP model systems based on ligand 
HBPMP, their coordination chemistry with FeIII should be relatively easy to understand. Our 
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expectation was that both ligands form dinuclear complexes, named K2 and K3, when reacted 
with two equivalents of a ferric salt in situ. In order to investigate the coordination behavior in 
solution, various experiments were conducted, including UV/vis titrations, Evans-NMR 
measurements and ESI mass spectrometry. Tetraethylammonium tetrachloroferrate was used 
as the iron source in all experiments. 
Ligand HL2 with its additional amino groups should result in a multiply charged species 
when two eq of FeIII are added. Highly charged complexes are seldom seen in mass 
spectrometry. And in fact, only small signals of dinuclear complexes can be detected in ESI 
mass spectra of HL2 recorded in MeOH, regardless of one or two eq of FeIII or additional base 
added (see Table 3.8). Due to the experimental setup, formic acid was automatically added to 
the measured solution, resulting in formates as counter ions in several cases.  
 
Table 3.8: Results of ESI MS experiments with ligand HL2 in MeOH. 
conditions species calc. m/z exp. m/z peak height 
L2 + 1 FeIII [H2L2]+ 561.31 561.49 67 % 
        “ [HL2Fe2Cl(HCOO)3]+ 842.13 842.48 3 % 
        “ [NaL2Fe2Cl(HCOO)3]+ 864.11 864.46 2 % 
L2 + 1 FeIII + 1 NEt3 [H2L2]+ 561.31 561.48 75 % 
        “ [HL2FeCl2(HCOO)] x HNEt3+ 833.30 833.49 6 % 
        “ [HL2Fe2Cl(HCOO)3]+ 842.13 842.49 18 % 
        “ [NaL2Fe2Cl(HCOO)3]+ 864.11 864.47 8 % 
L2 + 2 FeIII [HL2Fe2Cl(HCOO)3]+ 842.13 842.50 18 % 
        “ [NaL2Fe2Cl(HCOO)3]+ 864.11 864.46 23 % 
L2 + 2 FeIII + 2 NEt3 [NaL2Fe2Cl(HCOO)3]+ 864.11 864.34 2 % 
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With only one eq of FeIII, peaks attributable to mononuclear complexes and protonated 
ligand appear in the spectrum, which is not the case when two eq of FeIII are added. This is a 
good indication for the formation of at least some dinuclear complexes with deficient FeIII, as 
well as for full complexation of HL2 with two eq of FeIII. If exclusively mononuclear 
complexes would be formed with one eq of FeIII, no free ligand should be observed in the 
mass spectrum. It is as yet unknown if addition of triethylamine as base supports the 
formation of the complexes or only helps to make them visible in the mass spectra. Probably 
the latter case is more appropriate, as the ligand itself can already act as base in an 
intramolecular acid-base reaction. 
In contrast, H3L3 with its amido groups can be deprotonated up to three times, resulting 
in less positively charged diferric complexes. And indeed, ESI mass spectra of H3L3 with two 
eq of FeIII show dinuclear species. With additional formic acid, only mononuclear species can 
be seen. This is also the case when only one eq of FeIII is added, regardless of the presence of 
additional acid or base. The obtained results (summarized in Table 3.9) indicate that the 
ligand H3L3 preferably forms mononuclear complexes, when only one eq of FeIII is added. 
The complexation seems to be incomplete, as there is some free ligand observable in the mass 
spectra with additional acid. Still, this observation might only be a consequence of the applied 
conditions, as addition of acid can shift the complexation equilibrium towards the reactants. 
Upon addition of a second eq of FeIII, dinuclear complexes are formed, but some mononuclear 
complexes are still present. Unfortunately, the detection of these two classes of compounds 
requires different conditions (with and without formic acid, which protonates the amide 
functions). They never appear together in one spectrum. Therefore, it is impossible to directly 
compare their intensities. As in the case with only one eq of FeIII, the addition of acid during 
the measurement might not only influence the visibility of different species in the spectra, but 
also the complexation equilibrium, leading to formation of mononuclear complexes instead of 
dinuclear. Other techniques are needed to clarify, if full complexation of ligand H3L3 can be 
achieved in situ.  
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Table 3.9: Results of ESI MS experiments with ligand H3L3 in MeOH. 
conditions species calc. m/z exp. m/z peak height 
L3 + 1 FeIII [HL3Fe]+ 782.34 782.52 100 % 
        “ [H2L3FeCl]+ 818.31 818.52 47 % 
L3 + 1 FeIII w. acid [H4L3]+ 729.42 729.64 100 % 
        “ [NaH3L3]+ 751.41 751.62 45 % 
        “ [NaH2L3Fe(HCOO)2]+ 896.33 896.60 25 % 
        “ [H2L3FeCl]+ 818.31 818.57 7 % 
L3 + 1 FeIII + 1 NEt3 [HL3Fe]+ 782.34 782.50 88 % 
        “ [H2L3FeCl]+ 818.31 818.54 7 % 
L3 + 1 FeIII + 1 NEt3 w. acid [H4L3]+ 729.42 729.65 100 % 
        “ [NaH2L3Fe(HCOO)2]+ 896.33 896.60 40 % 
        “ [NaH3L3]+ 751.41 751.64 38 % 
        “ [H2L3FeCl]+ 818.31 818.56 10 % 
L2 + 2 FeIII [L3Fe2Cl]2+ 436.12 436.24 100 % 
        “ [HL3Fe2Cl2]2+ 454.10 454.24 5 % 
L2 + 2 FeIII w. acid [H2L3FeCl]+ 818.31 818.55 100 % 
        “ [NaH2L3Fe(HCOO)2]+ 896.33 896.59 78 % 
L3 + 2 FeIII + 2 NEt3 [L3Fe2Cl]2+ 436.12 436.24 100 % 
        “ [HL3Fe2Cl2]2+ 454.10 454.23 31 % 
L3 + 2 FeIII + 2 NEt3 w. acid [NaH2L3Fe(HCOO)2]+ 896.33 896.60 100 % 
        “ [H2L3FeCl]+ 818.31 818.56 75 % 
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More information was obtained by UV/vis titrations, where spectra of methanolic 
solutions with different ligand to metal ratios were recorded (spectra shown in Figure 3.25 
and 3.26): Addition of FeIII to HL2 results in the formation of a broad band in the visible 
region, which can be interpreted as phenolate-to-iron CT transition (see Figure 3.25 b). With 
substoichometric amounts of FeIII, the maximum wavelength of this absorption is at λ = 
558 nm and suddenly shifts to around λ = 650 nm when one or more than one equivalents are 
added. Yet, in the two spectra with 0.8 and 1 eq of FeIII, (5th thin line and 1st bold line, 
respectively), small shoulders are visible, which indicate that a mixture of products is present 
in these cases. Therefore, a Gaussian analysis was performed on the absorptions, assuming 
two overlapping bands for 0.2 to 1.8 eq of FeIII. The resulting spectra are shown in Appendix 
6. They clearly show that, already starting from 0.2 eq of FeIII, a small amount of dinuclear 
complex is present. The ration between mono- and dinuclear complex changes upon addition 
of more FeIII towards a higher amount of the dinuclear one. With 2 eq of FeIII, only one band 
with λ = 655 nm (1532 cm-1M-1) is visible, which belongs to the dinuclear complex K2. In the 
UV region between 300 and 400 nm, two intense bands are observable, which can also be 
attributed to Fe-oxo type transitions (see Figure 3.25 a). The absorption at 300 nm is 
consecutively rising in intensity, when up to two equivalents of FeIII are added, and hardly 
changes with further addition. In contrast, the band at 370 nm is getting even stronger with 
excess of FeIII but also slightly shifts to lower wavelengths. No shoulder is visible at this band 
in the spectrum with two eq of FeIII so that most probably all FeIII is bound in the ligand under 
these conditions. 
 
       
Figure 3.25: UV/vis titration of HL2 (0.2 mM) with [FeCl4](NEt4) in MeOH (in steps of 0.2 eq; bold lines 
indicate 1 and 2 eq of FeIII, respectively); a) full spectrum, b) phenolate-to-iron CT band. 
a)  b) 
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In summary, a mixture of mononuclear and dinuclear complexes is formed with 
substoichometric amounts of FeIII. More dinuclear complexes are formed upon addition of up 
to two equivalents of FeIII to reach full complexation of the ligand HL2. These findings nicely 
support the results from the ESI MS experiments described above. 
When H3L3 is reacted with FeIII, similar spectra to those with HL2 are obtained. The 
phenolate to ron CT band (Figure 3.26 b) shifts progressively from 533 to 629 nm with 
substoichometric amounts of FeIII and stays at this value when more than one eq of FeIII is 
added. Nevertheless, a shoulder on the lower wavelengths side of the band remains. In 
contrast to HL2, the intensity increases almost linearly up to addition of 1.2 eq of FeIII. These 
findings suggest that at small FeIII concentrations a mixture of mono- and dinuclear 
complexes is formed (see Appendix 6 for Gaussian analysis of the bands), which is in contrast 
to the ESI MS results. Moreover, the formation of mononuclear complexes seems to be 
incomplete with an equimolar amount of FeIII, as the intensity rises significantly from one to 
1.2 eq of FeIII. With two eq of FeIII, complexation seems to be incomplete, due to a significant 
amount of mononuclear species in the Gaussian fitted spectra. This is in agreement with the 
ESI MS results.  
 
       
Figure 3.26: UV/vis titration of H3L3 (0.2 mM) with [FeCl4](NEt4) in MeOH (in steps of 0.2 eq; bold lines 
indicate 1 and 2 eq of FeIII, respectively); a) full spectrum, b) phenolate-to-iron CT band. 
 
With respect to the addition of base to the in situ prepared complex solutions, K2 and K3 
show a slightly different behavior. Addition of two equivalents of triethylamine to K2 causes a 
a)  b) 
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hypsochromic shift of about 40 nm and simultaneously a loss in intensity (Figure 3.27 a). 
Assuming that at first MeOH or methanolate was coordinated, a ligand exchange reaction 
seems plausible. By addition of base, hydroxo anions are formed due to water impurities and 
they can easily hydrolyze the complex. The result is the observed hypsochromic shift of the 
CT band, which cannot be interpreted in detail. The spectra of K3 on the other hand hardly 
change with up to two equivalents of base, which can be explained by the additional acidic 
amido functions of the ligand, which are deprotonated by two equivalents of triethylamine. 
When more base (four equivalents) is added, the same behavior as with K2 can be observed 
(Figure 3.27 b). 
 
       
Figure 3.27: Changes of phenolate-to-iron CT band of a) K2 upon addition of one (dashed line) and two eq. 
(dotted line) of NEt3 b) and K3 upon addition of two (dashed line) and four (dotted line) eq. of NEt3 in MeOH. 
 
In order to analyze the behavior of K2 and K3 in partly aqueous solution (MeOH/buffer 
1:1), UV/vis spectra were recorded at pH 6 and pH 10 and compared to each other as well as 
to the original spectra in pure MeOH (Figure 3.28). And indeed, some differences can be seen 
with both complexes: The phenolate to iron CT band shifts to lower wavelengths, which again 
might be explained by ligand exchange (methanol(ate) vs. aqua/hydroxo). Another 
observation is the loss of the shoulder around 400 nm. Probably some free iron was still 
present and is now fully coordinated when buffer is added. Small differences are present 
between the pH 6 and pH 10 spectra, leading to the conclusion that a pH dependent 
equilibrium is present.  
b) a) 
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Figure 3.28: Comparison of UV/vis spectra of a) K2 and b) K3 in MeOH (solid line), MeOH/buffer pH 6 (dashed 
line) and MeOH/buffer pH 10 (dotted line); all 0.2 mM. 
 
Encouraged by these results, a spectrophotometric pH-titration of the two complexes was 
performed to analyze their pH dependent equilibria. The spectra (Figure 3.29) were fitted with 
the program Specfit,[148] at first by assuming three species in the pH range between 4.6 and 11 
and thus two protonation equilibria with single proton transfers, equivalent to the published 
schemes for similar systems (see Scheme 3.16). The additional µ-hydroxo group is based on 
X-ray structures of analogous complexes,[92] but there is no experimental evidence for that in 
our case. The resulting species distributions for a three-species-model are shown in Figure 
3.30 (a and b) and Table 3.10 gives the associated pKa values. 
 
 
Scheme 3.16: Protonation equilibrium of K2 and K3 in a three-species-model. 
 
Regarding the additional acid and base functionalities at HL2 and H3L3, further 
protonation equilibria become possible. At low pH, the pyridine-bound amines of HL2 are 
a)  b) 
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protonated (pKa = 6.8 for 2-aminopyridine)[144] and should not be able to form hydrogen 
bonds to the FeIII bound aqua ligands. The first deprotonation step leads to the possibility of 
an extended hydrogen bonding network, including the aqua/hydroxo ligands as well as the 
protonated amines. Their deprotonation will be the second step, probably with a simultaneous 
loss of two protons per complex unit. This fact was later included in the fitting procedure and 
resulted in only small changes with respect to the pKa values. Nevertheless, the pKa values for 
a four-species–model of K2 shown in Table 3.10 already represent the corrected fit. At last, 
another aqua ligand is deprotonated leading to a di-hydroxo species, which can still interact 
with the second coordination sphere amines. This equilibrium (Scheme 3.17) is more 
plausible for K2 than the simple three-species-model presented above.  
 
 
Scheme 3.17: Protonation equilibria of K2 in a four-species-model, incorporating interactions with the second 
coordination sphere amines. 
 
In the case of K3, the amides should coordinate to the ferric ions. This would result in 
only one free coordination site at each FeIII. A µ-hydroxo bridge seems unlikely under these 
conditions because of steric strain arising from the tertiary butyl groups at the amides (see 
Appendix 7 for calculated structures). The first deprotonation step with pKa (1) (Scheme 3.18) 
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should occur at low pH due to the coordination mentioned above and not contribute to the 
observed spectral changes (for comparison: pKa (acetamide in H2O) = 0.63).[149] Therefore, a 
three-species model with pKa (2) = 5.19 and pKa (3) = 8.69 seems more likely for K3.  
 
Scheme 3.18: Protonation equilibrium of K3 in a four-species-model with coordinated amide functions. 
 
        
Figure 3.29: Spectrophotometric titration spectra of a) K2 and b) K3 in MeOH/buffer between pH 4.6 and 11 
(arrows are indicating the changes from low to high pH) at 0.2 mM complex concentration. 
a)  b) 
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Figure 3.30: Species distribution for a three- and four-species-model, respectively for K2 (a, c) and K3 (b, d). 
 
Table 3.10: Fitted pKa values from spectrophotometric titrations of K2 and K3.  
K2  K3 
3 species 4 species  3 species 4 species 
5.98 ± 0.12 5.18 ± 0.19  5.19 ± 0.17 4.85 ± 0.22 
 7.31 ± 0.25   6.99 ± 0.28 
10.57 ± 0.57 10.38 ± 0.35  8.69 ± 0.14 9.05 ± 0.19 
 
a)  b)
c)  d)
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As in the case of K1, the magnetic properties of K2 and K3 were examined by Evans-
NMR,. Methanolic solutions of ligand and tetrachloroferrate were mixed in 1:1 or 1:2 ratios. 
The results are summarized in Table 3.11. In contrast to K1, the 1:1 mixtures with both 
ligands, HL2 and H3L3 have significantly larger µeff values than the 1:2 samples. This is 
consistent with uncoupled monomeric high spin FeIII complexes, although the experimental 
values are higher than the expected spin-only value of 5.92. This is a usual observation, as 
contributions of spin-orbit coupling lead to higher values. Nevertheless, addition of base leads 
to a decrease of µeff which can be explained by formation of at least a small fraction of 
dinuclear complexes. With two eq of FeIII, µeff takes values that correspond to dinuclear 
systems with relatively strong coupling. The expected spin state of S = 2 is the closest value 
corresponding to the experiment. Based on known complexes of this type, -J values between 5 
and 15 cm-1 should be expected,[112, 113] originating from moderate coupling through the 
phenoxide bridge. This value would however lead to a larger µeff. Spin states of S = 3 or S = 4 
can be populated at room temperature in this case. Thus, additional bridging ligands, like µ-
oxo, might be present to increase the coupling. Assuming that no unbound FeIII is present in 
the sample, coupling constants of larger than 30 cm-1 can be expected for both complexes.  
  
Table 3.11: Results of Evans-NMR experiments with HL2 and H3L3. 
sample 
exp. µeff [B.M.] 
per complex unit 
expected           
spin state S 
calc. µeff [B.M.] for 
expected spin state 
HL2 + 1 FeIII 6.77 5/2 5.92 
HL2 + 1 FeIII + 1 NEt3 6.16 5/2 5.92 
HL2 + 2 FeIII 4.73 2 4.90 
HL2 + 2 FeIII + 2 NEt3 4.24 2 4.90 
H3L3 + 1 FeIII 6.52 5/2 5.92 
H3L3 + 1 FeIII + 1 NEt3 6.03 5/2 5.92 
H3L3 + 2 FeIII 4.63 2 4.90 
H3L3 + 2 FeIII + 2 NEt3 4.24 2 4.90 
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EPR spectra of K2 and K3 were recorded in MeCN and MeOH at 1.7 K. Only the high 
spin ferric ion g=4.3 signal can be observed in all cases, with a rather moderate intensity. This 
leads to the conclusion that mainly an EPR-silent species is present, i.e. a rather strongly 
coupled diferric complex. Again, coupling through the phenoxo bridge should lead to 
moderate coupling constants, what is in contradiction to the observed EPR silence of the 
samples. Nevertheless, these results support the data obtained by the Evans-NMR 
measurements.  
 
 
3.3.2.2. Interactions of K2 and K3 with Phosphate and Phosphoesters 
 
UV/vis and EPR experiments were performed to investigate the interactions of K2 and K3 
with phosphate and phosphoesters as substrate mimics in MeCN/buffer mixtures. As in the 
case of K1, 1-NP was used as a phosphomonoester and DPP as a diester in the UV/vis 
measurements, whereas the monoester pNPP was used in the EPR experiments (for substrate 
mimic structures see Scheme 3.9 in Chapter 3.2.2.4).  
The UV/vis spectra of the phenolate to iron CT transition region around 500 nm are 
shown in Figure 3.31. In the case of phosphate as co-ligand (Figure 3.31 a and b), only small 
changes can be observed. λmax is slightly shifted to higher wavelengths and the intensity of the 
transition is reduced. When 1-NP is added to K2 or K3, there are also some changes 
observable (Figure 3.31 c and d): The phenolate to iron band of K2 is significantly shifted to 
higher wavelengths and broadened in comparison to the K2 spectrum. In the case of K3 with 
1-NP, it shifts to lower wavelengths becoming a shoulder. The most interesting observation 
can be made in spectrum e, which is K2 in combination with the diester DPP. As indicated in 
the figure, a second shoulder at around 580 nm is developing in addition to the original one. 
This suggests a monodentate coordination mode for DPP, which causes two distinct ferric 
ions in the complex. As no such observation is made in the case of K3 with DPP (Figure 3.31 
f), one might conclude that, due to hydrogen bonding interactions with the additional amines, 
K2 stabilizes the monodentate binding mode of the diester, whereas K3 does not.  
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Figure 3.31: UV/vis spectra of a) K2 and b) K3 with phosphate, c) K2 and d) K3 with 1-NP and e) K2 and f) K3 
with DPP in MeCN/buffer pH 6.5 at 0.15 mM complex and substrate concentration, i.e. 1:1 ratio (solid lines). 
The “free” complex spectra are shown as dashed lines.  
 
EPR experiments on K2 and K3 with pNPP in MeCN/buffer pH 5 were performed at 1.6 
to 20 K, showing rather complicated signals around geff = 4.3 and geff = 2. At first, simulations 
a)  b)
e)  f)
c)  d)
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with MoSophe[137] were attempted by assuming an antiferromagnetically coupled diferric 
system. The metal-metal distance was taken from geometry-optimized structures and the J 
value was roughly estimated from temperature dependent measurements to be between 0 and 
-1.1 cm-1 (maximum of signal intensity is at temperatures lower than 1.6 K; see Figure 3.32 
for temperature dependent spectra).  
 
 
 
 
Figure 3.32: VT X-band EPR spectra of a) K2pNPP (9.37863 GHz) and b) K3pNPP (9.379757 GHz). 
a) 
b) 
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No acceptable agreement between the simulated and experimental spectra was found with 
this model. Only the proposal of a coupled heterovalent FeIIIFeII species with a resulting 
S = ½ spin state lead to better results in both cases. The initial parameter values for the g and 
D tensors were estimated by DFT calculations (see Chapter 4.5 for details). Based on 
equations 3.6 and 3.7, the individual values for the ferric and ferrous ion, respectively, were 
calculated from the total values gS and DS. Table 3.12 summarizes the calculated and 
simulated parameters for K2pNPP and K3pNPP. The resulting spectra and their preliminary 
simulations are shown in Figure 3.33. 
 ݃ௌ ൌ ܿଵ ଵ݃ ൅ ܿଶ݃ଶ[135] (eq. 3.6) 
 ܦௌ ൌ ݀ଵܦଵ ൅ ݀ଶܦଶ ൅ ݀ଵଶܦଵଶ[135] (eq. 3.7) 
 
The g tensor coefficients are c1 = 7/3 and c2 = -4/3 (for S = ½)[135]and the zero-field splitting 
coefficients are d1 = 5/18 and d2 = 1/6 (for S = 9/2)[150] in an S = 2 / S = 5/2 system. The 
dipole-dipole contributions d12 and D12 were calculated using the EPR calculator[137] with 
d(Fe-Fe) = 4.01 Å for K2pNPP and d(Fe-Fe) = 3.90 Å for K3pNPP. For additional help, the 
zero-field splitting for the ferric ions was approximately calculated by DFT by exchanging 
FeII with ZnII in the geometry-optimized structure. This value was used for D2 in eq. 3.7. 
 
       
Figure 3.33: Experimental (black) and preliminary simulated (blue) X-band EPR spectra of a) K2 with pNPP and 
b) K3 with pNPP in MeCN/buffer pH 5 at 0.5 mM and 10 mM complex and substrate concentration, 
respectively; spectra were measured at a) 1.5 K and 9.37863 GHz and b) 1.6 K and 9.379757 GHz. 
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Table 3.12: Calculated and simulated parameters for K2 and K3 with pNPP (MoSophe).[a] 
parameter K2 + pNPP [b] K3 + pNPP [c] 
 calc. sim. calc. sim. 
giso FeIII 2.07 2.09 2.07 2.08 
giso FeII 2.24 2.15 2.10 2.14 
D1 FeIII [cm-1] -1.091 0.0012 1.161 0.021 
E/D FeIII 0.095 0.000 0.118 0.002 
D2 FeII [cm-1] -2.327 0.82 1.262 1.002 
E/D FeII [d] - 0.045 - 0.180 
d (Fe-Fe) [Å] 4.012 3.900 3.904 3.900 
Jiso [cm-1][d] - -2.06 - -1.84 
[a] see Chapter 4.5 for details on calculation procedures; [b] D tensor orientation α/β/γ [°] = 20/-60/0 for FeIII and 
-20/60/0 for FeII; [c] D tensor orientation α/β/γ [°] = 10/-50/0 for FeIII and -10/50/0 for FeII; [d] no calculated 
values available. 
 
The presented simulations (Figure 3.33 and Table 3.12) are not satisfying, as the signals 
of the simulation do not fully match to the experimental spectrum in both cases. Nevertheless, 
they support the interpretation of the the observed spectra as antiferromagnetically coupled 
S = 5/2 + S = 2 systems. In these kind of spin systems (see Appendix 5 b for the schematic 
energy diagram), the ground state is S = 1/2 and is populated at low temperatures. With 
increasing temperature, the S = 3/2 spin state will be populated as well, where the two Kramer 
doublets ± 1/2 and ± 3/2 lead to a second S =1/2 like signal and a Δ Ms= ± 3 transition around 
geff = 12. A further increase in temperature populates the S = 5/2 spin state, giving rise to a 
typical S = 5/2 spectrum with geff = 4.3 (middle Kramer doublet) and additional resonances 
around geff = 8.6 and 5.2. All these signals are observable in the experimental and simulated 
spectra, although they are slightly shifted in the latter. This is probably due to non-accurate 
values for the zero-field splitting D and E/D. However, with MoSophe it has been unfeasible 
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to simulate the spectra to a perfect state. The next approach will be to use an automatic 
optimizer in combination with simultaneous simulation of the VT spectra. 
Since a ferric salt is used as a precursor under aerobic conditions and the results from the 
Evans-NMR experiments suggest that K2 and K3 are diferric complexes, it seems that the 
addition of pNPP alters the redox potential and the complexes are reduced in situ. The 
question arises about the nature of the reductant. In the low temperature spectra shown in 
Figure 3.32 and 3.33, a sharp signal is visible around geff = 2.00, which suggests the presence 
of a radical species. This might be the oxidized reaction partner. EPR spectra of the same 
sample were recorded in a more narrow field range at 5 K as well as at room temperature in 
order to have a closer look at this radical signal. At room temperature, a fine structure of the 
signal can be observed consisting of 24 equidistant lines (see Appendix 8). As pNPP is used 
in a large excess and pre-dissolved in buffer (pH 5), a substantial amount of the hydrolysis 
product, i.e para-nitrophenolate (p-NP), can be expected. It is known that phenolates with 
para substituents form relatively stable radicals, especially in the case of a nitro group which 
is electron withdrawing.[152] A simulation using the published coupling constants of the para-
nitrophenoxy radical[151] did not match to the experimental spectrum. Another possible 
interpretation is that at room temperature, the para-nitrophenoxy radical reacts with the 
complex, K2 or K3, and withdraws an electron from the ligand, leading to a ligand-based 
radical. The simulation of this signal, using couplings to the phenolate protons, the methyl 
protons and the protons at the methylene bridges between phenolate and the tertiary amines, 
as well as couplings to the two tertiary amine nitrogen atoms, is shown in Appendix 8. 
Interestingly, a direct reaction of K2 or K3 with p-NP did not lead to the previously observed 
signals, i.e. neither the sharp radical nor the S = ½ like signal at geff < 2 could be seen. The 
exact analysis of the obtained spectra is still under investigation. 
The redox potential of p-NP is reported to be + 0.668 V (in MeCN) and around + 1.0 V 
(in H2O) vs. SCE.[153] No redox potential measured in MeCN/buffer mixtures was found in 
literature, but we expect it to be in between. The redox potentials of pure K2 and K3 in MeCN 
or MeCN/buffer mixtures with or without pNPP could not be investigated by cyclic 
voltammetry, as the relatively low solubility of the ligands prevented the in situ prepararation 
of the complexes at high concentrations. Therefore, attempts were made to isolate complexes, 
which should be more soluble in the media mentioned above. 
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3.3.2.3. Isolation and Characterization of Diferric Complexes of HL2 and 
H3L3 
 
Solid diferric complexes of HL2 and H3L3 were obtained by stirring the ligand with ferric 
perchlorate with and without sodium L-tartrate as an additional bridging ligand in hot 
methanol. Diffusion of diethylether into the complex solutions precipitated the complexes 25 
to 28 (Scheme 3.19).  
The use of the chiral anion tartrate as coligand is based on the idea that two possible 
isomers can be formed with ligands HL2 and H3L3, where the residues at the pyridines can be 
on one side of the complex (cisoid) or on opposite sides (transoid). In the latter case, a C2 
symmetric complex would result, whereas the cisoid structure would be asymmetric (see 
Scheme 3.20). The hope was to drive the complexation reaction to one or the other structure 
and, by this, facilitate crystal growth.  
 
 
Scheme 3.19: Synthesis of diferric complexes of HL2 and H3L3. 
 
Unfortunately, no X-ray quality crystals were obtained, so we focus on the results from 
analytic and spectroscopic studies as well as DFT calculations to describe the properties of the 
complexes. For clarity reasons, the complexes 25 and 27 without additional tartrate are called 
K2 and K3, whereas 26 and 28 are called K2 tartrate and K3 tartrate. It should be noted that the 
complexes K2 and K3 do not necessarily have the same structure and composition as the in 
situ prepared complexes K2 and K3 described in the previous chapters. 
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Scheme 3.20: Possible isomers of K2 and K3 with L-tartrate as coligand. 
 
Elemental analysis fits to the presence of two ferric ions per complex unit in each case. 
The coordination sphere is assumed to be completed by a µ-hydroxo bridge and two terminal 
hydroxides in the case of K2 (based on structures of similar published complexes, see Chepter 
2.3 for examples and references). The amide oxygen of H3L3 most probably coordinate to the 
ferric ions, leaving one free site on each FeIII, which can be occupied by terminal hydroxides 
as well. K2 tartrate contains two tartrate anions according to the elemental analysis. We 
assume that due to the sterical demand of the coligands, only one tartrate is coordinated. This 
should be also the case for K3 tartrate. Based on these data, different structures were 
geometry-optimized and their free energies were compared (see Table 3.13 for values and 
Chapter 4.5 for calculation details; structures are shown in Appendix 7): The tartrate-free 
complexes K2 and K3 do not show large energetic differences between the cisoid and transoid 
conformers. In the case of K2, the cisoid conformer is slightly more favored when the amines 
are deprotonated (entry 1 in Table 3.13). In contrast, the transoid conformer of K3 is a little 
lower in energy than the cisoid one (entry 3). Yet, the energy differences are so small 
(1.5 kcal/mol) that the different structures can be seen as energetically equal within the 
accuracy of the method. For K2 with protonated amines, the transoid conformer is lower in 
energy, having a larger energy difference (almost 7 kcal/mol) than without the protons (entry 
2). In the calculated structures (Appendix 7) one can see, that this should be mainly due to 
opening of the µ-OH bridge in the cisoid conformer. 
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Things become different when tartrate is coordinated to K2. Now, even K2 with 
deprotonated amines shows significant energy differences between cisoid and transoid 
conformer (around 5 kcal/mol; entry 4). Protonation of the amines enables better interactions 
between tartrate and the ligand. Moreover, a cisoid arrangement, where all pyridines are 
coordinated would lead to a large steric strain due to the bulky ammonium groups. Therefore, 
only a structure, where one pyridine is rotated away from the metal ions converged to a 
minimum. In the transoid conformer, the ammonium group is located on the “backside” of the 
complex and not on the side where the tartrate is present, reducing the steric strain and 
enabling the coordination of all pyridines. These differences lead to a huge energy gap of 
more than 30 kcal/mol (entry 5). In the case of K3, coordination of tartrate does not have an 
impact on favoring one conformer over the other, resulting in only a small energy difference 
of 1.17 kcal/mol. This can be explained by the missing hydrogen bonding interactions. 
 
Table 3.13: Relative free energies of cisoid and transoid conformers of different K2, K3, K2 tartrate and K3 
tartrate species. 
entry complex species rel. free energy cisoid 
[kcal/mol] 
rel. free energy transoid 
[kcal/mol] 
1 K2  1.54 0.00 
2 K2 with prot. amines 0.00 6.98 
3 K3  0.00 1.56 
4 K2 tartrate 5.16 0.00 
5 K2 tartarte with prot. amines 33.44 0.00 
6 K3 tartrate 0.00 1.17 
 
UV/vis spectra were recorded in solution (MeCN and MeOH) as well as in solid state. 
The spectra of K2 and K3 (Figure 3.34 a and c) show some differences regarding the three 
media. In both cases, the λmax values of the phenolate to iron transitions differ significantly 
(see also Table 3.14). The largest shift is observable with K3, where a change from MeCN to 
MeOH causes a hypsochromic shift of 168 nm. Compared to the wavelengths in solid state, 
the wavelength difference in the MeCN spectra is a lot smaller than in MeOH, which 
indicates that in MeCN the solid state structure is hardly changed. MeOH is more likely to 
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coordinate to the ferric ions than MeCN due to its more hard character. In the case of K2 
tartrate and K3 tartrate (Figure 3.34 b and d), the spectra in MeCN and MeOH (solid and 
dashed line, respectively) look quite similar to each other, what is quite surprising at first. The 
wavelengths of the phenolate to iron CT transitions differ by only few nm in both cases, but 
the intensities are slightly different. There is a hypsochromic shift of nearly 100 nm from the 
solid state to the solution spectra. It seems that in these cases, the solid structure changes 
significantly when the complexes are dissolved. Probably, the L-tartrate anions are 
coordinated in solid state and dissociate in solution. The question remains why the resulting 
wavelengths are so similar, although in one case MeCN and in the other MeOH would be 
coordinated. One possibility is that the basic L-tartrate produces hydroxides in solution which 
are then bound to the ferric ions. The wavelengths of around 500 nm agree with this 
explanation, as they resemble those at high pH in the spectrophotometric titrations (Chapter 
3.3.2.1).  
   
   
Figure 3.34: UV/vis spectra of a) K2, b) K2 tartrate, c) K3 and d) K3 tartrate in MeCN (solid line), MeOH 
(dashed line) and as solid (dotted line in inset). 
 
a)  b)
c)  d)
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Table 3.14: Phenolate-to-iron CT transitions of the four complexes. 
 K2 K2 tartrate K3 K3 tartrate 
λMeCN [nm] (ε [M-1cm-1]) 589 (1892) 513 (1250) 685 (1166) 504 (1538) 
λMeOH [nm] (ε [M-1cm-1]) 560 (1465) 512 (1654) 517 (1630) 498 (1961) 
λsolid [nm] 630 615 681 612 
 
Solid state IR spectra of all four complexes were measured and are compared to the free 
ligand spectra in Figure 3.35. The HL2 spectrum (black line in Figure 3.35 a) has three 
interesting regions. The two peaks at 792 and 760 cm-1 represent deformation vibrations of 
aromatic C-H groups. Almost the same values are obtained in the case of H3L3 (black line in 
Figure 3.35 b). The absorptions at around 1500 cm-1 and 1600 cm-1 are C=N valence 
vibrations within the pyridines. In the region around 1600 cm-1, also the NH2 spreading 
vibration is present. Comparison of the free ligand spectrum with the spectra of the complexes 
enables the various vibrations to be assigned. A significant shift of the 1600 cm-1 region and 
the peaks at 1465 cm-1 towards higher wave numbers can be observed in the K2 spectrum (red 
line in Figure 3.35 a), which accounts for coordination of the pyridines. The peak at 1571 cm-1 
is almost unchanged, only the relative intensity is decreased. It can be assigned to the NH2 
spreading vibration, and its loss can be interpreted as protonation of the amine group. In the 
K2 tartrate spectrum (blue line in Figure 3.35 a), the peaks are very similar to the signals in 
the K2 spectrum. An additional weak and broad band at 1748 cm-1 belongs to a valence 
vibration of the carboxylate part of the tartrate anion. In free tartrate, this vibration appears as 
broad peak at 1600 cm-1. The observed shift accounts for coordination of the tartrate to the 
complex.  
In contrast to HL2, the spectrum of H3L3 (black line in Figure 3.35 b) is much more 
complex, a consequence of the presence of amido groups in the ligand. The C=O stretching 
vibration is seen at 1690 cm-1 and is very typical. The N-H bending vibration comes at 
1523 cm-1. The pyridine bands are again in the region around 1600 cm-1 and 1500 cm-1. Other 
intense absorptions can be seen at 1304 and 1152 cm-1. They belong to the O-H deformation 
vibration and the C-OH valence vibration of the phenol moiety, respectively. Interestingly, 
these vibrations are not well resolved in the HL2 spectrum. Probably, the phenol is, at least 
partly, deprotonated in this case. In comparison, the spectra of K3 and K3 tartrate have a 
similar appearance as the K2 and K2 tartrate ones. The pyridine peaks are shifted towards 
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higher wave numbers in all cases and the aromatic proton fingerprint bands are retained. The 
dominant C=O vibration in the H3L3 spectrum at 1690 cm-1 is almost lost in the K3 and K3 
tartrate cases, which accounts for coordination of the carbonyl oxygen to FeIII. In contrast, the 
amido NH vibration at 1523 cm-1 is retained, i.e. the amide part is still protonated in the 
complexes. Similar to K2 tartrate, the broad weak band at 1741 cm-1 suggests coordination of 
the tartrate anion to the complex. The broad and intense signals around 1100 cm-1 as well as 
the sharp peak around 600 cm-1 in the complex spectra belong to perchlorate vibrations. 
 
    
Figure 3.35: Comparison of IR spectra (fingerprint region) of a) HL2 with K2 and K2 tartrate and b) H3L3 with 
K3 and K3 tartrate; ligands in black (top), complexes in red (middle) and tartrate complexes in blue (bottom). 
 
X-band EPR spectra of K2 and K3 in solid state showed only moderate signals at 
geff = 4.3, which belong to high spin ferric ions. Most FeIII ions seem to be 
antiferromagnetically coupled, leading to an EPR-silent complex. Assuming similar structures 
in the solid state and in the in situ prepared complexes described in Chapter 3.3.2.1, these 
results are consistent with the data from the Evans-NMR measurements. 
The redox properties of K2 and K3 as well as the tartrate complexes were examined by 
cyclic voltammetry. Different chart speeds were applied, from 50 to 800 mV per second in 
each case, every time resulting in the same voltage for the oxidation and reduction peaks. The 
results for the four complexes are summarized in Table 3.15. 
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Table 3.15: Redox potentials[a] for K2, K3, K2 tartrate and K3 tartrate vs. FeCp2 and SCE.  
 K2 K3 K2 tartrate K3 tartrate 
E1/2 vs. FeCp2 [V] -0.064 0,022 -0,293 / 0,382 -0,108 
E1/2 vs. SCE [V]  0,316 0,402  0,087 / 0,762  0,272 
[a] recorded in MeCN with 0.1M NBu4ClO4 vs. Ag/Ag+ with E1/2 (FeCp2) = 0.068 V. 
 
The potentials most probably belong to an FeIII2/FeIIIFeII couple and are in the range for 
reported values (see Table 2.6 in Chapter 2.4 for values and references). In comparison to 
literature-known complexes with tetra-pyridyl ligands, the redox potentials of K2 and K3 are 
slightly lower. This explains why K2 and K3 were obtained in their homovalent state. 
Nevertheless, a reduction to the heterovalent FeIIIFeII complex should be feasible in both cases 
and result in stable species under anaerobic conditions. The tartrate complexes of K2 and K3 
have redox potentials that are around 230 and 130 mV lower, respectively, than the tartrate-
free complexes. Although we concluded from the UV/vis spectra that the tartrate anions are 
dissociated in solution, they strongly influence the redox behavior of K2 and K3. This can be 
again explained by the coordination of hydroxides, which are produced by the basic tartrate 
anions. K2 tartrate has a second redox step at E1/2 = 0.762 V vs. SCE, which is quasi-
reversible. It belongs most probably to an oxidation to FeIV.  
No signals were obtained for K2 or K3 in MeCN/buffer mixtures. Probably, the water is 
responsible for bad signals. Therefore, only the values in MeCN can be compared to the redox 
potential of para-nitrophenolate (see Chapter 3.3.2.1) to judge if the observed reduction of K2 
and K3 with pNPP in MeCN/buffer is caused by the hydrolysis product para-nitrophenolate. 
In order to make this redox process possible, the reduced species, i.e. the complexes K2 or K3, 
need to have a more positive redox potential than the reductant. This is not the case here. In 
conjunction with the result, that no radical and no S = ½ signal is visible in EPR upon reaction 
of K2 or K3 with para-nitrophenylphosphate, i.e. without pNPP, we conclude that 
coordination of pNPP alters the redox potentials of K2 and K3 towards more positive values. 
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3.3.3. Summary HL2 and H3L3  
 
The HBPMP derivatives HL2 and H3L3 with additional amino and amido functions at two of 
the four pyridines, show some striking differences compared to ligand L1. The most 
prominent distinction is their in situ coordination chemistry with FeIII. HR ESI mass 
spectrometry in combination with UV/vis spectroscopy and Evans NMR measurements 
revealed that at low FeIII concentrations mainly mononuclear complexes are formed and only 
a small fraction of dinuclear species is present. Only with two eq of FeIII, dinuclear complexes 
are predominantly formed.  
The redox potentials of the diferric complexes are slightly smaller compared to the values 
of HBPMP and HBIMP complexes bearing unsubstituted pyridine and imidazol donors.[76, 116] 
However, a one-electron reduction to the heterovalent complexes should be easier than with 
K1, and moreover lead to stable complexes. This can be mainly attributed to the phenoxo 
linker included in the ligand backbone. K3 has a higher redox potential than K2, which reflects 
differences in coordination due to the additional amido functions of H3L3. 
A spectrophotometric analysis of K2 and K3 was performed in a pH range between 4.6 
and 11. K2 with its basic amino groups most probably exists in four different species during 
the titration, including a di-aqua complex with protonated amines, an aqua-hydroxo species 
with protonated or deprotonated amines and finally a di-hydroxo complex. In the case of K3, 
only three different species are observed in the mentioned pH range. The amides are probably 
already deprotonated at low pH values. 
Concerning the structures of K2 and K3, the main distinctive feature is the possibility of 
isomerism, with respect to the relative position of the functional amino and amido groups. A 
conformational search of the ligands showed them to be quite flexible with the cisoid and 
transoid isomers having similar energies. Also, the complexes without further co-ligands 
reveal only relatively small energetic differences between a cisoid and a transoid structure, as 
shown by DFT calculations. Coordination of the chiral anion L-tartrate to K2 leads to a 
differentiation of the structures in the calculations, producing larger energy gaps between 
cisoid and transoid complexes. With K3, this is not the case due to the missing hydrogen 
bonding interactions. The predicted formation of only one possible conformer of K2 with 
chiral co-ligands should in principle make it easier to crystallize the complexes. 
Unfortunately, no crystals suitable for X-ray analysis could be obtained so far. 
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Phosphate and phosphoester substrate mimics coordinate in a similar way as seen with K1. 
Whereas reactions with phosphate and the monoester 1-NP results in the formation of only 
one phenolate to iron CT transition at around 500 to 600 nm in the UV/vis spectra of K2, 
indicating a bridging coordination mode, the diester DPP most probably coordinates 
monodentately and the UV/vis spectrum of this mixture shows two absorptions in this region. 
K3, in contrast, does not show this behavior, what leads to the conclusion that the amines of 
K2 stabilize the monodentate coordination of DPP. This is important with respect to the 
envisioned activity of K2 in hydrolysis of phosphodiesters, and probably also monoesters, as a 
monodentately coordinated substrate represents the active conformation of the catalyst-
substrate complex.  
Addition of pNPP in a partly aqueous medium results in in situ reduction of both 
complexes, yielding heterovalent FeIIIFeII complexes. This is supported by EPR spectra of the 
mixtures at low temperatures, which show a broad signal at geff < 2 and an additional peak 
around geff = 4.3. This kind of spectrum is typical for antiferromagnetically coupled 
complexes with an S = ½ ground state and has been already observed in spectra of reduced 
mammalian PAP. A sharp peak at geff = 2 indicates the presence of a relatively stable radical, 
which is formed slowly over several hours. The fine structure and the g value suggest a 
phenoxo based radical. A para-nitrophenoxy radical coming from autohydrolysis of pNPP 
can be excluded, based on the simulation of the room temperature spectrum. The simulation 
rather suggests a ligand based radical, delocalized on the central phenolate part. The 
preliminary interpretation is that para-nitrophenolate still acts as reductant towards K2 and K3 
that have a higher redox potential due to the coordination of pNPP. At room temperature, the 
radical character is transferred to the ligand backbone. 
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3.4.   Phosphatase Activity of K1, K2 and K3 
 
The activity of all described complexes towards hydrolysis of the activated phosphoesters bis-
(2,4-dinitrophenyl)-phosphate (BDNPP)[154] and 2,4-dinitrophenylphosphate (DNPP)[155] (see 
Scheme 3.21) was investigated by a spectrophotometrical assay. During hydrolysis, 2,4-
dinitrophenolate is released as product with an intense absorption band at λ = 400 nm 
(ε = 12100 M-1cm-1). BDNPP hydrolysis is a commonly used test reaction for PAP 
mimetics,[69, 92] although enzymes are known to almost exclusively hydrolyze monoesters.[55, 
156] Nevertheless, the results provide important information about the catalytic activity and 
pKa values of the complexes, which can be compared to other biomimetic systems. 
 
 
Scheme 3.21: Activated substrates a) DNPP and b) BDNPP and their hydrolysis reactions. 
 
To characterize K1, K2 and K3 as phosphatase catalysts, the activity at different pH 
values (4.6 to 10 or 11) was measured as well as with different substrate and catalyst 
concentrations. The measured pH profiles were fitted with equation 3.8, which is based on a 
model for a diprotic system with two active species.[157] The thus obtained Ka values are 
transformed to their negative logarithms (base 10) to give pKa(I) and pKa(II), i.e. the pKa 
values of the deprotonation steps between the different active and inactive species (see 
Schemes 3.22 and 3.25). Factor γ describes how active the last species in the equilibria is in 
comparison to the most active one. V0,max is the maximum activity that can be reached at given 
conditions and optimum pH.  
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Substrate dependent measurements were treated according to Michaelis-Menten theory. 
The data are fitted using eq. 3.9. Vmax is the maximum activity at saturation conditions; KM is 
the Michaelis-Menten constant and can be seen as a measure of affinity of the substrate 
towards the catalyst. 
 ܸ ൌ ௏೘ೌೣ∗ሾௌሿబ௄೘ାሾௌሿబ    (eq. 3.9) 
 
Additional information about catalyst activity and efficiency, respectively, can be 
obtained from eq. 3.10 and ݇௖௔௧ ܭெ⁄ . These numbers are used to compare different catalysts 
as well as the activity of one catalyst towards different substrates. 
 
 ݇௖௔௧ ൌ ௠ܸ௔௫ ሾܭሿ଴⁄  (eq. 3.10) 
 
 
3.4.1. Phosphatase Activity of K1  
 
As described in Chapter 3.2.2.3, no information could be obtained by spectrophotometric 
titrations regarding species distribution of K1 at different pH values. The pH dependent 
UV/vis spectra of K1 do not show differences that are large enough to be fitted and therefore, 
no pKa values could be obtained by this technique. Nevertheless, assuming a similar behavior 
of K1 to known model systems and taking into account the various results reported in Chapter 
3.2.2.3., the following reaction scheme can be proposed (see Scheme 3.22): At low pH, a 
tetra-aqua form should be present, which lacks a suitable nucleophile and therefore remains 
inactive towards phosphoesters. Deprotonation of one water at each FeIII leads to a di-aqua/di-
hydroxo species, where the aqua ligands can be easily exchanged by the substrate and the 
hydroxides can act as nucleophiles. This species is supposed to be the active form of K1. 
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Although the two FeIII centers are strongly antiferromagnetically coupled, simultaneous 
deprotonation should be possible. Further deprotonation results in a tetra-hydroxo species, 
which might show some activity, provided that the hydroxo ligands can also be substituted by 
substrate molecules. The pKa values of these processes will be determined with the help of 
kinetic measurements. Coordinated substrate molecules should be able to interact with the 
protonated form of the cyclam moiety of L1. This will also be discussed in the following 
chapters. 
 
 
Scheme 3.22: Proposed species of K1 at different pH. The proposed active species is highlighted. 
 
 
3.4.1.1. Diesterase Activity of K1  
 
Hydrolysis experiments with K1 and BDNPP (see Scheme 3.21 b) were conducted according 
to literature known procedures:[87-90] BDNPP (c0 = 5 mM) and K1 (c0 = 0.04 mM) were 
reacted in MeCN/buffer at 25°C. For the substrate and catalyst dependent measurements, their 
concentrations were varied. The resulting pH profiles of K1 as well as L1 with one eq of FeIII 
and the Michaelis-Menten diagram of K1 are shown in Figure 3.36. Using equations 3.8, 3.9 
and 3.10, respectively, the curves were fitted (red lines in the figures) giving the pKa values 
and the kinetic parameters presented in Table 3.16. Comparison of the two pH profiles shows 
an approximately halved activity with only one eq of FeIII and very similar curve shapes. This 
supports again the suggested predominant formation of dinuclear complexes with L1. 
Experiments with varying catalyst concentration showed a linear behavior, which excludes 
cooperativity or other effects.  
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Figure 3.36: pH profiles of a) K1, b) L1 with 1 eq of FeIII, c) Michaelis-Menten diagram (pH 6) of K1 and d) K1 
concentration dependence of BDNPP hydrolysis. The experimental data are shown as black squares, the red lines 
represent the fits using equations 3.8 and 3.9 for pH-profiles and Michaelis-Menten diagrams, respectively. 
 
Table 3.16: Kinetic parameters of K1 and L1 with 1 eq of FeIII. 
catalyst pHmax pKa(I) pKa(II) 
kcat 
[s-1] *10-3 
KM 
[M] *10-3 
kcat/KM 
[M-1s-1] 
K1 6.17 5.03 ± 0.10 7.28 ± 0.12 1.33 ± 0.08 1.94 ± 0.37 0.68 ± 0.02 
L1Fe 6.01 5.21 ± 0.08 6.75 ± 0.09 n.a. n.a. n.a. 
 
Stoichometric experiments were conducted and followed spectrophotometrically as well 
as via 31P-NMR. No signal could be identified in the NMR experiment, although 2,4-
dinitrophenol had been liberated from the phosphoester (as seen by UV/vis). Experiments 
with catalytic amounts of K1 did not show any product peaks either; only the reactant was 
c) 
a)  b) 
d) 
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visible. These findings suggests that after hydrolysis the product (DNPP or phosphate) 
remains bound to K1, which is consistent with the observed inhibition, when phosphate 
containing buffer is used for kinetic assays. Most probably, this behavior is a result of the 
homovalency of K1, leading to generally high affinity for bridging co-ligands. Analysis of the 
spectrophotometric experiment reveals the formation of only one equivalent of 2,4-
dinitrophenol per BDNPP and K1. Thus, only the first hydrolysis step, from BDNPP to 
DNPP, occurs and no formation of phosphate is observed. 
 
 
3.4.1.2. Monoesterase Activity of K1 
 
So far, no PAP mimetics have been reported to hydrolyze monoester substrates.[55, 87, 88, 90, 92] 
Only the background reaction has been observed, independently of the substrate used (pNPP 
or DNPP). This was explained by a bridging coordination of the substrate, leading to a µ-OH 
bridge as the only possible nucleophile, which is proposed to be significantly less active than 
terminal hydroxides.[92] 
A diferric system, like K1, would normally be expected to coordinate phosphates or 
phosphoesters in a bridging mode. And indeed, as reported in Chapter 3.2.2.4., pNPP most 
probably coordinates in that way, even without any additional bridging nucleophile, and is not 
hydrolyzed by K1. Nevertheless, our hope was to stabilize DNPP long enough in a 
monodentate coordination mode for a nucleophilic attack, as the discussed structure with two 
pNPP and the characteristic EPR spectrum slowly builds up over several hours. 
Hydrolysis experiments were conducted in a similar way as for BDNPP (Scheme 3.21 a), 
only with 10-fold lower substrate concentration (c0 = 0.5 mM). The substrate dependency 
measurement indicates why this was changed: At concentrations larger than 0.5 mM, 
saturation is observed, which is due to a relatively high autohydrolysis rate of DNPP (see 
Appendix 9 for data). The results are presented in Figure 3.37 and Table 3.17. 
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Figure 3.37: a) pH profile and b) Michaelis-Menten diagram (pH 6) of DNPP hydrolysis with K1. The 
experimental data are shown as black squares, the red lines represent the fits using equations 3.8 and 3.9 for pH-
profiles and Michaelis-Menten diagrams, respectively. 
 
Table 3.17: Kinetic data for DNPP hydrolysis with K1. 
pHmax pKa(I) pKa(II) 
kcat 
[s-1] *10-3 
KM 
[mM] 
kcat/KM 
[M-1s-1] 
6.09 5.68 ± 0.27 6.33 ± 0.41 0.21 ± 0.01 0.17 ± 0.02 1.23 ± 0.14 
 
 
The observed kcat is not high, but significant; compared to the autohydrolytic rate, K1 
accelerates the reaction only by a factor of 1.45 (at pH 6, with 0.5 mM DNPP). Nevertheless, 
the typical bell-shaped pH profile is observed and the resulting pH maximum and pKa values 
indicate the same active species of K1 and a very similar mechanism as observed with 
BDNPP.  
 
 
3.4.1.3. Mechanistic Suggestions 
 
A comparison of the kinetic pH profiles for BDNPP and DNPP hydrolysis with K1 suggests 
that both reactions have a similar reaction mechanism. The main differences are the 
a)  b) 
 108  Chapter 3.4: Phosphatase Activity of K
1, K2 and K3 
significantly lower values for kcat and KM for DNPP hydrolysis. In summary, DNPP 
hydrolysis is slower than BDNPP hydrolysis, but the affinity for the latter substrate is lower. 
One has to be careful in comparing these data as a tenfold lower substrate concentration is 
applied in the DNPP case. This is due to the high autohydrolysis rate of DNPP that also leads 
to a low KM. Therefore, the efficiency kcat/KM is higher for DNPP than for BDNPP hydrolysis 
(1.23 vs. 0.68 M-1s-1). These findings suggest subtle differences for both reactions. Due to the 
high similarity of both substrates with the same leaving group (2,4-dinitrophenolate), no 
significant alterations in activation energy for the hydrolysis step would be expected. The 
following results highlight the differences between the two substrates. 
Density functional theory calculations (see Chapter 4.5 for details) were used to elucidate 
the pathways and structures that contribute to the different reactivity of K1 towards DNPP and 
BDNPP. At first, the relative energies of substrates bound monodentately vs. bridging were 
calculated and compared (see Table 3.18), assuming an equilibrium between both structures. 
In the case of BDNPP, two different structures were geometry-optimized, where the P=O 
moiety is interacting with the protonated cyclam and an FeIII bound water, respectively. The 
latter structure is the precursor for bridging coordination. From the difference in free energies, 
the equilibrium constant K can be obtained by using eq. 3.11 and 3.12. 
 
 KRTG ln  (eq. 3.11) 
 with 
][
][
bridging
emonodentatK   (eq. 3.12) 
 
Table 3.18: Relative energies for K1 with monodentately bound vs. bridging DNPP and BDNPP [kcal/mol]. 
 K1 + DNPP K1 + BDNPP 
monodentate coordination 3.08 0 / 4.94[a] 
bridging coordination[b] 0 8.09 
equilibrium constant K 5.5*10-3 8.5*105 
[a] Energies refer to the two different structures, where the P=O moiety is interacting with the protonated cyclam 
and an FeIII bound water, respectively. [b] One pyridine belonging to L1 is dissociated upon bridging 
coordination of the substrate molecule. 
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The resulting relative free energies and equilibrium constants suggest that DNPP is more 
likely bound in a bridging way to K1, whereas BDNPP is more stable when coordinated 
monodentately. A closer look at the geometry-optimized structures of the K1BDNPP 
complexes reveals some interesting facts (see Appendix 10 for structures): The most stable 
structure is K1 with monodentate BDNPP, where an interaction between the P=O moiety and 
the protonated cyclam is possible. In this conformation, a direct reaction to the bridging 
arrangement is impossible due to the second phenolate residue. A rotation around the existing 
FeIII-BDNPP bond results in a structure where the P=O moiety is situated in an appropriate 
position for coordination to the second FeIII, forming hydrogen bonds to an FeIII bound water. 
Yet, this structure is higher in energy than the previous one and the rotation provokes a loss of 
the hydrogen bond between BDNPP and the protonated cyclam, which suggests a high 
activation barrier for this process. Therefore, an equilibrium between the monodentate and 
bridging conformers seems unlikely. Only a minor fraction of the K1BDNPP complex should 
be present in a bridging inactive form. In contrast, K1DNPP can directly interchange between 
the monodentate and bridging coordination modes and the obtained equilibrium constant is 
reasonable. 
In order to obtain kinetic information on the different pathways, DFT-based calculations 
on the two competing reactions, i.e. deactivation by formation of bridged structures vs. 
nucleophilic attack of a hydroxide at the phosphorous, were performed for K1 with DNPP. 
Starting from monodentately bound DNPP, the distance between the DNPP oxygen and the 
non-coordinated FeIII was decreased stepwise for a relaxed scan potential surface towards the 
bridging DNPP (see Scheme 3.23 pathway a and Figure 3.38 a). Interestingly, the approach of 
the DNPP oxygen does not result in release of a bound aqua or hydroxo ligand, but a pyridine 
is displaced and finally rotated away from the coordination site. Pathway b is obtained by 
stepwise decreasing the distance between the terminal hydroxide at the second FeIII and the 
phosphorous atom of the DNPP. The resulting energies are plotted in Figure 3.38 b. The black 
lines represent the energies of K1 with protonated cyclam. Hydrogen bonding interactions are 
found between the cyclam N-H group and the DNPP, as indicated in Scheme 3.23 and Figure 
3.38 (bottom structure). In order to have a closer look on the effects of this interaction, an 
analogous scan was performed without the cyclam protons (grey lines). Obviously, no 
interactions between DNPP and the cyclam are possible in this case and a significantly 
different structure of the K1DNPP complex is observed (Figure 3.38, top structure). 
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Scheme 3.23: Competing reaction pathways of DNPP coordinated to K1. 
 
The resulting energy profiles give rise to the following conclusions. In both cases, the 
activation barrier for bridging coordination is considerably larger than the one for the 
hydrolysis reaction. However, the ratio is different: it is more favorable to hydrolysis in the 
protonated case. With the interaction between DNPP and cyclam, a nearly barrierless 
hydrolysis pathway is obtained. This result clearly supports the positive effects of the second 
coordination sphere on PAP like reactivity.  
 
 
Figure 3.38: Energy profiles of a) bridging binding vs. b) hydrolysis of DNPP and K1 with protonated cyclam 
(black line) or K1 with deprotonated cyclam (grey line); the two structures shown in the middle are 
monodentately bound DNPP at K1 with protonated cyclam (bottom) and at K1 with deprotonated cyclam (top). 
 
In combination with the results from experiments of K1 with the inactive substrate 
mimics 1-NP, pNPP and DPP (see Chapter 3.2.2.4), the following mechanistic suggestions for 
DNPP and BDNPP hydrolysis can be made (Scheme 3.24). The substrate is bound to one FeIII 
a)  b) 
  Chapter 3.4: Phosphatase Activity of K1, K2 and K3 111
in a monodentate coordination mode, which is proposed to be the active conformation. An 
equilibrium between monodentately bound and bridging DNPP results in a smaller fraction of 
active species, as shown in Table 3.18, whereas no equilibrium is expected with BDNPP. This 
fact explains the observed difference in activities of K1 towards DNPP and BDNPP. Possible 
interactions with the protonated cyclam moiety can help to stabilize the active coordination 
mode. Subsequently, a hydroxide which is bound to the second FeIII attacks the substrate and 
the leaving group 2,4-dinitrophenol is cleaved off. This process can either be concerted or 
stepwise as this question has yet to be addressed for K1 so far. The pentavalent phosphorous 
structure in Scheme 3.24 is then either a transition state or an intermediate. The product 
(phosphate or) DNPP stays bound in a bridging mode, which is suggested to be an inactive, 
inhibitory species. The only remaining nucleophiles are a µ-oxo group, which is not reactive 
enough to hydrolyze bound DNPP and the second hydroxide, which is too far away from the 
phosphorous atom. The diferric state of the complex results in tight binding of the product and 
prevents ligand exchange against water or another substrate molecule. Therefore, the reaction 
stops after one cycle. 
 
 
Scheme 3.24: Proposed reaction mechanism for BDNPP and DNPP hydrolysis with K1. 
The coordination of BDNPP and DPP to K1 in MeCN was monitored by stopped-flow 
UV/vis spectroscopy, as it was assumed that this is a very fast process. The use of 
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MeCN/buffer mixtures (like in the kinetic assays) was not possible in this case due to the 
experimental setup. The traces at 530 nm (ferric ion dd band) for K1 with BDNPP and DPP 
(1:1 ratio; 1 mM each) were compared to the trace of K1 and DPP at 400 nm (iron-oxo band; 
0.04 mM K1 and 5 mM DPP; i.e. pseudo-first order conditions of the kinetic assays). No 
experiment with K1 and BDNPP could be made at the latter conditions due to the strong 
absorption of the 2,4-dinitrophenolate at 400 nm. Nevertheless, the trace with the inactive 
diester substrate mimic DPP and the one with BDNPP (Figure 3.39 b) show a very similar 
slope and shape. Therefore, we assume a similar kinetic behavior. The pseudo-first order 
reaction of K1 with DPP (Figure 3.39 a) was fitted with the first-order kinetic equation 
(eq. 3.13). The reaction rate for the formation of the K1DPP complex was estimated to be 
k = 3.21 ± 0.09 s-1, which is significantly faster than the observed reaction rate kcat 
(1.33 * 10-3 s-1) for BDNPP hydrolysis (see Figure 3.16 a for extinction coefficients of K1 and 
K1DPP at 400 nm; A0 is the absorption of K1, A∞ the final absorption of K1DPP). Therefore, 
it can be concluded that the nucleophilic attack of an FeIII bound hydroxide at the substrate is 
the rate determining step of the observed reaction. 
 
 ܣ௧ ൌ ܣஶ ൅ ሺܣ଴ െ ܣஶሻ ∗  ݁ି௞∗௧ (eq. 3.13) 
 
  
Figure 3.39: Kinetic traces of a) K1 + DPP (0.04 mM K1, 5 mM DPP) at 400 nm with fitted curve (red line) and 
b) K1 + DPP (black line) and K1 + BDNPP (blue line) at 1 mM and 530 nm in MeCN. 
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Neither UV/vis nor EPR spectroscopy could give evidence for a monodentate 
coordination of phosphomonoesters to K1. Stopped-flow UV/vis spectra were recorded on a 
1:1 mixture of K1 and the inactive monoester 1-NP in MeCN at 1mM concentration. 
Unfortunately, the region between 500 and 600 nm did not show two bands; only one weak 
band was observed independent of the time scale (0 to 0.5 or 16 seconds). These findings are 
in line with the obtained values for the equilibrium constant K between monodentately bound 
and bridging DNPP (Table 3.18). 
 
 
3.4.2. Phosphatase Activity of K2 and K3  
 
For simplicity reasons, the in situ prepared diferric complexes of HL2 and H3L3 were used in 
the phosphatase activity assays. The different species of K2 and K3 were already described in 
detail in Chapter 3.3.2.1., based on spectrophotometric titrations. For K2, four species in the 
pH range between 4.6 and 11 were determined, whereby it is assumed that both aqua/hydroxo 
species, with and without protonated amino residues, are active catalysts. K3 revealed only 
two deprotonation steps over the pH range and therefore should have only one active species, 
similar to K1. The proposed active species of K2 and K3 are shown in Scheme 3.25. 
 
 
Scheme 3.25: Proposed active species of K2 and K3 (highlighted). 
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The heterovalent FeIIIFeII complexes of HL2 and H3L3 that are formed after reaction of 
K2 and K3 with excess pNPP (see Chapter 3.3.2.2.) are not considered in the kinetic analysis 
of phosphoester hydrolysis in this case. As it was previously shown, the diferric K2 and K3 
complexes are only slowly reduced by para-nitrophenol. Therefore, no significant amounts of 
the FeIIIFeII species are expected in the kinetic assays and only the diferric species have been 
taken into account. 
 
 
3.4.2.1. Diesterase Activity of K2 and K3 
 
In analogy to K1, the activity of K2 and K3 towards hydrolysis of the activated phosphodiester 
BDNPP was measured. The resulting pH profiles of K2 and K3 as well as L2 and L3 with one 
eq of FeIII and the Michaelis-Menten diagrams of K2 and K3 are shown in Figure 3.40. From 
the fitted data, the important kinetic parameters are extracted and listed in Table 3.19. It is 
worth noting that K2 has a higher activity than K3, but also a slightly higher Michaelis-
Menten constant, i.e. lower substrate affinity. Nevertheless, the efficiency kcat/KM is still 
higher for K2 than for K3. The pH profile of the experiment with L2 and one eq of FeIII 
(Figure 3.40 c) reveals somewhat different parameters than the one with K2. This leads to the 
conclusion that with less than two eq of FeIII dinuclear complexes are not predominantly 
formed. Otherwise one would expect the same pKa values and pHmax as well as halved activity 
at this pH, like in the case with K1. Unfortunately, no suitable fit was obtained with L3 and 
one eq of FeIII (Figure 3.40 d). The pH profile resembles that of a mononuclear complex or, in 
other words, a monoprotic system. These findings are in good agreement with the analytic 
results of in situ prepared complex solutions described in Chapter 3.3.2.1. Again, a linear 
behavior was observed in experiments with varying catalyst concentrations (the data are not 
shown). 
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Figure 3.40: Results from kinetic analysis of BDNPP hydrolysis: pH profiles for a) K2, b) K3, c) L2 with 1 eq of 
FeIII, d) L3 with 1 eq of FeIII and Michaelis-Menten diagrams for e) K2 (pH 7.5) and f) K3 (pH 6.5). The 
experimental data are shown as black squares, the red lines represent the fits using equations 3.8 and 3.9 for pH-
profiles and Michaelis-Menten diagrams, respectively. 
 
 
a)  b) 
c)  d) 
e)  f) 
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Table 3.19: Kinetic parameters for BDNPP hydrolysis with K2 and K3 as well as L2 and L3 with 1 eq of FeIII. 
catalyst pHmax pKa(I) pKa(II) 
kcat 
[s-1] *10-4 
KM  
[M] *10-3 
kcat/KM 
[M-1s-1] *10-2 
K2 7.44 5.39 ± 0.03 9.38 ± 0.10 6.48 ± 0.34 7.38 ± 0.69 8.79 ± 0.12 
L2Fe 6.90 5.24 ± 0.08 8.34 ± 0.11 n.a. n.a. n.a. 
K3 6.45 5.16 ± 0.10 7.43 ± 0.11 4.67 ± 0.26 5.92 ± 0.62 7.89 ± 0.09 
L3Fe n.a. n.a. n.a. n.a. n.a. n.a. 
 
The pH dependent activity profiles and pKa values obtained can now be judged against 
the fitted data from the spectrophotometric titrations (Chapter 3.3.2.1). However, one must 
consider that these two experiments were performed in different media (MeCN/buffer vs. 
MeOH/buffer for kinetic and spectrophotometric assays, respectively). Therefore, some 
differences can be expected, although the pH should not change dramatically due to the use of 
buffered solutions. Furthermore, the kinetic data are obtained in the presence of substrate, 
which also might change the pH dependent properties of the complexes. As one can see in 
Figure 3.41, the pH profile of K2 fits better to the four-species-model fit (c) than to the one 
with only three species (a). In contrast, the profile of K3 resembles more the fit with three 
species only (b). These trends are also evident for the pKa values compared in Table 3.20. In 
summary, this is a further support for the protonation equilibria depicted in Chapter 3.3.2.1. 
 
Table 3.20: Comparison of pKa values for K2 and K3 obtained by kinetic analysis and spectrophotometric 
titration (Chapter 3.3.2.1) with a three-species- or four-species-model, respectively. 
 K2 K3 
 kinetic 3 species 4 species kinetic 3 species 4 species 
pKa(I) 5.39 ± 0.03 5.98 ± 0.12 5.18 ± 0.19 5.16 ± 0.10 5.19 ± 0.17 4.85 ± 0.22 
pKa(II) 9.38 ± 0.10 10.57 ± 0.57 10.38 ± 0.35 7.43 ± 0.11 8.69 ± 0.14 9.05 ± 0.19 
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Figure 3.41: Overlays of species distribution (from spectrophotometric titrations) and kinetic pH profiles of 
BDNPP hydrolysis with a) K2 and b) K3 in the three-species-model as well as c) K2 and d) K3 in the four-
species-model. 
 
 
3.4.2.2. Monoesterase Activity of K2 and K3  
 
Despite the relatively low activity of K2 and K3 towards hydrolysis of BDNPP, both 
complexes were tested for activity towards monoesters. DNPP was used as substrate with c0 = 
0.5 mM, as in the case with K1. At first, quick tests were performed regarding activity at the 
pH which had maximum activity with BDNPP. K2 was tested at pH 7.5 and resulted in V0 = 
4.2*10-9 Ms-1, which corresponds to an acceleration of only 20 % vs. the autohydrolysis 
reaction. K3 had its maximum activity at pH 6.5 and revealed a V0 of only 2.4*10-9 Ms-1 
a)  b) 
c)  d) 
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under these conditions (10 % acceleration). Due to the very low activity of K3 we decided to 
perform a full pH profile analysis only on K2 (Figure 3.42 a).  
 
   
Figure 3.42: Results from kinetic analysis of DNPP hydrolysis by K2: a) pH profile and b) Michaelis-Menten 
diagram (pH 7). The experimental data are shown as black squares, the red lines represent the fits using 
equations 3.8 and 3.9 for pH-profiles and Michaelis-Menten diagrams, respectively. 
 
The large errors and the flat curve make it difficult to fit the data properly. However, the 
pKa values of 5.17 ± 0.12 and 8.32 ± 0.59 and the maximum activity pH of 6.95 resemble in 
some way the values for BDNPP hydrolysis with K2. Substrate dependent measurements 
show that the plateau of the reaction rate is already reached at very low DNPP concentrations 
but also with a small value of V0 (KM = 9.7 ± 4.5 µM; Vmax = 5.3 ± 0.3 * 10-9 Ms-1; Figure 
3.42 b). One can even observe a decrease of the reaction rate at concentrations larger than 
2 mM, which is certainly due to the high autohydrolysis rate of the DNPP molecule (see 
Appendix 9). The resulting kcat is 1.33 ± 0.08*10-4 s-1 and the catalytic efficiency kcat/KM is 
13.6 ± 0.1. 
 
 
 
 
 
a)  b) 
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3.4.3. Comparison of K1, K2 and K3 in Hydrolysis of Phosphoesters 
 
The presented PAP mimics K1, K2 and K3 have quite different kinetic parameters, which is 
due to their completely different ligands. Nevertheless, these data are important to analyze the 
effects of alterations of the model systems, i.e. the incorporation of a second coordination 
sphere mimic in this case. Table 3.21 summarizes the results and compares them to literature 
known catalysts. Although PAP enzymes show no activity in the diferric state,[55, 156] some 
PAP mimetics containing a di-FeIII core are reported to catalyze BDNPP hydrolysis.[97, 98, 100, 
158] Unfortunately, only in one case the same experimental conditions (concentrations, 
temperature, buffer system) were applied (entry [a] in Table 3.20),[158] so only these results 
can be directly related to ours. In comparison to known PAP mimetics, K1 has the highest 
catalytic efficiency kcat/KM (last column in Table 3.21; see also Table 2.3 in Chapter 2.3 for 
heteronuclear systems), which is mainly due to the low KM value, i.e. K1 has a high affinity 
for BDNPP. This is a result of the diferric state of the complex, as FeIII is known to be more 
lewis-acidic than divalent metals and therefore more efficiently binds substrates. 
 
Table 3.21: Kinetic parameters for BDNPP hydrolysis with K1, K2 and K3 in comparison to literature-known 
complexes. 
catalyst pHmax pKa(I) pKa(II) 
kcat 
[s-1] *10-4 
KM  
[M] *10-3 
kcat/KM 
[M-1s-1] *10-2 
K1 6.17 5.03 ± 0.10 7.28 ± 0.12 13.3 ± 0.8 1.94 ± 0.37 68.3 ± 2.2 
K2 7.44 5.39 ± 0.03 9.38 ± 0.10 6.48 ± 0.34 7.38 ± 0.69 8.79 ± 0.12 
K3 6.45 5.16 ± 0.10 7.43 ± 0.11 4.67 ± 0.26 5.92 ± 0.62 7.89 ± 0.09 
[a] n.a. 5.00 10.50 35.0 ± 2.0 8.70 ± 0.60 40.0 ± 6.0 
[b] 6.00 4.74 7.54 30.0 13.0 23.0 
[c] 6.35 5.00 ± 0.11 7.15 ± 0.14 1.69 ± 0.14 1.74 ± 0.35 9.71 ± 0.08 
 
[a] [LFeIII2(µ-OAc)2]2+;[158] L = N-(2-hydroxybenzyl)-N-(2-hydroxy-5-methyl-3{[(pyridine-2-ylmethyl)amino]-
methyl}benzyl)amino-acetic acid; [b] [LFeIII(µ-OAc)2FeII]+;[86] L = 2-bis[{2-pyridyl-methyl)-aminomethyl}-6-
{(2-hydroxy-benzyl)-(2-pyridyl-methyl)}-amino-methyl]-4-methylphenol; [c] = [(BPMP)FeIII2]5+; n.a. = data not 
available. 
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The obtained pKa values and pH maximum for K1 are quite different to the cited diferric 
complex [a] but similar to the data for the heterovalent di-iron complex [b] (see Table 3.21). 
The second pKa of the heterovalent complex belongs to an aqua/hydroxo to di-hydroxo 
deprotonation step, where the reaction takes place at an FeII bound water molecule. It is 
unclear, what causes the high second pKa of 10.50 with the diferric complex [b]; an FeIII 
bound water can be excluded. In both complexes, [a] and [b], only one co-ligand can be 
bound in addition to the ligand and a bridging oxo group. In our case, two potentially free 
coordination sites are present. Therefore, the second pKa of K1 should be attributed to water 
bound to a ferric ion already bearing a hydroxo ligand (see Scheme 3.26). The difference of 
nearly two between the first and second pKa fits nicely to the difference between two 
deprotonation steps at FeIII hexa-aqua ions.[159] 
 
Scheme 3.26: Proposed deprotonation steps of K1. 
 
K2 and K3 have an almost 10 fold lower catalytic efficiency kcat/KM in comparison to 
other diferric PAP mimetics. The substrate affinity KM is in the same order of magnitude as 
catalyst [a], which is also based on a phenolate type ligand. In contrast, K1 has a significantly 
smaller KM. Regarding the catalytic activity kcat, catalyst [a] is ca. five times faster than K2 
and K3. This might be due to the different ligand setup with an additional acidic residue. No 
data are available in the literature regarding the catalytic abilities of the unsubstituted diferric 
HBPMP complex. Therefore, the ligand was synthesized, reacted with two eq of FeIII in situ 
and tested for hydrolysis of BDNPP and DNPP under the same conditions as the other 
catalysts. The resulting kcat is significantly smaller (ca. 4 times) than the one of K2, but due to 
the low KM of 1.74 mM the efficiency kcat/KM is in the same range as for K2 and K3. 
Nevertheless, the higher activity kcat in the K2 case accounts for a measurable effect of the 
additional amines.  
Regarding the abilities of the different catalysts to hydrolyze monoester substrates, K2 is 
the most efficient catalyst so far, (kcat/KM in Table 3.22), whereas K1 has a slightly higher 
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activity kcat. The main difference between both systems is the large deviation of the KM 
values. Interestingly, K2 has a higher affinity to DNPP than K1, whereas in the case of 
BDNPP it is the other way round (see Table 3.21). 
 
Table 3.22: Kinetic parameters for DNPP hydrolysis with K1 and K2. 
catalyst pHmax pKa(I) pKa(II) 
kcat 
[s-1] *10-4 
KM  
[µM] 
kcat/KM 
[M-1s-1] 
K1 6.17 5.68 ± 0.27 6.33 ± 0.41 2.09 ± 0.09 170 ± 37 1.23 ± 0.14 
K2 6.95 5.17 ± 0.12 8.32 ± 0.59 1.33 ± 0.08 9.73 ± 4.48 13.60 ± 1.41 
 
No other PAP mimic is known in the literature that can hydrolyze phosphomonoesters. 
Only bridging coordination of pNPP or DNPP is reported so far.[55, 92] K3 as well as the 
diferric complex of HBPMP show only minor acceleration of DNPP hydrolysis, which is in 
the range of the experimental error. We trace the observed activities of K1 and K2 back to the 
fact that both systems have an environment, which can act as a second coordination sphere 
mimic and favor hydrolysis over bridging binding of the monoester substrates. This was 
shown for K1 in Chapter 3.4.1.3. but is not yet proven in the case of K2. Nevertheless, the 
large differences in KM suggest that the influence of the second coordination sphere in both 
cases should be not identical.  
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3.5.   Summary and Outlook 
 
Purple acid phosphatases are versatile enzymes found in a large number of different species, 
including mammals, plants, fungi and bacteria. One of their roles is the hydrolysis of 
phosphoester substrates, more exactly phosphomonoesters. This function is for example used 
in plants for the mobilization of organic phosphates in soil, or bone resorption in mammals.  
So far, no PAP mimetics with the ability to hydrolyze phosphomonoesters were reported 
in literature. Only the hydrolysis of activated phosphodiesters is possible with the known 
types of model compounds. Recent publications suggest that a) a monodentate coordination 
mode is necessary for hydrolytic activity and this is what takes place in the natural enzymes 
and b) in the PAP mimetics, a very fast reaction to bridging phosphomonoesters occurs, 
which produces a conformation that is inactive towards hydrolysis. In the enzymes, an 
extended hydrogen bonding network is responsible for perfect positioning of substrate and 
nucleophile. Also, it prevents the bridging coordination of substrates as well as products, 
which leads to a high activity. The new PAP mimetics presented in this work, K1, K2 and K3, 
are the first examples of diferric systems with additional functionalities that are designed to 
act as second coordination sphere mimic.  
The µ-oxo bridged diferric complex K1 is readily formed from in situ reaction of the 
cyclam-based ligand L1 and tetrachloroferrate in MeCN. The high basicity of L1 is 
responsible for the formation of a µ-oxo bridged diferric precursor, which is then enclosed by 
the ligand´s coordinating units, leading to exclusive formation of dinuclear complexes. A 
thorough investigation of the coordination chemistry of K1 has been performed and the 
following conclusions can be drawn from the results: The in situ formed µ-oxo bridged 
character of K1 is retained under partly aqueous conditions, suggesting an inherent complex 
stability in the diferric state. Attempts to obtain the heterovalent FeIIIFeII complex of L1 by 
bulk electrolysis of K1 were principally successful. Yet, the heterovalent complex cannot be 
isolated, even under anaerobic conditions. Most probably, a dispropotionation to the diferric 
and the diferrous state takes place. This behavior is typical for diferric complexes, where a 
direct ligand-based linker is missing. Experiments of K1 with different inactive phosphoesters 
gave interesting results regarding coordination modes and reaction equilibria. A clear 
distinction is drawn between phosphomono- and phosphodiesters. Whereas the results with 
monoesters suggest a bridging coordination mode of these substrate mimics, diesters are 
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rather bound in a monodentate conformation. DFT calculations gave insight into the reasons 
for this observation: Hydrogen bonding interactions of the substrate BDNPP with the 
protonated cyclam moiety lead to the preference of a molecular structure, where the 
monodentately bound substrate is arranged in a way that disables direct coordination to the 
second metal ion. Therefore, the hydrolytically active monodentate coordination mode is 
retained. This is nicely reflected in a relatively high activity and efficiency of K1 towards 
BDNPP hydrolysis. In the case of the monoester analogue DNPP, the presence of only one 
2,4-dinitrophenol group instead of two enables direct coordination to the second ferric ion 
without losing the energetically favorable interaction to the remote ligand parts. As a 
consequence, the inactive bridging coordination mode is preferred with monoesters. 
Nevertheless, the hydrogen bond to the protonated cyclam also influences the desired 
pathway, i.e. hydrolysis of the substrate by a terminal hydroxide bound to the second ferric 
ion. The calculated reaction profile shows an almost barrierless transition to the hydrolysis 
product. We therefore conclude that a certain part of the monoester will be hydrolyzed by K1 
before reaching the inactive bridging mode. And in fact, a significant activity of K1 towards 
DNPP hydrolysis is observed – the first example of a truly functional PAP mimetic.  
The two related complexes K2 and K3, synthesized from the phenolate based ligands HL2 
and H3L3, have a completely different structural setup compared to K1. They are designed in 
analogy to known model systems, like the symmetric ligand HBPMP, in order to directly 
compare the effects of a second coordination sphere mimic containing model in contrast to 
PAP mimetics without additional functionalities. K2 with its pendant amino groups represents 
a complex, where hydrogen bonding interactions between a coordinated substrate and the 
remote ligand parts are possible. In contrast, the pivaloylamido substitution of complex K3 
leads to only one free coordination site per ferric ion, due to the coordination of the carbonyl 
oxygen atoms, and also induces a considerable steric strain onto the system. Reaction of K2 
with phosphoesters shows similar results as seen with K1, namely bridging coordination of 
monoesters and monodentate coordination of diesters. This is rather unusual with these kinds 
of systems, as many crystal structures of phenolate based dinuclear complexes are known 
where a diester is bound in a bridging mode. Interestingly, K3 does not show signs of 
monodentate coordination of diesters, although one would expect steric interactions between 
their bulky residues and the ligand´s amido groups. These facts account for a significant effect 
of the amino groups in K2, suggesting interactions similar to those proposed for K1 and 
leading to a preference for monodentate binding of phosphodiesters. Regarding the 
phosphoester hydrolysis, this difference is nicely reflected by a significantly larger activity of 
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K2 towards hydrolysis of BDNPP as well as DNPP in contrast to K3 and the diferric complex 
of ligand HBPMP. Another exciting result regarding K2 and K3 is the observed formation of 
heterovalent complexes upon reaction with pNPP. This behavior is evocative of the proposed 
substrate driven in vivo redox regulation in mammalian PAP. 
 
Many questions concerning both systems, K1 and K2/K3, remain under investigation. A 
direct proof for the positive influence of the cyclam and amino parts in K1 and K2 on 
phosphoester hydrolysis must be provided. So far, we base our suggestions on results from 
DFT calculations, which should be supported by experimental work. The main problem is 
how to knock out the proposed interactions selectively. In the case of K2 and K3, this problem 
is solved to some extent by the use of the pivaloyl protecting groups, which disable hydrogen 
bonding interactions. No successful experiments were performed so far regarding the 
interactions in K1. 
An interesting experiment would be the use of Mössbauer spectroscopy. On one hand, 
this approach would further back up the proposed µ-oxo or µ-phenoxo bridged diferric nature 
of the complexes as well as the heterovalent state observed in K2pNPP and K3pNPP. On the 
other hand, we hope to gain a more detailed insight into the interactions of substrates and 
substrate mimics with the complexes and the influence on their electronic structure, especially 
in combination with Mössbauer parameters calculated by DFT methods. 
Based on our results, the design and development of better and more realistic PAP 
mimetics should be continued. We have shown that the incorporation of a second 
coordination sphere into the model systems leads to a higher activity towards hydrolysis of 
phosphodiesters and, more importantly, allows hydrolysis of phosphomonoesters due to the 
stabilization of the active monodentate coordination mode. 
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4.1.   Physical Measurements 
 
NMR spectroscopy 
NMR spectra were recorded at 399.89 MHz (1H), 100.55 MHz (13C) and 161.88 MHz (31P) on 
a Bruker Avance II 400 instrument. For 1H and 13C spectra, the respective solvent peak and 
for 31P spectra, 85% H3PO4 (0 ppm) was used as reference for the chemical shift δ. All 
reported coupling constants nJ are for 1H-1H couplings. The following abbreviations are used 
for signal multiplicities: s = singlet, bs = broad singlet, d = doublet, t = triplet, q = quartet, 
quin = quintet, dd = doublet of doublets, ddd = doublet of doublets of doublets, dt = doublet 
of triplets, tt = triplet of triplets, m = multiplet. 
IR spectroscopy  
IR measurements were performed with a Perkin Elmer 16 PC FT-IR spectrometer in KBr. 
Signal intensities are abbreviated as followed: b = broad, w = weak, m = medium, s = strong. 
UV/vis spectroscopy 
UV/vis spectra and time-course measurements at fixed wavelengths were recorded on a 
JASCO V-570 spectrophotometer equipped with a JASCO ETC-505T cryostat at 25°C. Time-
dependent UV/vis measurements were performed by using a TIDAS II J&M 
spectrophotometer. The baseline was recorded prior to a measurement series using pure 
solvent and subtracted automatically. Fast processes were monitored by stopped-flow 
measurements using an Applied Photophysics PD.1 photodiode array stopped-flow 
spectrophotometer. A linear 256 element diode array APL xenon lamp served as the light 
source. For recording and handling the data, the software suite !XScan 1.09 by P.J. King (© 
AP Ltd. 1995) was used.  
EPR spectroscopy 
Liquid helium temperature X-band EPR spectra (ca. 9 GHz) were recorded on a Bruker 
Biospin ELEXSYS E580 spectrometer equipped with a Super High Q cavity and an Oxford 
Instruments ESR 910 cryostat with an ITC503 temperature controller at 1.8 to 16 K, located at 
the CAI (University of Queensland, Australia). The microwave frequency and magnetic field 
were calibrated with a Bruker frequency counter and an ER036 TM Tesla meter. Liquid 
nitrogen temperature and room temperature X-band EPR spectra (ca. 9 GHz) were recorded 
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on a Bruker Biospin ELEXSYS E500 spectrometer with a Super High Q cavity located at the 
Institute of Inorganic Chemistry (University Heidelberg). In the case of liquid nitrogen 
cooling, an ITC4 temperature controller was used. Spin-Hamiltonian parameters were 
determined from computer simulation of the experimental spectra using MoSophe.[137] The 
simulated and experimental spectra were visualized with Xepr.[136] 
Elemental analyses 
Elemental analyses were performed in the analytical laboratories of the Chemical Institutes at 
the University of Heidelberg on an Elementar Vario EL machine. 
Mass spectrometry 
FAB mass spectra were measured on a Finnigan TSQ 700 instrument with nitrobenzylalcohol 
as matrix at the Institute of Inorganic Chemistry at the University of Heidelberg. ESI mass 
spectra were measured on a Micromass Q-TOF Ultima spectrometer at the Institute of 
Inorganic Chemistry at the University of Heidelberg. HR-ESI mass spectra were measured on 
a Bruker Apex-Qe hybrid 9.4 T FT-ICR instrument at the Institute of Organic Chemistry at 
the University of Heidelberg. 
Cyclic voltammetry 
CV measurements were performed on a CH Instruments CHI660D electrochemical 
workstation equipped with a faraday cage using a three-electrode setup consisting of a glassy 
carbon working electrode, a platinum wire as counterelectrode and a Ag/Ag+ (0.1 mM in 
MeCN) reference electrode. The samples were prepared in degassed solvents with 0.1 M 
NBu4ClO4 as electrolyte. The redox potentials of the obtained signals were determinded by 
comparison to a FeCp2 sample measured at the same conditions and referenced vs. SCE.  
pH meter 
pH values were adjusted at 25°C with a Metrohm 713 pH meter equipped with a KCl 
electrode and calibrated with pH standard solutions at pH 4, 7 and 9. 
X-Ray Structure Analysis 
The measurements were performed with a Stoe IPDS image plate and MoKα radiation at low 
temperatures (200 K) in the laboratory of Prof. G. Linti at the Institute of Inorganic 
Chemistry, University of Heidelberg. The structures were solved and refined by Prof. G. Linti 
and Mr. T. Zessin using the software package SHELXTL 5.10.[160]  
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4.2.   Chemicals 
 
Solvents for organic synthesis were of standard quality and distilled prior to use. Solvents for 
complex synthesis and spectroscopy were of p.a. grade and used without further purification. 
Dry solvents were purchased form Sigma-Aldrich, stored over molecular sieves and used 
without further purification. For the kinetic assays, MilliQ water was used (R > 18 MΩ). 
Cyclam was purchased from ChemaTech, other chemicals from Sigma-Aldrich. All were used 
without purification, except 2,4-dinitrophenol, which was recrystallized, and phosphoryl 
chloride, which was distilled before use. 
1,8-Dimethylcyclam,[119] N-tosylaziridine,[123, 124] di-(2-pyridyl)methyl chloride,[126] 
tetraethyl ammonium tetrachloroferrate,[128] 2,6-bis(chloromethyl)-4-methylphenol,[146, 147] 2-
formyl-6-pivaloyl-amidopyridine,[145] BDNPP[154] and DNPP[155] were synthesized according 
to known literature procedures. 
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4.3.   Syntheses 
 
4.3.1. Synthesis of Ligand L1 
 
Di-(2-pyridyl)methyl chloride (12). 
 
molecular formula: 
C11H9N2Cl 
molecular weight: 
204.66 
 
Di-(2-pyridyl)ketone 10 (5.00 g, 27.10 mmol) is dissolved in dry MeOH (50 ml) and cooled 
to 0°C. NaBH4 (1.30 g, 34.40 mmol) is added in small portions and the reaction mixture 
stirred over night at room temperature (rt). The solvent is removed in vacuo, the residue is 
taken up in water, acidified with 2M HCl and stirred for 10 min. The solution is made basic 
with diluted ammonia and extracted with DCM (3 x 50 ml). The organic phase is dried over 
Na2SO4 and the solvent is removed in vacuo to give di-2(pyridyl)methanol 11 as an orange oil 
(5.26 g, 100 %). It is dissolved in MeCN (60 ml) and cooled to 0°C. Triphenylphosphine 
(8.90 g, 22.9 mmol) in CCl4 (50 ml) is added dropwise over 1.5h. The reaction mixture is 
stirred over night at rt, MeOH (5.5 ml) is added and after 15 min the reaction mixture is 
concentrated to ca. 1/3 original volume. Water (55 ml) is added and the mixture is brought to 
pH 1 with 2M HCl. It is washed with chloroform (2 x 55 ml), neutralized with K2CO3 and 
extracted with Et2O (4 x 40 ml). The organic phase is dried over Na2SO4 and the solvent 
removed in vacuo to yield di-(2-pyridyl)methyl chloride 12 as a tan solid (4.32 g, 75 %). 
1H-NMR (400 MHz, CDCl3): δ = 8.57 (d, 3JH,H = 9.6 Hz, 2H, N-CHar), 7.77 – 7.62 (m, 4H, 
CHar), 7.25 – 7.15 (m, 2H, CHar), 6.20 (s, 1H, Cl-CH). 
13C-NMR (100 MHz, CDCl3): δ = 158.6 (Cq), 149.3, 137.1, 123.0, 122.8 (CarH), 64.6 (Cl-
CH). 
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N-Tosylaziridine (9). 
 
molecular formula: 
C9H11NO2S 
molecular weight: 
197.25 
 
Tosylchloride (80.26 g, 0.42 mol) is dissolved in dry pyridine (50 ml) and cooled to -40°C. 2-
Aminoethanol 7 (12.22 g, 0.20 mol) is added dropwise while maintaining the temperature and 
stiring. The reaction mixture is warmed up to -10°C, stirred for 1h, then warmed up to 0°C 
and stirred over night. Ice is added and the resulting precipitate is filtered off and washed with 
water. It is dissolved in chloroform, washed again with water and dried over Na2SO4. The 
solvent is removed in vacuo. The crude product is recrystallized in hot CCl4 to give 2-
tosylamidoethyltosylate 8 as white crystals (70.3 g, 95 %). In the next step, 2-
tosylamidoethyltosylate (17.76 g, 48.10 mmol) is suspended in toluene and 3.5M KOH 
solution added dropwise. The resulting biphasic mixture is stirred vigorously for 2h, then the 
aqueous phase is removed. The organic phase is washed with water three times and dried over 
Na2SO4. The solvent is removed in vacuo to give N-tosylaziridine 9 as a brown oil, which 
solidifies upon standing (5.80 g, 61 %). 
1H-NMR (200 MHz, CDCl3): δ = 7.83 (d, 3JH,H = 8.2 Hz, 2H, CHar-CSO2), 7.35 (d, 3JH,H = 
8.2 Hz, 2H, CHar-CCH3), 2.45 (s, 3H, CH3), 2.36 (s, 4H, CH2). 
13C-NMR (50 MHz, CDCl3): δ = 144.6 (Cq-SO2), 134.8 (Cq-CH3), 129.7 (CarH-CCH3), 128.0 
(CarH-CSO2), 27.4 (CH2), 21.6 (CH3). 
 
1,8-Dimethylcyclam (4).   
NH N
N HN
 
molecular formula: 
C12H28N4 
molecular weight: 
228.38 
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Cyclam 1 (1.65 g, 8.24 mmol) is dissolved in water (100 ml) and cooled to 0°C. Formalin 
(36 % in water, 1.50 ml) is added quickly and the reaction mixture stirred for 2h. The 
resulting white precipitate of 1,4,8,11-tetraazatricyclo[9.3.1.14,8]hexadecane 2 is filtered off, 
washed with water and dried in vacuo (1.65 g, 89 %). In the next step, it is dissolved in dry 
MeCN (50 ml) and methyl iodide (2.02 g, 14.23 mmol) is added quickly. After stirring for 2h, 
the white precipitate of 1,4,8,11-tetraazatricyclo[9.3.1.14,8]-1,8-dimethylhexadecanyl bis-
iodide 3 is filtered off, washed with MeCN and dried in vacuo (3.51 g, 96 %). It is then stirred 
in 3M NaOH solution (750 ml) for 3h. After extraction with chloroform (5 x 200 ml), the 
organic phase is dried over Na2SO4 and the solvent is removed in vacuo. The product 1,8-
dimethylcyclam 4 is obtained as a yellowish oil (1.60 g, 98 %). 
1H-NMR (400 MHz, CDCl3): δ = 3.98 (bs, 2H, NH2), 2.71 – 2.62 (m, 8H, N-CH2), 2.46 – 2.36 
(m, 8H, N-CH2), 2.17 (s, 6H, N-CH3), 1.73 (quin, 3JH,H = 5.2 Hz, 4H, C-CH2-C). 
13C-NMR (100 MHz, CDCl3): δ = 57.6, 56.6, 49.8, 47.2 (N-CH2), 41.8 (N-CH3), 25.8 (C-CH2-
C). 
 
1,8-Bis(2-tosylaminoethyl)-4,11-dimethylcyclam (5). 
 
molecular formula: 
C30H50N6O4S2 
molecular weight: 
622.89 
 
1,8-Dimethylcyclam 4 (1.00 g, 4.38 mmol) is dissolved in dry MeCN (30 ml). It is heated to 
reflux and N-tosylaziridine 9 (2.10 g, 10.66 mmol) in dry MeCN (30 ml) is added dropwise. 
The reaction mixture is refluxed for 6h. The solvent is removed in vacuo and the residue is 
recrystallized in hot DCM/EtOH (1:1) to yield 5 as a tan powder (1.80 g, 66 %). 
1H-NMR (400 MHz, CDCl3): δ = 8.94 (bs, 2H, NH), 7.72 (d, 3JH,H = 4.0 Hz, 4H, CHar-CSO2), 
7.24 (d,  3JH,H = 4.0 Hz, 4H, CHar-CCH3), 2.88 (bt, 3JH,H = 5.2 Hz, 4H, CH2NH), 2.5-2.3 (m, 
26H, Ph-CH3 and all N-CH2), 2.24 (s, 6H, N-CH3), 1.65 (bs, 4H, C-CH2-C). 
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13C-NMR (100 MHz, CDCl3): δ = 142.2 (Cq-SO2), 138.3 (Cq-CH3), 129.3 (CarH-CCH3), 126.8 
(CarH-CSO2), 55.0, 54.1, 50.9, 50.7, 47.1 (all N-CH2), 43.4 (N-CH3), 42.3 (CH2-NH), 24.8 
(C-CH2-C), 21.4 (CH3-Ph). 
FAB+-MS (nibeol): m/z (%): 623.5 (91) [M+H]+. 
El. analysis (%): calc. for C30H50N6O4S2: C: 57.85 H: 8.09 N: 13.49; 
(Rep. No. 26336) found:    C: 57.71 H: 8.12 N: 13.56. 
 
1,8-Bis(2-aminoethyl)-4,11-dimethylcyclam (6).  
 
molecular formula: 
C16H38N6 
molecular weight: 
314.51 
 
1,8-Bis(2-tosylaminoethyl)-4,11-dimethylcyclam 5 (1.00 g, 1.61 mmol) and conc. H2SO4 
(7.5 ml) are heated to 100°C for 48h. The reaction mixture is added dropwise to diethylether. 
The resulting white precipitate is filtered off and washed with diethylether, dissolved in water 
(20 ml) and 3M NaOH solution is added until the solution reached pH 14. The product is 
extracted with chloroform (5 x 15 ml). The organic phase is dried over Na2SO4 and the 
solvent is removed in vacuo to yield 6 as a yellowish oil (0.50 g, 100 %). 
1H-NMR (400 MHz, CDCl3): δ = 2.64 (t, 3JH,H = 5.6 Hz, 4H, CH2-NH2), 2.47-2.35 (m, 20H, 
all N-CH2), 2.13 (s, 6H, N-CH3), 1.85 (bs, 4H, NH2), 1.55 (quin, 3JH,H = 6.8 Hz, 4H, C-CH2-
C).  
13C-NMR (100 MHz, CDCl3): δ = 57.5, 54.6, 54.5, 51.5, 51.8 (N-CH2), 43.2 (N-CH3), 39.6 
(CH2-NH2), 24.6 (C-CH2-C).  
FAB+-MS (nibeol): m/z (%): 315.3 (100) [M+H]+. 
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4,11-Dimethyl-1,8-bis[N-(2-di-(2-pyridyl)methyl)ethylamino]cyclam (L1).  
molecular formula: 
C38H54N10 
molecular weight: 
650.90 
1,8-Bis(2-aminoethyl)-4,11-dimethylcyclam 6 (0.45 g, 1.43 mmol), di-(2-pyridyl)methyl-
chloride 12 (0.60 g, 2.86 mmol) and potassium carbonate (0.41 g, 2.86 mmol) are dissolved in 
dry acetonitrile under argon and refluxed for 24h. After cooling down, the reaction mixture is 
poured into water (60 ml). Sodium hydroxide is added until the solution reached pH 14. The 
product is extracted with ethyl acetate (3 x 50 ml). The organic phase is dried over K2CO3 and 
the solvent is removed in vacuo. The crude product is purified by column chromatography 
(neutral alumina, chloroform/methanol 99:1 till 95:5). The resulting oil is recrystallized in hot 
hexane to yield L1 as pale yellowish crystals (0.24 g, 26 %). 
1H-NMR (400 MHz, CDCl3): δ = 8.53 (dd, 3JH,H = 4.8 Hz, 4JH,H = 1.2 Hz, 4H, CHarN), 7.60 
(dt, 3JH,H = 8.0 Hz, 4JH,H = 1.2 Hz, 4H, CHar para to N), 7.48 (d, 4H, CHarCq), 7.10 (ddd, 4H, 
3JH,H = 8.0 Hz, 3JH,H = 4.8 Hz, 4JH,H = 1.2 Hz,  CHarCHN), 5.06 (s, 2H, CHPy2), 3.12 (bs, 2H, 
NH), 2.7-2.2 (m, 24H, all N-CH2), 2.11 (s, 6H, N-CH3), 1.47 (quin, 4H, 3JH,H = 6.8 Hz, 4H, C-
CH2-C). 
13C-NMR (100 MHz, CDCl3): δ = 161.9 (Car,q), 149.2, 136.5, 122.2, 122.0 (Car), 70.3 
(CHPy2), 54.5, 54.3, 53.9, 51.7, 50.8 (all N-CH2), 45.7 (CH2-NH), 43.5 (N-CH3), 24.1 (C-
CH2-C). 
IR (KBr): ν̃ [cm-1]= 3439 (b), 3282 (m), 2981 (m), 2937 (m), 2846 (m), 2792 (s), 1674 (s), 
1565 (s), 1599 (m), 1473 (s), 1466 (s), 1435(s), 1294 (m), 1162 (m), 1125 (m), 1114 (m), 999 
(w), 929 (m), 887 (w), 809 (m), 771 (m). 
FAB+-MS (nibeol): m/z (%): 651,6 (97) [M+H]+. 
El. analysis (%): calc. for C38H54N10 x H2O: C: 68.23 H: 8.44 N: 20.94; 
(Rep. No. 26337) found:    C: 68.69 H: 8.43 N: 21.05. 
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4.3.2. Synthesis of Complexes of L1. 
 
Tetraetylammonium tetrachloroferrate (13). 
 
molecular formula: 
C8H20NFeCl4 
molecular weight: 
327.91 
 
Ferric chloride (779 mg, 4.80 mmol) and tetraethylammonium chloride (794 mg, 6.10 mmol) 
are dissolved separately in 10 ml EtOH each. The solutions are combined and the resulting 
yellow precipitate is filtered off, washed with EtOH and dried in vacuo (1.15 g, 73 %). 
UV/vis (MeCN): λmax [nm] (ε [M-1cm-1]) = 272 (4643), 315 (sh) (6943), 363 (7308). 
El. analysis (%): calc. for C8H20NFeCl4 x 0.1 FeCl3: C: 27.95    H: 5.85    N: 4.10; 
(Rep. No. 24914) found:     C: 27.95    H: 5.92    N: 3.95. 
 
[H2L1Fe2OCl4](Cl)2 (14). 
molecular formula: 
C38H54N10OFe2Cl4 x 5H2O x 2HCl 
molecular weight: 
1083.40 
 
Ligand L1 (195 mg, 0.30 mmol) and [FeCl4](NEt4) (197 mg, 0.60 mmol) are separately 
dissolved in MeCN (30 and 3 ml, respectively) and the solutions are combined while stirring. 
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The resulting ochre precipitate is filtered off, washed with cold MeCN and dried in vacuo 
(215 mg, 67 %). 
HR-ESI+-MS (MeCN, 1% H2O): m/z (%): 921.19821 (calc. 921.19838) (100) 
[HLFeIII2Cl4O]+; 883.22483 (calc. 883.22439) (69) [LFeIII2Cl3O]+; 741.35780 (calc. 
741.35709) (14,6) [LFeIICl]+.  
UV/vis (MeCN, 1% H2O): λmax [nm] (ε [M-1cm-1]) = 256 (48470), 315 (sh) (23783), 378 
(16450), 480 (sh) (900), 600 (143). 
IR (KBr):  ν̃ [cm-1] = 3439 (b), 2964 (w), 2859 (w), 1608 (s), 1593 (w), 1471 (s), 1449 (s), 
1290 (w), 1158 (w), 1052 (w), 1022(m), 831 (m), 817 (m), 769 (m). 
El. analysis (%): calc. for C38H54N10OFe2Cl4 x 5H2O x 2HCl: 
(Rep. No. 26479) C: 68.23 H: 8.44 N: 20.94 Cl: 19.63 Fe: 10.48; 
                 found: C: 68.69 H: 8.43 N: 21.05 Cl: 18.63 Fe: 10.51. 
 
[L1Zn](OTf)2 (15). 
[L1ZnII](OTf)2 x 1/3 Zn(OH)2 
molecular formula: 
C40H54N10O6S2F6Zn x 1/3 Zn(OH)2 
molecular weight: 
1045.43 
 
Ligand L1 (32.5 mg, 0.05 mmol) and Zn(II) triflate (18.2 mg, 0.05 mmol) are stirred in dry 
MeCN (9 ml) for one hour at rt. Diffusion of diethylether into the solution yields colourless 
crystals of 15 (0.05 g, 96 %).  
HR-ESI+-MS (MeCN): m/z (%): 357.19138 (calc. 357.19122) (87) [LZnII]2+; 863.33451 
(863.33446) (61) [LZnII(OTf)2]+. 
El. analysis (%):     calc. for: C40H54N10O6S2F6Zn x 1/3 Zn(OH)2  C: 45.86 H: 5.26 N: 13.37; 
(Rep. No. 26225)        found:                C: 45.90 H: 5.13 N: 13.00. 
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[L1Cu](OTf)2 (16). 
[L1CuII](OTf)2 x MeCN 
molecular formula: 
C42H57N11O6S2F6Cu 
molecular weight: 
1053.64 
 
Ligand L1 (32.5 mg, 0.05 mmol) and Cu(II) triflate (18.1 mg, 0.05 mmol) are stirred in dry 
MeCN (4 ml) for one hour at rt. Diffusion of diethylether into the solution yields colourless 
crystals of 16 (50,0 mg, 95 %).  
HR-ESI+-MS (MeCN): m/z (%): 356.69148 (calc. 356.69145) (100) [LCuII]2+; 431.67117 
(calc. 431.67137) (98) [HLCuII(OTf)]2+; 862.33687 (calc. 862.33492) (20) [LCuII(OTf)]+. 
UV/vis (MeCN): λmax [nm] (ε [M-1cm-1]) = 639 (45). 
EPR (MeCN/buffer pH 6 1:1): g║ = 2.23; g┴ = 2.05; A║ = 180*10-4 cm-1. 
El. analysis (%): calc. for: C42H57N11O6S2F6Cu C: 47.88    H: 5.45    N: 14.62; 
(Rep. No. 26226) found:     C: 47.29    H: 5.47    N: 14.30. 
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4.3.3. Syntheses of Ligands HL2 and H3L3  
 
2,6-Bis(chloromethyl)-4-methylphenol (24). 
 
molecular formula: 
C9H10Cl2O 
molecular weight: 
205.08 
 
2,6-Bis(hydroxymethyl)-4-methylphenol (16.50 g, 98.00 mmol) is stirred at rt in conc. HCl 
(200 ml) over night. After extraction with DCM (3 x 100 ml), the organic phases are dried 
over Na2SO4 and the solvent is removed in vacuo to give 2,6-bis(chloromethyl)-4-
methylphenol as a yellow solid, which was stored at -20°C (19.49 g, 97 %). 
1H-NMR (400 MHz, CDCl3): δ = 7.09 (s, 2H, CHar), 4.66 (s, 4H, CH2-Cl), 2.28 (s, 3H, CH3). 
13C-NMR (100 MHz, CDCl3): δ = 151.0 (Cq-OH), 131.6 (CHar), 130.5 (Cq-CH3), 124.7 (Cq-
CH2Cl), 42.4 (CH2Cl), 20.3 (CH3). 
 
2-Formyl-6-pivaloylamidopyridine (20). 
 
molecular formula: 
C11H14N2O2 
molecular weight: 
206.24 
 
2-Amino-6-methylpyridine 17 (54.07 g, 0.50 mol) is dissolved in a mixture of DCM (500 ml) 
and triethylamine (65.80 g, 0.65 mol). Pivaloylchloride (66.32 g, 0.55 mol) is added dropwise. 
The reaction is stirred at rt for 2h and quenched by adding water (100 ml). Phases are 
separated, the aq. phase is extracted with DCM (2 x 50 ml). The combined organic phases are 
dried over Na2SO4 and the solvent is removed in vacuo. The crude product is recrystallized 
from diethylether to give 2-methyl-6-pivaloylamidopyridine 18 as white crystals (79.84 g, 
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83 %). In the next step, 18 (9.62 g, 50.00 mmol) is dissolved in CCl4 (130 ml). NBS (2.66 g, 
15.00 mmol) and a catalytic amount of benzoylperoxide are addedand the mixture is refluxed 
(80°C). More portions of NBS (2.66 g, 15.00 mmol each) and benzoylperoxide are added 
after 2, 3, 4, 5, 6, 7 and 8h (i.e 120 mmol NBS, 2.4 eq). After the last addition, the solution is 
refluxed for a further hour and then cooled to rt over night. The next day, a 9th portion of NBS 
and benzoylperoxide is added and refluxed further 7h. After cooling to rt and filtering, the 
solvent is removed in vacuo. The resulting solid is dissolved in MeOH (70 ml) and KOH 
(5.20 g) in H2O (30 ml) is added. The mixture is stirred at rt for 4h. The solvent is removed in 
vacuo and the residue dissolved in hexane (50 ml). The organic phase is washed with 6M 
HCl, then with NaHCO3 solution and with brine, dried over Na2SO4. The solvent is removed 
in vacuo to yield 2-dibromomethyl-6-pivaloylamidopyridine 19 as an orange oil (10.25 g, 
60%). 19 (8.00 g, 22.90 mmol) is dissolved in acetone (70 ml). AgNO3 (11.65 g, 68.60 mmol) 
in H2O (18 ml) is added and the mixture is stirred at rt over night in the dark. After filtration 
the solvent is removed in vacuo. The residue is dissolved in DCM (100 ml). The organic 
phase is washed with water, 0.5N NaHCO3 and brine and dried over Na2SO4. The solvent is 
removed in vacuo to give 2-formyl-6-pivaloyamidopyridine 20 as clear oil (2.41 g, 51 %). 
1H-NMR (300 MHz, CDCl3): δ = 9.86 (s, 1H, CH=O), 8.44 (d, 3JH,H = 8.4 Hz, NHC-CHar), 
8.16 (bs, 1H, NH), 7.82 (t, 3JH,H = 8.4 Hz, 1H, CHar para to N), 7.61 (dd, 3JH,H = 7.5 Hz, 4JH,H 
= 0.9 Hz, 1H, HC(=O)C-CHar), 1.30 (s, 9H, CH3). 
13C-NMR (75 MHz, CDCl3): δ = 192.4 (CH=O), 177.4 (C(=O)NH), 152.2 (N-Cq-NH), 150.9 
(N-Cq-CHO), 139.4 (CHar para to N), 118.6, 118.4 (CHar meta to N), 40.4 (Cq,alkyl), 27.5 
(CH3). 
 
N-(6-Pivaloylamido-2-pyridylmethyl)-N-(2-pyridylmethyl)amine (21). 
molecular formula: 
C17H22N4O 
molecular weight: 
298.38 
 
2-Formyl-6-pivaloyamidopyridine 20 (2.20 g, 10.70 mmol) and picolylamine (1.27 g, 
11.70 mmol) are dissolved in methanol (45 ml) and stirred for 2.5h at rt. The solution is 
 140  Chapter 4: Materials and Methods 
cooled to 0°C and NaBH4 (0.44 g, 11.70 mmol) is added in small portions. The mixture is 
stirred over night. H2O (45 ml) is added and methanol is removed in vacuo. The aqueous 
phase is extracted with ethyl acetate (3 x 70 ml). The organic phase is dried over Na2SO4 and 
the solvent is removed in vacuo to give 21 as a yellow oil (3.52 g, 100 %). 
1H-NMR (300 MHz, CDCl3): δ = 8.54 (d, 3JH,H = 4.8 Hz, 1H, N-CHar), 8.10 (d, 3JH,H = 8.0 Hz, 
1H, CHar), 7.68 – 7.56 (m, 2H, CHar), 7.34 (d, 3JH,H = 7.8 Hz, 1H, CHar), 7.10 – 7.20 (m, 1H, 
CHar), 7.01 (d, 3JH,H = 7.4 Hz, 1H, CHar), 4.00 (s, 2H, CH2), 3.90 (s, 2H, CH2), 3.50 (bs, 1H, 
NHaliph), 1.31 (s, 9H, C(CH3)3). 
13C-NMR (100 MHz, CDCl3): δ = 177.1 (C=O), 158.4, 156.6, 151.2 (Cq,ar), 149.2, 138.8, 
136.6, 122.5, 122.2, 118.0, 112.1 (CHar), 54.2, 53.7 (CH2), 39.7 (C(CH3)3), 27.4 (C(CH3)3). 
FAB+-MS (nibeol): m/z (%): 299.2 (100) [M+H]+. 
 
N-(6-Amino-2-pyridylmethyl)-N-(2-pyridylmethyl)amine (22). 
 
molecular formula: 
C12H14N4 
molecular weight: 
214.27 
 
N-(6-Pivaloylamido-2-pyridylmethyl)-N-(2-pyridylmethyl)amine 21 (1.80 g, 6.00 mmol) is 
refluxed in 2M HCl (75 ml) for 48h. After cooling to rt, 1M NaOH solution is added until the 
pH reached 14. After extraction with DCM (3 x 200 ml), the organic phase is dried over 
Na2SO4 and the solvent is removed in vacuo to give 22 as a yellow oil (1.29 g, 100 %). 
1H-NMR (400 MHz, MeOH-d4): δ = 8.55 (d, 3JH,H = 4.8 Hz, 1H, N-CHar), 7.82 (dt, 3JH,H = 
7.8 Hz, 4JH,H = 1.6 Hz, 1H, CHar), 7.50 – 7.30 (m, 3H, CHar), 6.61 (d, 3JH,H = 7.2 Hz, 1H, 
CHar), 6.49 (d, 3JH,H = 8.2 Hz, 1H, arom. H), 4.12 (s, 2H, CH2), 3.91 (s, 2H, CH2). 
13C-NMR (100 MHz, CDCl3): δ = 161.0, 157.0, 154.3 (Cq,ar), 150.2, 139.8, 138.7, 124.3, 
124.2, 112.4, 109.2 (CHar), 53.4 (2x) (CH2). 
FAB+-MS (nibeol): m/z (%): 215.2 (100) [M+H]+. 
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2,6-Bis[[[(6-pivaloylamido-2-pyridinyl)methyl](2-pyridinylmethyl)amino]methyl]-4-
methylphenol (H3L3). 
molecular formula: 
C43H52N8O3 
molecular weight: 
728.92 
2,6-Bis(chloromethyl)-p-cresol 24 (1.03 g, 5.00 mmol) is dissolved in DCM (8 ml) and 
cooled to 0°C. N-(6-Pivaloylamido-2-pyridylmethyl)-N-(2-pyridylmethyl)amine 21 (2.98 g, 
10.00 mmol) and triethylamine (1.01 g, 10.00 mmol) are dissolved in THF (9 ml) and added 
dropwise. The solution is stirred at rt for 2d. It is filtered and the solvents are removed in 
vacuo. The residue is dissolved in DCM (75 ml), washed with brine, dried over Na2SO4 and 
the solvent is removed in vacuo to give H3L3 as a pale-brown foam (3.64 g, 100 %). 
1H-NMR (500 MHz, CDCl3): δ = 8.48 (d, 3JH,H = 4.1 Hz, 2H, CHpy-N), 8.25 (bs, 2H, NH), 
8.08 (d, 3JH,H = 9.0 Hz, 2H, HNCq-CHpy), 7.61 (t, 3JH,H = 7.8 Hz, 2H, para to N), 7.56 (dt, 3JH,H 
= 7.6 Hz, 4JH,H = 1.8 Hz, 2H, CHpy para to N), 7.48 (d, 3JH,H = 7.8 Hz, 2H, CHpy), 7.14 – 7.06 
(m, 4H, CHpy), 7.05 (s, 2H, CHphenol), 3.86 (s, 4H, CH2), 3.80 (s, 4H, CH2), 3.77 (s, 4H, CH2), 
2.26 (s, 3H, phenol-CH3), 1.31 (s, 18H, C(CH3)3). 
13C-NMR (125 MHz, CDCl3): δ = 177.2 (NH-C=O); 155.5 (Cq,py), 153.1 (Cq,py), 151.1 (Cq-
OH), 148.8 (CHpy-N), 148.7 (Cq-NH), 138.9, 136.7 (CHpy), 136.6 (Cq-CH3), 130.0 (CHphenol), 
127.8 (Cq-CH2), 123.0, 122.0, 117.9, 111.8 (CHpy), 59.8, 58.7 (N-CH2-py), 54.8 (N-CH2-
phenol), 39.8 (C(CH3)3), 28.0 (C(CH3)3), 20.6 (CH3). 
FAB+-MS (nibeol): m/z (%): 729.4 (100) [M+H]+. 
IR (KBr):  ν̃ [cm-1] = 3559 (b), 3396 (w) 3065 (w), 2964 (m), 2929 (m), 2870 (m), 2821 (m), 
1690 (s), 1596 (s), 1578 (s), 1523 (s), 1478 (s), 1455 (s), 1403 (m), 1367 (m), 1304 (s), 1224 
(m), 1152 (m), 1125 (w), 1082 (w), 996 (m), 861 (w), 799 (m), 760 (m), 623 (w), 577 (w). 
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El. analysis (%): calc. for C43H52N8O3 x 0.33 DCM: C: 68.73    H: 7.01    N: 14.80; 
(Rep. No. 27951) found:     C: 68.69    H: 7.07    N: 14.56. 
 
2,6-Bis[[[(6-amino-2-pyridinyl)methyl](2-pyridinylmethyl)amino]methyl]-4-methyl-
phenol (HL2). 
molecular formula: 
C33H36N8O 
molecular weight: 
560.69 
 
2,6-Bis(chloromethyl)-p-cresol 24 (0.62 g, 3.00 mmol) is dissolved in DCM (5 ml) and 
cooled to 0°C. N-(6-Amino-2-pyridylmethyl)-N-(2-pyridylmethyl)amine 22 (1.29 g, 
6.00 mmol) and tri-ethylamine (0.61 g, 6.00 mmol) are dissolved in THF (6 ml) and added 
dropwise. The solution is stirred at rt for 2d. It is filtered and the solvents are removed in 
vacuo. The residue is dissolved in DCM (50 ml), washed with brine, dried over Na2SO4 and 
the solvent is removed in vacuo to give HL2 as a pale-brown foam (1.62 g, 96 %). 
1H-NMR (500 MHz, CDCl3): δ = 8.47 (d, 3JH,H = 4.4 Hz, 2H, CHpy-N), 7.56 (t, 3JH,H = 8.2 Hz, 
2H, CHpy para to N), 7.35 (t, 3JH,H = 7.8 Hz, 2H, CHpy para to N), 7.08 (m, 4H, CHpy), 6.97 (s, 
2H, CHphenol), 6.78 (d, 2H, 3JH,H = 7.2 Hz, NH2Cq-CHpy), 6.34 (d, 2H, 3JH,H = 8.0 Hz, CHpy), 
4.50 (bs, 4H, NH2), 3.84 (s, 4H, CH2), 3.74 (s, 4H, CH2), 3.69 (s, 4H, CH2), 2.22 (s, 3H, 
CH3). 
13C-NMR (125 MHz, CDCl3): δ = 159.2 (Cq-NH2), 157.9, 153.5 (Cq,py), 149.1 (Cq-OH), 148.6 
(CHpy-N), 138.5, 136.5, 130.1 (CHphenol), 127.2 (Cq-CH3), 123.0 (CHpy), 122.4 (Cq-CH2), 
121.9, 112.5, 107.2 (CHpy), 59.7, 58.9 (N-CH2-py), 55.0 (N-CH2-phenol), 20.6 (CH3). 
FAB+-MS (nibeol): m/z (%): 561.3 (100) [M+H]+. 
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IR (KBr):  ν̃ [cm-1] = 3454 (b), 3380 (b), 3342 (b), 3187 (w), 2915 (w), 2814 (w), 1615 (s), 
1594 (s), 1571 (s), 1465 (s), 1434 (s), 1361 (m), 1298 (m), 1229 (m), 1159 (w), 1119 (w), 
1092 (w), 1045 (w), 996 (m), 864 (w), 790 (m), 760 (m). 
El. analysis (%): calc. for C33H36N8O x 0.33 DCM: C: 67.97    H: 6.27    N: 19.02; 
(Rep. No. 24914) found:     C: 68.11    H: 6.28    N: 17.51. 
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4.3.4. Syntheses of Diferric Complexes of HL2 and H3L3  
 
[H2L2Fe2(OH)3](ClO4)3(OH) (25). 
molecular formula: 
C33H40N8Cl3Fe2O16 x MeOH x OH- 
molecular weight: 
1071.81 
 
Ligand HL2 (200 mg, 0.35 mmol) is dissolved in 50 ml MeOH and heated to 50°C. Ferric 
perchlorate hydrate (250 mg, 0.70 mmol) is added in 5 ml MeOH while stirring. The solution 
immediately turns dark blue and is heated at 50°C for 1h. The solvent is removed in vacuo 
and the residue is taken up in a small volume of MeCN. The complex is precipitated by 
diffusion of diethylether into the solution. The product is filtered off and dried in vacuo to 
yield 25 as a very dark blue powder (0.29 g, 77 %). 
HR-ESI+-MS (MeOH): not detectable.  
UV/vis (MeCN): λmax [nm] (ε [M-1cm-1]) = 232 (28065), 256 (sh) (19297), 302 (16044), 365 
(sh) (4374), 593 (1893). 
IR (KBr):  ν̃ [cm-1] = 3370 (b), 3201 (b), 3094 (w), 2940 (w), 2865 (w), 2022 (w), 1661 (s), 
1634 (s), 1572 (m), 1480 (m), 1445 (m), 1298 (w), 1265 (w), 1144 (s), 1111 (s), 1088 (s), 
1025 (w), 1008 (w), 855 (w), 802 (m), 763 (m), 636 (m), 627 (m). 
El. analysis (%): calc. for C33H36N8Cl4Fe2O18 x Et2O: 
(Rep. No. 28451) C: 38.30 H: 4.00 N: 9.66; 
                 found: C: 38.47 H: 4.25 N: 9.97. 
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[H2L2Fe2(C4H4O6)(OH)2](ClO4) (26). 
molecular formula: 
C41H43N8O17Fe2Cl x 2 H2O 
molecular weight: 
1103.00 
 
Ligand HL2 (200 mg, 0.35 mmol) is dissolved in 35 ml MeOH and heated to 50°C. Ferric 
perchlorate hydrate (250 mg, 0.70 mmol) in 5 ml MeOH and sodium tartrate (140 mg, 
0.70 mmol) in 15 ml MeOH are added while stirring. The solution immediately turns dark 
blue and is heated at 50°C for 1h. The complex is precipitated by diffusion of diethylether 
into the solution. The product is filtered off and dried in vacuo to yield 26 as a very dark blue 
powder (0.21 g, 54 %). 
HR-ESI+-MS (MeCN): m/z (%): 817.14752 (calc. 817.14840) (53.5) [LFeIII2(C4H2O6)]+.  
UV/vis (MeCN): λmax [nm] (ε [M-1cm-1]) = 232 (27710), 299 (13241), 374 (sh) (3278), 522 
(1239). 
IR (KBr):  ν̃ [cm-1] = 3419 (b), 3217 (b), 3071 (w), 2925 (w), 2858 (w), 2022 (w), 1730 (w), 
1636 (s), 1609 (s), 1580 (m), 1480 (m), 1441 (m), 1262 (w), 1340 (w), 1311 (w), 1286 (w), 
1142 (m), 1121(s), 1109 (s), 1089 (s), 1018 (w), 803 (w), 765 (w), 636 (m), 626 (m). 
El. analysis (%): calc. for C41H43N8O17Fe2Cl x 2 H2O: 
(Rep. No. 28412) C: 44.65 H: 4.29 N: 10.16; 
                 found: C: 44.64 H: 4.33 N: 10.07. 
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[L3Fe2](ClO4)3 (27). 
molecular formula: 
C43H53N8O17Fe2Cl3 x MeOH x 3 H2O 
molecular weight: 
1257.05 
 
Ligand H3L3 (110 mg, 0.15 mmol) is dissolved in 10 ml MeOH and heated to 50°C. Ferric 
perchlorate hydrate (100 mg, 0.30 mmol) is added in 2 ml MeOH while stirring. The solution 
immediately turns dark green and is heated at 50°C for 1h. The complex is precipitated by 
diffusion of diethylether into the solution. The product is filtered off and dried in vacuo to 
yield 27 as a very dark green powder (0.13 g, 69 %). 
HR-ESI+-MS (MeOH): m/z (%): 882.29171 (calc. 882.29187) (100) [H2LFeIII(ClO4)]+; 
896.32903 (calc. 896.32843) (49) [NaH2LFeIII(HCO2)2]+; 934.22315 (calc. 934.22220) (38) 
[LFeIII2SO4]+.  
UV/vis (MeCN): λmax [nm] (ε [M-1cm-1]) = 228 (sh) (32473), 258 (sh) (20290), 284 (17562), 
361 (sh) (4134), 687 (1166). 
IR (KBr):  ν̃ [cm-1] = 3430 (b), 3085 (w), 2975 (w), 2936 (w), 2875 (w), 2016 (w), 1679 (w), 
1624 (s), 1608 (s), 1573 (w), 1528 (m), 1463 (m), 1431 (m), 1371 (w), 1263 (w), 1143 (s); 
1111 (s), 1089 (s), 1023 (m), 922 (w), 809 (w), 767 (w), 636 (m), 626 (m). 
El. analysis (%): calc. for C43H53N8O17Fe2Cl3 x MeOH x 3 H2O: 
(Rep. No. 28453) C: 42.04 H: 4.97 N: 8.91; 
                 found: C: 41.78 H: 4.86 N: 8.71. 
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[H2L3Fe2(C4H4O6)](ClO4)3 (28). 
molecular formula: 
C47H55N8O21Fe2Cl3 x 4 H2O 
molecular weight: 
1357.08 
 
Ligand H3L3 (110 mg, 0.15 mmol) is dissolved in 15 ml MeOH and heated to 50°C. Ferric 
perchlorate hydrate (100 mg, 0.30 mmol) in 2 ml MeOH and sodium tartrate (60 mg, 
0.3 mmol) in 10 ml MeOH are added while stirring. The solution immediately turns dark blue 
and is heated at 50°C for 1h and the solvent is removed in vacuo. The residue is taken up in a 
small volume of MeCN and the complex is precipitated by diffusion of diethylether into the 
solution. The product is filtered off and dried in vacuo to yield 28 as a very dark blue powder 
(0.09 g, 44 %). 
HR-ESI+-MS (MeOH): m/z (%): 985.26368 (calc. 985.26343) (100) [LFeIII2(C4H4O6)]+. 
UV/vis (MeCN): λmax [nm] (ε [M-1cm-1]) = 234 (sh) (32329), 286 (18963), 354 (sh) (5646), 
515 (1537). 
IR (KBr):  ν̃ [cm-1] = 3432 (b), 3075 (w), 2971 (w), 2933 (w), 2869 (w), 2033 (w), 1608 (s), 
1578 (m), 1530 (m), 1461 (s) 1436 (m), 1409 (w), 1370 /w), 1251 (w), 1304 (m), 1271 (w), 
1147 (s), 1117 (s), 1086 (s), 1022 (w), 943 (w), 804 (m), 767 (m), 637 (m), 626 (m). 
El. analysis (%): calc. for C47H55N8O21Fe2Cl3 x 4 H2O: 
(Rep. No. 28452) C: 41.60 H: 4.60 N: 8.26; 
                 found: C: 41.37 H: 4.58 N: 8.21. 
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4.3.5. Syntheses of Phosphoester Substrates 
 
Bis-(2,4-dinitrophenyl)phosphate (BDNPP) pyridinium salt (29). 
molecular formula: 
C17H12N5O12P 
molecular weight: 
509.28 
 
2,6-Dinitrophenol (2.76 g, 15.00 mmol) is dissolved in dry acetonitrile (30 ml). Dry pyridine 
(2.5 ml) is added and the solution is cooled to 0°C. Freshly distilled POCl3 (0.5 ml) is added 
and the reaction is stirred for 15 min. It is poured onto ice/water (200 ml) and the turbid 
mixture is cooled to 0°C over night. The resulting precipitate is filtered off, washed with a 
small amount of cold water and dried in vacuo. The crude product is recrystallized twice from 
acetone/Et2O (1:1) to give BDNPP pyridinium salt 29 as a yellowish powder (0.68 g, 24 %). 
1H-NMR (400 MHz, acetone-d6): δ = 9.03 (dd, 3JH,H = 6.8 Hz, 4JH,H = 1.6 Hz, 2H, N-CHpy), 
8.78 (tt, 3JH,H = 7.6 Hz, 4JH,H = 1.2 Hz, 1H, CHpy para to N), 8.71 (d, 3JH,H = 2.8 Hz, 2H, 
NO2C-CHar-CNO2), 8.50 (dd, 3JH,H = 9.2 Hz, 4JH,H = 2.8 Hz, 2H, CHpy meta to N), 8.25 (dd, 
3JH,H = 7.2 Hz, 4JH,H = 6.8 Hz, 2H, CHar-CNO2), 8.12 (d, 3JH,H = 9.2 Hz, 2H, POC-CHar). 
31P-NMR (162 MHz, acetone-d6): δ = -14.16 
El. analysis (%): calc. for C17H12N5O12P: C: 40.09 H: 2.37 N: 13.75; 
(Rep. No. 27589) found:    C: 40.19 H: 2.46 N: 13.66. 
 
2,4-Dinitrophenylphosphate (DNPP) lutidinium salt (30). 
 
molecular formula: 
C13H14N3O8P 
molecular weight: 
371.24 
  Chapter 4: Materials and Methods 149
BDNPP pyridinium salt 29 (1.28 g, 2.50 mmol) in MeOH (100 ml) is passed through a 
DOWEX 50 WX2 ion exchange column (Na+ form) and the pyridinium ion exchanged for 
Na+. The solvent is removed in vacuo (T < 30°C) and the resulting Na+-BDNPP is stirred in 
0.3M NaOH solution (50 ml) at 25°C for 1h. 5M HCl (ca. 15 ml) is added at 0°C until the pH 
reaches 0 and the resulting precipitate of 2,4-dinitrophenol is removed by filtration. The 
solvent is removed in vacuo (T < 40°C). The residue is taken up in Et2O, undissolved NaCl is 
filtered off and 2,6-lutidine is added dropwise while stirring until the solution becomes 
slightly yellow. The white precipitate is filtered off and recrystallized in hot EtOH to give the 
DNPP lutidinium salt 30 as white crystals (0.46 g, 50 %). 
1H-NMR (400 MHz, acetone-d6): δ = 8.67 (d, 3JH,H = 2.0 Hz, 1H, NO2C-CHar-CNO2), 8.46 
(dd, 3JH,H = 6.0 Hz, 4JH,H = 1.8 Hz, 1H, CHar-CNO2), 8.08 (d, 3JH,H = 6.0 Hz, 1H, CHlut para to 
N), 8.04 (m, 1H, POC-CHar), 7.46 (d, 3JH,H = 5.2 Hz, 2H, CHlut meta to N), 2.66 (s, 6H, CH3). 
31P-NMR (100 MHz, acetone-d6): δ = -5.69 
El. analysis (%): calc. for C13H14N3O8P: C: 42.06 H: 3.80 N: 11.32; 
(Rep. No. 24914) found:    C: 41.90 H: 3.79 N: 11.25.
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4.4.   General Procedures 
 
General Procedure 1: Preparation of Complex Solutions 
For L1, H3L3 and HBPMP, 2 mM ligand solution in MeCN or MeOH was mixed with 4 mM 
tetraethylammonium tetrachloroferrate solution in MeCN or MeOH The resulting complex 
solutions were 1 mM in MeCN or MeOH. In the case of HL2, the solubility of the ligand in 
MeCN is low. Therefore, 0.8 mM ligand solution was prepared and mixed with 1.6 mM 
tetraethylammonium tetrachloroferrate solution to give 0.4 mM solution of K2.  
 
General Procedure 2: Phosphoester Hydrolysis Experiments with BDNPP[87-90] 
Phosphatase activity for the activated diester substrate BDNPP was determined in 
acetonitrile/buffer (1:1) at 25°C between pH 4.6 and 10. The product formation (2,4-
dinitrophenolate) was observed spectrophotometrically at 400 nm. To obtain the starting 
activity, the time between 30 and 240 sec was analyzed by linear regression. A 
multicomponent buffer was used containing MES; HEPES and CHES (all 50 mM) and 
LiClO4 (250 mM) in MilliQ water. The desired pH was adjusted with aq. NaOH. The 
complex and substrate solutions were prepared separately in MeCN and their final 
concentrations in the cuvette were 0.04 mM and 5 mM, respectively. This was varied for 
complex-and substrate-dependency measurements. The resulting pH profiles were fitted in 
Origin 8.1G using the following equation for a diprotic system with two active species:[157] 
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The substrate-dependency data were fitted using the Michaelis-Menten equation: 
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General Procedure 3: Phosphoester Hydrolysis Experiments with DNPP 
 
Phosphatase activity for the activated monoester substrate DNPP was determined in a similar 
way as the BDNPP assays, with the following alterations: DNPP was dissolved in buffer of 
the desired pH. The final concentration in the cuvette was 0.5 mM. Autohydrolysis rates were 
determined prior to as well as directly after the two catalytic measurements for each pH. 
Spectral changes that affected the rates due to ligand exchange at the complex were also 
recorded and subtracted at the end.  
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4.5.   Details on DFT and Force Field Calculations 
 
DFT geometry optimizations were performed with Gaussian 03, rev. E.01[161] (K1) or 
Gaussian 09, rev. A.02[162] (K2 and K3) with the B3LYP[163, 164] functional, the TZVP[165, 166] 
basis set on Fe and P, and the SVP[165, 166] basis set on C, H, N and O. The optimized 
structures were confirmed by frequency calculations as minima on the PES and reported 
energies are zero-point corrected.  
J values, g values and zero-field splitting tensors[167] of the geometry-optimized K1, K2 
and K3 complexes were estimated in Orca 2.6, rev. 04 with the same functional and basis set 
as before, except using TZVP[165, 166] on O instead of SVP, [165, 166] J values were calculated 
using the broken symmetry method implemented in Orca.[141]  
The potential surface scans on K1DNPP as well as the equilibrium calculations on 
K1BDNPP and K1DNPP were performed in Gaussian 09, rev. A.02[162] with the B3LYP[163, 
164] functional and the lanl2dz[168] basis set and the PCM solvation model[169] with acetonitrile 
as solvent. The minimum structures of the latter were confirmed by frequency calculations 
and reported energies are zero-point corrected. 
Conformational searches on L1, HL2 and H3L3 were done in the program package 
Maestro 8.5.111 with the application Macromodel 9.6.[127] Torsional sampling (monte carlo 
multiple minimum) with 1000 steps is used to produce between 50 and 200 different 
structures, which are subsequently geometry-optimized in up to 50000 iterations (MM3* 
force field,[170] steepest descent method, gradient convergence threshold = 0.01). 
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Appendix 1: Abbreviations 
 
1-NP  1-naphthyl phosphate 
BDNPP bis-(2,4-dinitrophenyl)phosphate 
B.M.  Bohr magnetons 
(BzO)2  dibenzoyl peroxide 
CD  circular dichroism 
CHES  2-(N-cyclohexylamino)ethanesulfonic acid 
CT  charge transfer 
CV  cyclovoltammetry 
CW  continuous wave 
D  zero field splitting 
Δ  reflux temperature 
DCM  dichloromethane 
DFT  density functional theory 
dipa  di-(2-pyridyl)methylamine 
DMF  N,N´-dimethylformamide 
DMP  dimethyl phosphate 
DNPP  (2,4-dinitrophenyl)phosphate 
DPP  diphenyl phosphate 
E  rhombicity parameter of zero field splitting 
eq  equivalents 
eq.  equation 
ESI  electron spray ionisation 
EPR  electron paramagnetic resonance 
Et2O  diethylether 
EtOH  ethanol 
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FAB  fast atom bombardment 
FeCp2  ferrocene 
h  hour 
HBPMP 2,6-bis[(bis-pyridin-2-ylmethyl-amino]-methyl]-4-methylphenol 
HEPES 4-(2-hydroxyethyl)-1-piperazinylethanesulfonic acid 
HL2  2,6-bis[[[(6-amino-2-pyridinyl)methyl](2-pyridinylmethyl)amino]methyl]-4-
methylphenol 
H3L3 2,6-bis[[[(6-pivaloylamido-2-pyridinyl)methyl](2-pyridinylmethyl)amino]-
methyl]-4-methylphenol 
HR  high resolution 
HSAB  hard and soft acids and bases 
IR  infra red 
K1  diferric complex of L1, formed in situ 
K2  diferric complex of HL2 
K3  diferric complex of H3L3 
L1  4,11-dimethyl-1,8-bis[N-(2-di-(2-pyridyl)methyl)ethylamino]cyclam 
LMCT  ligand metal charge transfer 
M  molar, [mol/L] 
MCD  magnetic circular dichroism 
MeCN  acetonitrile 
MeOH  methanol 
MES  2-(N-morpholino)ethanesulfonic acid 
min  minutes 
MS  mass spectrometry 
mV  millivolt 
NBS  N-bromosuccinimide 
NHE  normal hydrogen electrode 
nibeol  4-nitrobenzylalcohol 
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NMR  nuclear magnetic resonance 
PAP  purple acid phosphatase 
PCM  point charge model 
pNPP  para-nitrophenyl phosphate 
ppm  parts per million 
py  pyridine 
ROS  reactive oxygen species 
rt  room temperature 
SCE  saturated calomel electrode 
Ts  tosyl 
UV/vis ultraviolet/visible 
VT  variable temperature 
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Appendix 2: EPR spectra of [FeCl4](NEt4), K1 in MeCN and MeCN/buffer. 
X-band EPR spectra (1.7 K) of [FeCl4](NEt4) 0.2 mM in MeCN (black line) at 9.376422 GHz, 
K1 0.1 mM in MeCN (blue line) at 9.376783 GHz and K1 0.1 mM in MeCN/buffer pH 5 1:1 
(orange line) at 9.377746 GHz. 
 
 
Appendix 3: EPR spectra of K1 and reduced K1 in MeCN. 
X-band EPR spectra (140 K) of K1 0.5 mM in MeCN (black line) at 9.432774 GHz and K1 
after bulk electrolysis (1h at -0.3 V) 0.5 mM in MeCN (blue line) at 9.431626 GHz.  
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Appendix 4: UV/vis spectrum of K1 with acetamide. 
Time dependent UV/vis spectrum of K1 (0.05 mM) with acetamide (1 mM) in MeCN/buffer 
pH 5; spectra were recorded over 30 min with one scan each minute. 
 
 
Appendix 5: Schematic energy diagrams of exchange coupled systems. 
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Appendix 6: Gaussian analysis of UV/vis spectra of K2 and K3. 
 
 K2: 
 
0.2 eq FeIII 0.4 eq FeIII 
0.6 eq FeIII 0.8 eq FeIII 
1.0 eq FeIII 1.2 eq FeIII 
1.4 eq FeIII 1.6 eq FeIII 
1.8 eq FeIII 2.0 eq FeIII 
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 K3:  
 
0.2 eq FeIII 0.4 eq FeIII 
0.6 eq FeIII 0.8 eq FeIII 
1.0 eq FeIII 1.2 eq FeIII 
1.4 eq FeIII 1.6 eq FeIII 
1.8 eq FeIII 2.0 eq FeIII 
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Appendix 7: Calculated structures of K2, K2 tartrate, K3 and K3 tartrate. 
 
 
 K2 cisoid K2 transoid 
 
         
 
 
 K2 cisoid with prot. amines K2 transoid with prot. amines 
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 K3 cisoid K3 transoid 
 
             
 
 
 K2tartrate cisoid K2tartrate transoid 
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 K2tartrate cisoid with prot. amines K2tartrate transoid with prot. amines 
 
   
 
 
 K3tartrate cisoid K3tartrate transoid 
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Appendix 8: EPR spectrum of the radical generated by K3pNPP. 
        
Experimental (black) and simulated (blue) X-band EPR spectrum of the radial generated by 
K3pNPP in MeCN/buffer pH 5 (0.5 mM K3, 10 mM pNPP) measured at 9.788782 GHz, 
298 K and 1.0 Gauss modulation amplitude. The simulated coupling constants are (in mT): 
0.045 (8 x, CH2 1), 0.72 (2 x, N 2), 0.72 (4 x, CH2 3), 0.24 (2 x, CH 4), -0.24 (3 x, CH3 5). 
 
 
Appendix 9: Autohydrolysis rates of DNPP. 
 
 concentration dependency at pH 6 pH dependency at c0 = 0.5 mM 
c0(DNPP) 
[mM] 
V0 
[10-8 M/s] 
ΔV0 
[10-8 M/s] 
 pH V0 
[10-8 M/s] 
ΔV0 
[10-8 M/s] 
0,10 0,60 0,02  4,64 0,31 0,07 
0,30 1,07 0,04  5,04 0,77 0,02 
0,50 1,91 0,01  5,50 1,16 0,11 
0,70 2,17 0,01  5,62 1,49 0,03 
0,90 2,92 0,08  5,74 1,57 0,07 
1,50 4,64 0,28  6,00 1,85 0,14 
2,00 5,86 0,04  6,19 1,99 0,12 
2,50 7,55 0,15  6,50 1,98 0,18 
3,00 8,72 0,15  7,00 2,13 0,04 
    8,02 2,46 0,11 
    9,00 2,34 0,04 
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Appendix 10: Calculated structures of K1DNPP and K1BDNPP. 
 
 
 K1DNPP monodentate, front view K1DNPP monondentate, side view 
 
      
 
 
 K1DNPP monodentate deprotonated, front view K1DNPP monodentate deprotonated, side view 
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 K1DNPP bidentate, front view K1DNPP bidentate, side view 
 
           
 
 
 K1DNPP bidentate deprotonated, front view K1DNPP bidentate deprotonated, side view 
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 K1BDNPP monodentate, front view K1BDNPP monodentate, side view 
 
         
 
 
 K1BDNPP monodentate rotated, front view K1BDNPP monodentate rotated, side view 
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 K1BDNPP bidentate, front view K1BDNPP bidentate, side view 
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Appendix 11: Crystal Structure Data 
 
Data for L1 x 2 H2O: 
 
Identification code  mz5abs 
Empirical formula  C38 H58 N10 O2 
Formula weight  686.94 
Temperature  200(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P -1 
Unit cell dimensions a = 8.4924(17) Å α = 102.85(3) ° 
 b = 10.681(2) Å β = 93.32(3) ° 
 c = 11.126(2) Å γ = 108.57(3) ° 
Volume 923.6(3) Å3 
Z 1 
Absorption coefficient 0.079 mm-1 
F000 372 
Crystal size 0.235 · 0.228 · 0.100 mm3 
θ range for data collection 1.90 to 22.47 ° 
Index ranges -9 <= h <= 9, -11 <= k <= 11, -11 <= l <= 11 
Reflections collected 2274 
Independent reflections 1033  [Rint = 0.1036] 
Completeness to θ = 25.68 ° 94.5 %  
Absorption correction Numerical 
Max. and min. transmission 0.9918 and 0.9812 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2274 / 0 / 238 
Goodness-of-fit on F2 0.829 
Final R indices [I > 2σ(I)]  R1 = 0.1323, wR2 = 0.1704 
R indices (all data) R1 = 0.0663, wR2 = 0.1502 
RMS residual density, largest diff.  
peak and hole 0.088, 0.340 and -0.265 e·Å-3 
 
Data for [H2L1](ClO4)2 x 2 MeCN: 
 
Identification code  mz2m 
Empirical formula  C42 H62 N12 Cl2 O8 
Formula weight  933.94 
Temperature  200(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P 21/c 
Unit cell dimensions a = 14.210(3) Å α = 90.00 ° 
 b = 8.8923(18) Å β = 101.59(3) ° 
 c = 18.919(4) Å γ = 90.00 ° 
Volume 2341.9(8) Å3 
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Z 2 
Absorption coefficient 0.203 mm-1 
F000 992 
Crystal size 0.37 · 0.26 · 0.14 mm3 
θ range for data collection 2.20 to 26.12 ° 
Index ranges -17 <= h <= 17, -10 <= k <= 10, -23 <= l <= 22 
Reflections collected 4614 
Independent reflections 2324  [Rint = 0.0579] 
Completeness to θ = 25.68 ° 99.2 %  
Absorption correction none 
Max. and min. transmission n.a. 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4614 / 21 / 334 
Goodness-of-fit on F2 0.688 
Final R indices [I > 2σ(I)]  R1 = 0.0967, wR2 = 0.1346 
R indices (all data) R1 = 0.0478, wR2 = 0.1180 
RMS residual density, largest diff.  
peak and hole 0.046, 0.450 and -0.445 e·Å-3 
 
Data for [L1Zn](OTf)2: 
 
Identification code  mz9a 
Empirical formula  C40 H54 F6 N10 Zn O6 S2 
Formula weight  1014.42 
Temperature  200(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P 21/c 
Unit cell dimensions a = 13.873(3) Å α = 90.00 ° 
 b = 17.163(3) Å β = 104.08(3) ° 
 c = 19.895(4) Å γ = 90.00 ° 
Volume 4594.8(16) Å3 
Z 4 
Absorption coefficient 0.707 mm-1 
F000 2112 
Crystal size 0.674 · 0.285 · 0.256 mm3 
θ range for data collection 2.28 to 28.22 ° 
Index ranges -18 <= h <= 18, -22 <= k <= 22, -26 <= l <= 24 
Reflections collected 10518 
Independent reflections 5522  [Rint = 0.0708] 
Completeness to θ = 25.68 ° 92.8 %  
Absorption correction Numerical 
Max. and min. transmission 0.8577 and 0.7596 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 10518 / 0 / 594 
Goodness-of-fit on F2 0.970 
Final R indices [I > 2σ(I)]  R1 = 0.1352, wR2 = 0.0798 
R indices (all data) R1 = 0.2400, wR2 = 0.2126 
RMS residual density, largest diff.  
peak and hole 0.107, 3.082 and -1.972 e·Å-3 
 
 180  Appendices 
Data for [L1Cu](OTf)2: 
 
Identification code  mz10a 
Empirical formula  C42 H57 F6 N11 Cu O6 S2 
Formula weight  1053.65 
Temperature  200(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P 21/c 
Unit cell dimensions a = 11.157(2) Å α = 90.00 ° 
 b = 30.396(6) Å β = 92.15(3) ° 
 c = 14.021(3) Å γ = 90.00 ° 
Volume 4751.4(16) Å3 
Z 4 
Absorption coefficient 0.630 mm-1 
F000 2196 
Crystal size 0.501 · 0.355 · 0.219 mm3 
θ range for data collection 1.95 to 26.15 ° 
Index ranges -13 <= h <= 13, -37 <= k <= 37, -17 <= l <= 17 
Reflections collected 9345 
Independent reflections 4651  [Rint = 0.0975] 
Completeness to θ = 25.68 ° 98.3 %  
Absorption correction Numerical 
Max. and min. transmission 0.8981 and 0.8033 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 9345 / 0 / 622 
Goodness-of-fit on F2 0.970 
Final R indices [I > 2σ(I)]  R1 = 0.1015, wR2 = 0.0979 
R indices (all data) R1 = 0.0470, wR2 = 0.0885 
RMS residual density, largest diff.  
peak and hole 0.066, 0.526 and -0.303 e·Å-3 
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